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Abstract 
It is uncommon for cardio-respiratory fitness and skeletal muscle metabolic function to be 
assessed independently within an exercise test. Exercise capacity may require adaptation 
of one or other of these systems to a greater or lesser extent and the presence of disease 
may affect them to different extents. The physiological mechanisms underpinning the 
decline in exercise tolerance with age/disease and the benefits of exercise-training as a 
preventative therapy for some diseases are not fully understood.   
In this thesis functional capacity was assessed in terms of oxidative capacity. Near-
Infrared Spectroscopy (NIRS) measures microvascular changes in oxygenated and 
deoxygenated haemoglobin and can be used to estimate oxidative capacity in skeletal 
muscle when combined with arterial occlusions. Oxidative capacity of skeletal muscle was 
determined as part of 3 studies; (1) in a group of older adults (>65 years old) with or 
without type 2 diabetes (T2D), (2) in a tri-ethnic group of older adults from the same cohort 
with the objective of determining ethnic difference in oxidative capacity independently of 
T2D and (3) in a group of young adults before and after a period of endurance training in 
preparation for their first marathon. 
NIRS measurements of muscle oxidative capacity revealed poorer function in older adults 
with diabetes (57.5±6.8 versus 38.7±2.6 s, p=0.02) and poorer oxidative capacity in South 
Asian older adults independently of T2D (difference (95%CI): 10.1 (2.3, 17.9) s, p=0.011). 
In young healthy men and women, skeletal muscle oxygen consumption post-exercise 
increased with endurance training (p<0.01) despite no improvement in cardio-pulmonary 
peakV̇O2 (p=0.81). Faster marathon completion time correlated with cardio-pulmonary 
peakV̇O2 (rpartial=-0.55, p< 0.01) but not oxidative capacity. 
Skeletal muscle oxidative capacity can be measured in old and young adults using NIRS 
combined with arterial occlusion performed immediately following exercise testing. People 
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with T2D have poorer oxidative capacity compared to people without and South Asians 
have poorer oxidative capacity compared to Europeans which African Caribbean’s and 
Europeans had similar skeletal muscle oxidative capacity. Skeletal muscle metabolic 
adaptions occur following 6 months of endurance training. Although the cardio-pulmonary 
system is limiting for running performance, skeletal muscle changes can be detected 
despite no significant improvement in cardio-pulmonary function.  
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Impact statement 
In this thesis Near-infrared Spectroscopy (NIRS) is employed to investigate skeletal 
muscle oxidative capacity in two distinct populations. The knowledge and expertise gained 
here could be put to beneficial use in the future through: (I) application of NIRS to further 
understand oxidative capacity in other populations (for example heart failure patients) (II) 
application of NIRS to understand different aspects of skeletal muscle function (for 
example vascular function) and (III) alignment with technical research departments to gain 
insight for development of novel NIRS devices.  
Exercise capacity and skeletal muscle NIRS measurements were carried out here in a 
longitudinal population-based cohort study of older adults; the scope for this dataset 
reaches far beyond the results presented here. Measurements were conducted as part of 
a clinic day where a whole host of cardiovascular, anthropometric and cognitive 
measurements were also carried out on the same individuals. Therefore, locally, this 
dataset provides a valuable resource for future academic publications. More widespread 
impact could occur with data sharing or sharing of testing methods developed here. 
Changes in haemoglobin/myoglobin at rest, during exercise and in the recovery phase 
from exercise were collected with a high sampling frequency (10Hz) from young and old 
participants with and without disease. These data are available for a greater number of 
participants than measurement of oxidative capacity was carried out in, therefore, this 
provides an immense resource with which development of novel algorithms designed to 
probe various different aspects of skeletal muscle function could be developed. This is 
likely to be of use within the field of cardio-metabolic health but shows potential for 
development in other fields where skeletal muscle is important; for example, sports 
science/medicine or units dedicated to understanding rare skeletal muscle myopathies. 
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Understanding the technology and its limitations is a valuable step towards developing 
more sophisticated NIRS devices. It is important that expertise in physiology is gained 
from this work which can be translated to develop the use of NIRS as a tool for 
investigating skeletal muscle. Furthermore, perhaps, through allowing these data to be 
available to developers (academic and commercial), the channels for discussion regarding 
the true physiological effects being detected in the NIRS signals could be opened. This 
could lead to development of improved understanding, development of improved devices 
and perhaps, devices made specific to task. 
Some of the work presented in this thesis has contributed to the academic literature by 
way of three peer-reviewed publications (see section: ‘Publications associated with this 
thesis’). Impact could further be brought about by disseminating other results presented 
here in scientific journals, for example, the ethnic differences in skeletal muscle oxidative 
capacity which have not previously been described in older adults.    
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Chapter 1: General Introduction  
1.1 Exercise capacity 
1.1.1 Definition of exercise capacity 
Exercise capacity can be defined as the maximal or sub-maximal amount of physical 
exertion that an individual can sustain during a designated exercise test.(1) Exercise 
capacity is a facet of physical function; physical function (or physical capability) describes 
ability to perform the physical tasks of everyday life.(2) Good exercise capacity indicates, 
but is not a requirement for, good physical function. Thus, having good physical function 
does not necessarily imply good exercise capacity. This relationship is depicted in figure 
1.1 which is a simplified model of the factors that influence physical function and exercise 
capacity. Figure 1.1 is not exhaustive; the key components which influence physical 
function; exercise capacity, body composition, and psychological factors are shown in pink 
rectangles and behaviors which influence physical function and exercise capacity are in 
blue ovals. Cardio-respiratory function is given as a determinant of exercise capacity and 
skeletal muscle metabolic capacity as components of Cardio-respiratory function in figure 
1.1; these terms are central to this thesis and will be defined and described in detail in 
subsequent sections (‘Cardio-respiratory function’ and ‘Skeletal muscle oxidative capacity’, 
respectively). 
Exercise training is distinct from physical activity. Physical activity can be defined as a 
behavior involving any bodily movement, produced by skeletal muscles, that requires 
energy expenditure(WHO:http://www.who.int/topics/physical_activity/en/); exercise training 
is purposeful, repeated exercises which have the objective of improving capacity 
(performance) in a given exercise; for example running speed of a specified distance 
(Figure 1.1).(3) Physical function can be assessed through self-report in questionnaires or, 
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objectively, via functional tests such as the timed up-and-go test or standing balance often 
designed for older adults.(2, 4) Quinn et al, have published an extensive clinical review of 
physical function tests for older adults.(4) Exercise tests vary in design; this will be 
described in detail in the following section.  
 
Figure 1.1 A simple conceptual diagram representing the key components that 
influence physical function. Features inside pink rectangles are factors that 
influence physical function, including exercise capacity. Behaviours which 
influence physical function and exercise capacity are inside blue ovals. For 
simplification the arrows highlight the main relationships and the diagram is not 
exhaustive.  
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It is greatly valuable to understand factors which influence physical function in older adults 
because, with ageing, loss of physical function can lead to loss of independent living.(2, 5) 
Loss of independent living in older adults is associated with increased social and economic 
costs.(6) As the older adult population is predicted to increase in numbers in the future, so 
too is the cost of care.  
Exercise capacity declines with age and as a result of many disease processes.(7, 8) 
Evidence overwhelmingly supports the role of exercise-training to prevent early onset of 
some disease processes and attenuate age-related declines in physical function.(5, 9) 
However, the physiological mechanisms underpinning the decline in exercise tolerance 
with age/disease and the benefits of exercise-training as a preventative therapy for some 
diseases are not fully understood. Understanding the factors which contribute to the age-
related decline in exercise capacity is likely to provide insight into therapeutic/preventative 
targets. 
1.1.2 Measuring maximal exercise capacity 
Treadmill and cycle ergometers 
The gold standard exercise test protocol is a maximal incremental (graded) workload test. 
Most common is the continuous exercise testing protocol which involves incrementally 
increasing the workload (intensity) of the exercise via either speed and/or gradient of the 
treadmill or resistance on the pedals of the cycle ergometer until the participant can no 
longer continue (self-reported exhaustion).(3, 10) Discontinuous versions of this test are 
also used where recovery between loads is given, such as the Naughton test which 
intersperses 3-minute bouts of treadmill walking at increasing gradients with 3-minute 
recoveries. Both continuous and discontinuous tests have been show to produce similar 
values for V̇O2max.(11) The obvious advantage of a continuous test is that it can be 
carried out relatively quickly.  
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An incremental exercise test can, theoretically, be conducted using any modality where the 
workload can be measured and adjusted. Modalities commonly used for maximal exercise 
testing are treadmill and stationary cycling (cycle ergometer) based tests. These 
modalities permit well-controlled increments in load to be delivered in a laboratory or clinic 
environmental where conditions such as temperature and humidity can be controlled. A 
further advantage of conducting tests in the laboratory or clinic, is that inclusion of 
continuously monitored gas exchange can be easily carried out. This permits 
measurement of changes in oxygen consumption (V̇O2), the highest achieved oxygen 
consumption (V̇O2max) indicates cardio-respiratory fitness. Assessment of cardio-
respiratory fitness will be discussed in detail in the subsequent section ‘Measuring cardio-
respiratory fitness’.  
Treadmill tests are an effective tool for evaluating maximal exercise capacity in healthy 
participants because walking is a form of exercise which most individuals are generally 
familiar with and able to undertake. Variations in the grade of the treadmill can be applied 
to increase the workload without having to increase the speed greatly; as in the Naughton 
testing protocol.(3, 11) Other example maximal treadmill running protocols include the: 
Astrand, Bruce, Balke, Ellestad and Harbor protocols.(12) Some protocols maintain speed 
and increase gradient; such as the Astrand or Balke protocols, while others combine 
changes in gradient and speed such as the Bruce protocol. Protocols can be smoothed so 
that the steps of increase in workload are small but more frequent, this is called a ramp 
protocol. One disadvantage of treadmill testing is its effect on gait mechanics, especially in 
older participants who are more likely to feel unstable, thus reducing the accuracy of the 
energy expenditure measurement(13)  
The protocols for a maximal cycle ergometer are also graded; workload is typically 
increased via the resistance on pedals with the revolutions per minute kept constant. Tests 
can be performed on an upright or supine ergometer. Most commonly, an upright 
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ergometer is selected, supine testing is useful if, for example, cardiac measurements using 
ultrasound are collected during exercise. An advantage of a cycle exercise test is that it 
does not affect gait mechanics in the way that a treadmill test does and the participant will 
have better stability on the stationary bike. This should improve uptake in older or frailer 
individuals. A large population-based study, carried out in Germany, described 97.4% 
uptake of a submaximal cycle exercise test in its adult participants (18-65 years old).(14) 
In contrast, a Danish study, that specifically enrolled older adults (>60 years old), 
examined 436 men and 366 women and found that, of all the women invited to exercise, 
only 56% were willing to undertake the cycle exercise test.(15)  
If exercise tests are carried with the objective of comparing fitness between individuals 
who are likely to have different fitness levels, the duration of the graded exercise test 
should be considered. If the starting workload is too low and the increments are too small 
the participant will have to spend a long time exercising before maximum is reached. If the 
starting load is too high and the increments too big the duration will be considerably 
shorter. The test duration is important because, with longer duration, factors such as 
fatigue have a stronger influence on the participants’ self-reported termination of the test. 
Therefore, it is necessary for the person conducting the test to select a starting workload 
appropriate for the individual. Selection is typically done based on the weight and sex of 
the participant. 
Field tests 
Field tests are also used to assess exercise capacity; these can include running on a 
designated course or running between points at increasing paces.(10) For example, the 
maximal multi-stage 20-meter shuttle run test (sometime called the beep test) can be used 
to determine maximum running speed achievable over 20 meters to indicate exercise 
capacity.(16) Field tests are useful as they permit exercise to be carried out in a ‘real-
world’ environment and, usually, only basic equipment is necessary, making them cheaper 
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to conduct. The limitations are that physiological changes are less easy to accurately 
measure. Portable devices for monitoring gas exchange, heart rate, ECG changes and 
blood pressure have been developed but they require the participant to carry/wear the 
equipment during the test which could influence the results. Aside from a basic heart rate 
monitor, this equipment is likely to encumber effort. Measuring exercise-induced changes 
in blood pressure is not only important to ensure safety during an exercise test,(17) but 
also, exercise blood-pressure is a useful indicator of cardiovascular health.(18) 
Although exercise testing provides an assessment of exercise capacity it is also commonly 
used clinically to diagnose pathologies such as arrhythmias or coronary disease. In this 
later context, the exercise test is referred to as an Exercise-stress test where exercise-
induced cardiac changes during the test act as a diagnostic marker.(19) In the case of an 
exercise–stress test, termination of the test may be based on the presence of diagnostic 
markers. ECG monitoring is always recommended for maximal exercise tests in 
cardiology, therefore, these tests must be carried out in a clinical environment.(2) 
In older adults maximal exertion protocols become increasingly more difficult with the 
onset of co-morbidities and increased frailty. Aside from the balance-related difficulty of 
treadmill walking, the risks associated with maximal testing become greater in older adults 
and medical supervision is recommended.(20)  This makes the process of maximal 
exercise testing relatively labor-intensive. There are also several absolute 
contraindications to maximal exercise testing which are more commonly associated with 
older adults, for example; a recent cardiovascular event such as a myocardial infarction 
(MI) in the past 5 days or unstable angina, severe aortic stenosis or diseases of the aorta 
such as an aortic aneurysm (or repair) and uncontrolled arrhythmias. Uncontrolled 
hypertension is among several relative contraindications that should also be considered 
prior to maximal exercise testing.(17) These become more frequently present with age. 
Submaximal exercise testing is a valuable alternative to maximal exercise testing if the 
32 
populations under investigation are older in age or likely to include individuals at risk of 
adverse events.(21) 
1.1.3 Measuring sub-maximal exercise capacity 
Sub-maximal exercise tests can be either predictive or performance tests.(21) Predictive 
tests are designed to permit prediction of maximal cardiorespiratory fitness. Performance 
tests involve measuring the responses to a standardized activity; for example a stair climb 
or a timed performance of running or walking a specified distance.  
Treadmill and cycle ergometers 
A variety of methods for determining V̇O2max from sub-maximal exercise tests have been 
described.(22) Treadmill and cycle ergometer protocols can be modified to assess sub-
maximal exercise capacity. The Modified Bruce treadmill protocol employs an additional 
initial phase with a lower workload than the initial stage of the maximal Bruce protocol and 
halves the increments in workload making the test feel smoother to the participant. The 
test is terminated when 85% of the predicted heart rate is reached. Predictive equations 
were subsequently developed using data from tests conducted in various groups (active 
and sedentary men, healthy adults and patients with cardiac disease). These equations 
use the exercise time achieved during the test which is a marker of the workload achieved, 
thus, exploiting the linear relationship between workload and oxygen uptake.(23, 24) 
Modification for the Bruce protocol allows it to be more suitable for less-able individuals; 
however, the disadvantages associated with stability on the treadmill persist. Pearson’s r 
values for the correlation between predicted and measured V̇O2max were reported 
between 0.87-0.94 depending on the participant group tested.(25)  
Ebbeling et al developed the Single-Stage Submaximal Treadmill Walking Test which 
involves treadmill walking at one speed and gradient.(26) The predictive equations 
developed from this test were established using the data from a sample of healthy adults 
aged 20-59 years old. Although the test itself is a useful means for assessing exercise 
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capacity in people who are less able or prone to fatigue, the value of predictive equations 
for use in older or disease populations is dubious.  
The Astrand-Ryhming nomogram can be used to estimate V̇O2max from a submaximal 
Cycle Ergometer test (the Astrand-Ryhming cycle test).(27) It uses the measured heart 
rate and the workload achieved on the final stage for the estimation of V̇O2max.The 
nonogram has undergone several modifications to make it suitable for use in a wider 
variety of study populations than previous predictive equations permitted.(28, 29) This 
includes incorporation of an age-correction factor permitting use in older adults.(30) 
Predictive equations depend on the assumption of a linear relationship between heart rate 
and V̇O2. Although this assumption fails at high workloads and can result in an 
underestimation of the predicted V̇O2max, it is a necessary assumption. Von Dobeln et al, 
describe an equation, based on the Astrand-Rhyming nonogram, which aimed to minimise 
the assumptions necessary to predict V̇O2max. They developed it using exercise data 
collected from men aged 30-70 years old, and included an age-correction factor permitting 
its use in older adults.(31) This equation was also developed for women.(30) Other 
examples of sub-maximal cycle ergometer protocols are: the YMCA bike test and the 
ACSM bike test. 
Self-paced walking tests 
Walking is a ubiquitous form of activity, appropriate for the majority of older adults, and is 
the principal requirement for performing daily activities independently. Therefore, it 
naturally provides a good basis for a submaximal exercise test. A single-stage, self-paced 
walking tests is commonly used. The 12 minute walk test (12-MWT) was first introduced by 
McGavin et al, in 1976 to assess exercise capacity in patients with pulmonary disease.(32) 
The test involves recording the distance that can be walked in 12 minutes. In this original 
protocol the test was carried out along a hospital corridor. 29 participants also undertook 
an incremental maximal cycle ergometer test including analysis of expired gases to 
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determine peak V̇O2. The authors report a significant positive correlation between distance 
travelled in the 2nd of three 12-MWTs (carried out to assess reproducibility of the test) and 
the peak V̇O2 achieved (r=0.52; p<0.01).(32) 
The 6 minute walk test (6MWT) was subsequently developed along the same principals as 
the 12MWT but was designed for patients with severe respiratory disease.(33) The 6MWT 
has since been applied to a range of groups of people with severe limitations in exercise 
capacity,(34-36)  including older adults aged 65-89 years old.(37) Strengths of the 6 and 
12 MWT are that they are easy to administer, inexpensive and involve walking which is an 
activity typical for everyday life; this may seem achievable by most participants to at least 
some extent. Limitations in self-paced walking tests include: requirement of a corridor or 
space that is big enough (and quiet in terms of thoroughfare) for the test to be carried out. 
The corridor should be at least 30 meters long(38) in order to reduce turning points during 
the test which inevitably slow participants(39).  
Step tests  
Step tests offer a low cost and simple method for assessment of exercise capacity without 
need for expensive equipment. The Astrand-Rhyming step test was developed as a simple 
way of predicting V̇O2max from a submaximal exercise test that could be carried out in the 
home.(40) Other examples of submaximal free-standing step test protocols are: 
McCardles step test and the Canadian Aerobic fitness test.The low cost of step tests 
makes them particularly appropriate for studies that enrol a high number of participants. A 
disadvantage of using a free-standing step test is that it also requires the participant to 
have reasonable balance and stability. 
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1.2 Cardio-respiratory fitness 
1.2.1 Definition 
Cardio-respiratory fitness describes the overall ability to perform moderate-high intensity 
dynamic exercise for prolonged periods.(41) Energy for performing exercise for periods 
greater than a few minutes is supplied, largely, via oxidative metabolism. Therefore, 
cardio-respiratory fitness can be judged as the ability of the body to uptake and utilize O2. 
Oxidative metabolism is the process by which oxygen (O2) and a fuel source are used for 
production of Adenosine tri-phosphate (ATP) from adenosine diphosphate (ADP) and 
inorganic phosphates (Pi).(3, 42) Oxidative metabolism (using glucose as its fuel source) 
results in the production of the waste products carbon dioxide (CO2) and water (H2O) 
according to the following: 
 
The processes involved in oxidative metabolism will be discussed in further detail the 
subsequent section; ‘Cellular oxygen consumption’. 
Maximal cardio-respiratory function is measured using a cardio-pulmonary exercise test 
(CPET), of which, the primary outcome measure is maximal oxygen consumption 
(V̇O2max) at the whole body level.(3) Specific CPET protocols are described in detail in the 
subsequent section ‘Measuring cardio-respiratory function’. Briefly, V̇O2max is measured 
by monitoring expired gases at the mouth during graded exercise; as exercise workload 
increases (via increase in speed or resistance) there is a parallel increase in oxygen 
consumption (V̇O2), if workload continues to increase it becomes impossible for the body 
to take-up enough oxygen to aerobically generate ATP, eventually, it is impossible to 
36 
generate enough ATP to sustain exercise.  There are 2 other energy systems activated 
with initiation of exercise which provide ATP to allow contraction of muscle to be initiated in 
the absence of oxygen; the Phosphocreatine (PCr) system and Glycolysis.(3) These 
systems can rapidly provide ATP when oxygen is not available but are limited to a very 
short period of time. These systems will be discussed in the subsequent section; ‘skeletal 
muscle metabolic function’.  
The first experiments to describe V̇O2max were carried out in the 1920s by Hill et al.(43) 
Much work has since been carried out to understand the individual components of V̇O2max 
and to determine which are rate-limiting.(44) Components contributing to the whole body’s 
capacity to uptake and utilize oxygen (O2) can be described broadly in terms of four main 
systems: (I) pulmonary diffusion; (II) the capacity for oxygen carriage in the blood (III) 
cardiovascular function; and (IV) mitochondrial and cellular energy metabolic function 
(figure 1.2).(44)  
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Figure 1.2 Components of oxygen (O2) transport. A simplified overview of the 
components contributing to the whole body’s capacity to uptake and utilize oxygen 
(O2): pulmonary diffusion, the capacity for oxygen carriage in the blood which is 
determined by haemoglobin, cardiovascular function (encompassing cardiac 
function and vascular function) and mitochondria oxidative capacity. Adapted from 
McArdle et al.(3) 
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If there is an increase in oxygen consumption (V̇O2), O2 transport must increase through 
the whole system; each component in the sequence (described above) has the potential to 
influence maximum throughput (V̇O2max) and therefore could become a rate-limiting 
factor.(45) Furthermore, each component can influence the performance of other 
components in the sequence.(45) The next 4 sections will discuss each of these systems 
(or components) in detail. 
1.2.2 Pulmonary diffusion & the capacity for oxygen carriage in the blood 
Breathing is under autonomic neural control, as the diaphragm moves downwards 
negative pressure is created inside the chest and air travels into the airway into the alveoli 
of the lungs. In healthy humans, in normal atmospheric conditions, a concentration 
gradient exists between the surface of the alveoli and the pulmonary capillaries, oxygen 
(O2) diffuses across this surface and binds with deoxygenated haemoglobin. Haemoglobin 
then exists in its oxygenated form acting as a transporter for oxygen around the body. The 
blood in arteries of healthy humans at rest is generally accepted to be >95% 
oxygenated.(46)  
In healthy, non-athletic humans exercising at sea level, pulmonary diffusion is not 
considered to be rate-limiting.(44) However, there are a couple of situations where this is 
not the case. Pulmonary diffusion is a limiting factor for maximal oxygen uptake (V̇O2max) 
in the presence of chronic obstructive pulmonary disease (COPD). This group of diseases, 
such as emphysema or chronic bronchitis, severely impair oxygen uptake by the alveoli as 
the lungs. Also, in elite athletes it has been shown that the capacity to greatly increase 
cardiac output results in rapid red blood cell transit through the pulmonary capillaries which 
reduces the ability of the lungs to perfuse in full. This is demonstrated by the increased 
likelihood of elite athletes for desaturation during exercise(47) and the restoration of 
arterial saturation in elite athletes when exercise is performed in a hyper-oxic (oxygen-rich) 
environment.(46)  
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1.2.3 Cardiovascular function 
From the lungs, oxygenated blood to carried to the left side of the heart which is 
responsible for pumping blood around the body; cardiac output is the amount of blood 
which the heart ejects in 1 minute which depends on the heart rate (contractions per 
minute) and the stroke volume (usually cardiac output is expressed in L/min).  
To initiate movement, central command provides feed-forward signalling which sets the 
pattern of motor activity in skeletal muscles and initiates cardiovascular activation in order 
to increase oxygen transport to the muscle. The cardiovascular response during exercise 
is co-ordinated via the autonomic nervous system (ANS).(48)  This comprises withdrawal 
of parasympathetic activity (vagal tone) and an increase in sympathetic activity which 
results in an increase in heart rate and cardiac contractility (increase in cardiac output).(48, 
49)  
The 1960s landmark studies by Ekblom, et al(50) and Saltin, et al(51) demonstrated 
response of V̇O2max to a 50 days or 16 week training program, respectively. They showed 
that, in healthy, young men (age 19-27 years old) training-induced changes in V̇O2max 
were the result of small changes in arterial-venous difference (a-vO2) but larger changes in 
cardiac output; estimated as a 3.6% improvement in a-vO2 and 8% increase in cardiac 
output.(50) These studies used the dye-dilution method to determine cardiac output and 
concluded that, as the change in max heart rate was small, it was changes in stroke 
volume that primarily accounted for improvements in V̇O2max.  
Blood travels from the heart through large blood vessels (arteries, arterioles) to very small 
blood vessels (capillaries) which are interspersed through skeletal muscle permitting 
diffusion O2 from the high concentration in the vessel to the cell. Local vasodilation in the 
active skeletal muscle, coupled with vasoconstriction in non-exercising muscle, viscera 
and skin, guides the oxygenated blood flow to the exercising muscles to meet the 
metabolic demand.(52) This specificity in oxygen delivery occurs via afferent mechano- 
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and metabo(chemo)-reflex signalling in skeletal muscle which send  signals to the control 
centre in the brainstem. Efferent nerve activation modulates the vascular response 
according to the muscle location and the exercise workload: this is termed the ‘exercise 
pressor response’ (EPR). (Figure 1.3) 
 
Figure 1.3 Autonomic cardiovascular regulation of the cardiovascular response 
during exercise. Shown are three neural systems which regulate the cardiovascular 
control of exercise; central command, the skeletal muscle exercise pressor reflex 
(EPR) and the arterial baroreflex. Central command recruits motor units for muscle 
contraction and stimulates cardiovascular control in the brainstem. Onset of muscle 
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contraction activates metabo- and mechanoreflex afferent neurons which stimulate 
the cardiovascular control centre. Efferent neural signalling co-ordinates the 
autonomic nervous system (sympathetic and parasympathetic branches) which 
controls heart rate/cardiac contractility/cardiac output appropriately for the exercise 
workload. Figure adapted from Spranger et al, 2015(49)  
A further feedback system is the arterial baroreflex; under resting conditions, baro-
receptors feedback blood pressure information to the control centre in order to maintain a 
normal resting blood pressure. During exercise blood pressure increases and the arterial 
baroreflex is reset in an exercise intensity-dependent manner but remains as sensitive in 
its regulatory response during exercise as it is at rest.(53)  It is thought that the EPR and 
central command play a role in re-setting the arterial baroreflex (Figure 1.3).(53)  
At rest cardiac output (CO) is ~5L/min, blood flow is distributed fairly evenly between the 
skeletal muscle (~15-20%; ~0.75L/min), brain (~15%; ~0.75L/min), liver & intestine (~20-
25%; ~1L/min) and kidneys (~20%; ~1L/min). A smaller proportion is distributed to cardiac 
muscle (coronary arteries) (4-5%; ~0.2L/min) (figure 1.4) and skin, bone and other organs 
(not shown here). During heavy exercise, cardiac output increases to as much as 25L/min; 
between 80-85% (~20L/min) of this blood flow is distributed to skeletal muscle. The 
absolute blood flow to the coronary arteries als increases (from 0.2L/min to 1L/min), while 
absolute blood flow to brain, kidneys and intestine remains fairly constant (figure 1.4) 
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Figure 1.4 Blood flow redistribution during heavy exercise. Cardiac output (CO) is 
~5L/min at rest, ~15-20% of this is distributed to the skeletal muscle, while blood 
flow is similar to the brain, gut and kidneys. A smaller proportion is distributed to 
coronary arteries (4-5%) and skin, bone and other organs (not shown here). During 
heavy exercise, cardiac output increases to as much as 25L/min; 80-85% of this 
output is distributed to skeletal muscle. Figure first described by Astrand.(52) 
Venous return is increased during exercise via the skeletal muscle ‘pump’ and also via the 
respiratory ‘pump’. This leads to an increase in end diastolic volume and, therefore, an 
increase in stroke volume. In humans, there is conflicting evidence regarding whether 
prolonged exercise is associated with a change in limb venous compliance.(54, 55)  
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1.2.4 Cellular respiration 
In human skeletal muscle cells ATP is broken down to provide energy for actin-myosin 
cross-bridge formation and generation of force by contracting muscle.(56) ATP is 
produced from adenosine diphosphate (ADP) and inorganic phosphate (Pi). There are 
several processes through which ATP can be generated. Two anaerobic energy systems 
allowing rapid supply of ATP for cross-bridge cycling and oxidative ATP production.(3) 
Initially, in the first few seconds of exercise, increased ATP demand is supplied by 
phosphocreatine (PCr) breakdown, this is followed by glycolytic ATP production and then 
complete activation of the oxidative phosphorylation pathway (1-2 minutes). Figure 1.5 is a 
schematic representation of these systems of ATP production during ~5minutes of 
exercise at a consistent, sub-maximal rate of exertion.(57) 
 
Figure 1.5 A schematic overview of the changes in energy systems required to 
generate adenosine triphosphate (ATP) during a short period of sub-maximal 
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constant-rate exercise. Rapid activation of ATP synthesis through phosphocreatine 
(PCr) breakdown is represented by the blue line, oxidative phosphorylation by the 
green line and glycolytic ATP production by the red line. During the recovery period, 
PCr is replenished through oxidative ATP synthesis only. The recovery can be fit by 
a mono-exponential curve from which a rate constant can be derived. This figure 
was adapted from Fiedler et al, 2016.(57) 
Glycolysis occurs in the cytoplasm of the cell and produces pyruvate. Under aerobic 
conditions (when oxygen is present) pyruvate is converted to acetyl CoA and continues to 
the Kreb's cycle (figure 1.6). Energy is released from the acetyle groups as reduced 
coenzymes (NADH, FADH2). These are oxidized in the ETC to facilitate proton (H+) 
transport across the inner mitochondrial membrane from the matrix to the inter-membrane 
space. The majority (32 molecules) of ATP is produced via ATP-synthase which is a 
protein spanning the inner membrane of the mitochondria (figure 1.6). Thus, mitochondria 
provide the site for oxidative ATP synthesis; this will be discussed in more detail in the 
subsequent section ‘Mitochondria’.  
Glycolytic ATP synthesis is also activated for short periods at high intensities of 
exercise(57). Under anaerobic conditions, pyruvate is converted to lactic acid (lactate) and 
a small amount of ATP is produced. As exercise intensity increases the glycolytic pathway 
is activated more to compensate for the slow speed of ATP production via the ETC, thus, 
more lactic acid (lactate) is produced. Lactic acid is buffered by bicarbonate (HCO3-) which 
increases pulmonary CO2, and the pulmonary system responds by increasing ventilation in 
an attempt to eliminate the excess CO2.   
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Figure 1.6 a simplified schematic representation of cellular generation of ATP. Two 
pathways for ATP generation are represented here. Glycolysis, which occurs in the 
cytoplasm, and, the Krebs cycle and electron transport chain (ETC), which occur in 
mitochondria in the presence of oxygen. ATP; adenosine triphosphate, NADH; 
Nicotinamide adenine dinucleotide, FADH; flavin adenine dinucleotide, TCA: 
tricarboxcylic acid cycle.  
Human studies have previously shown what might appear to be a discordant response to 
training between oxidative capacity (quantified by the levels of mitochondrial enzymes 
present in biopsy samples of skeletal muscle) and measured V̇O2max. Mitochondrial 
enzymes can be doubled with training while V̇O2max increases by only 20-40%.(58) 
However, this can be explained by the improvement in exercise performance that is 
aligned with the increase in oxidative capacity, specifically an increase in exercise 
endurance performance.(59, 60)  In addition, since these early studies, it has been shown 
that low-intensity training may improve mitochondrial function without improving 
V̇O2max.(61)  
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1.2.5 The importance of cardio-respiratory function  
In a large meta-analysis improved cardio-respiratory fitness was associated with lower risk 
of all-cause mortality and incidence of cardiovascular disease (CVD).(62) This analysis 
included 33 studies, cumulating data from 102,980 individuals who were followed-up for 
all-cause mortality and 84,323 individuals followed-up for a combined risk of CVD and 
coronary heart disease (CHD). Cardio-respiratory fitness was described in metabolic 
equivalents (METs). One MET is equal to energy expenditure during seated rest; the 
meta-analysis concludes that having a maximum cardio-respiratory fitness above 7.9 
METs (that is 8 times higher than resting) will substantially lower mortality risk (relative risk 
for all-cause mortality of low cardio-respiratory fitness compared to high was 1.70 (95%CI, 
1.51-1.92; P< 0.001) and risk for CHD/CVD events was 1.56 (95%CI, 1.39-1.75; 
P<0.001)).(62) Follow-up years of the studies included ranged from 1.1 to 26 years. This 
was a comprehensive analysis, including an adjustment for publication bias (trim and 
fill).(62)  
Interestingly, reduced muscle strength, captured by a simple hand-grip measurement, has 
also recently been described as a predictor of all-cause mortality and cardiovascular 
morbidity. This analysis was carried out using data from a large, international, longitudinal 
population study comprising 139 691 participants with a 4-year follow-up period; The 
Prospective Urban-Rural Epidemiology (PURE) study.(63) Further to this, Celis-Morales et 
al showed, in a large prospective UK-based study of 67, 702 participants, that strength and 
predicted V̇O2max, are moderators of the association between physical activity and 
mortality.(64) 
1.2.6 Measuring cardio-respiratory fitness  
Cardio-respiratory fitness is measured using a cardiopulmonary exercise test (CPET). This 
involves the individual undertaking a graded exercise protocol (as described in the 
previous section ‘Measuring maximal exercise capacity’) while continuously monitoring 
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changes in oxygen and carbon dioxide being inspired and expired. This is typically done 
with a face mask that covers the nose and mouth completely. The gold standard exercise 
protocol involves continuous incremental (graded) loading on a selected exercise 
ergometer until exhaustion. Cardio-respiratory fitness is reported in terms of V̇O2max, 
often also adjusted for body weight (ml/min/kg); some studies report V̇O2max as a 
representative measure of exercise capacity. However, although over a wide range of 
values, cardio-respiratory fitness and exercise capacity are positively correlated, strictly 
speaking, they are not necessarily in line with one another, especially when the range of 
V̇O2max values is narrow.(65) 
During a CPET the increase in exercise workload is linearly related to the increase in 
oxygen consumption throughout the test. Theoretically, a maximal CPET is defined by a 
plateau in the measured V̇O2 despite further increases in workload.(3) A plateau in V̇O2 is 
not always achieved, CPET protocols are generally terminated when the participant 
reports reaching exhaustion and an individual may terminate the test due to lack of 
motivation or fatigue. In this case, the V̇O2 achieved is referred to as the Peak V̇O2. 
Various physiological parameters, derived from the real-time gas analysis, allow 
investigators to decide if suitable effort has been made during the test to support 
attainment of a peak V̇O2. For example, if the respiratory exchange ratio (RER) is >1.1 or 
heart rate reaches within 10 beats of the age-predicted maximum. However, critical review 
suggests that a ‘true maximal’ cardio-respiratory effort is seldom reached at self-reported 
exhaustion and an extended rigorous protocol is necessary to ensure maximal V̇O2 has 
been achieved.(66) In this light, obtaining a ‘true’ measurement of V̇O2max becomes 
difficult even in the most motivated individuals. In older adults maximal effort is often not 
achieved during a CPET.(67) As described previously, sub-maximal exercise tests can be 
carried out in order to predict V̇O2max, this is a valuable alternative. 
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Typical exercise modalities employed for CPET are modalities which activate the large 
muscle groups, such as; treadmill running, stationary cycling (cycle ergometers) and 
bench stepping. Variation in the V̇O2max values exists when the tests are conducted using 
different modalities; this reflects the quantity of muscle enrolled in performing the exercise. 
For example, treadmill running usually produces a higher V̇O2max in the same person than 
they would achieve during a cycle ergometer test.(68, 69) 
1.3 Skeletal muscle metabolic function 
In this thesis skeletal muscle metabolic function is defined as the oxidative capacity of the 
mitochondria within skeletal muscle. Skeletal muscle metabolic dysfunction means 
‘impairment in the mitochondrial oxidation of substrates (lipid and carbohydrate) resulting 
from an impairment in oxidative phosphorylation’. 
1.3.1 Mitochondria  
As described previously in the section ‘Cellular oxygen consumption: Oxidative 
metabolism’, mitochondria provide the site for ATP production via oxidation of nutrients 
(carbohydrate and lipid) and phosphorylation of ADP; oxidative phosphorylation. 
Mitochondrial are subcellular organelles that can vary in size, shape, number and location 
within the cell. They have a smooth outer membrane and a folded inner membrane. The 
protein complexes of the ETC span the inner membrane and the mitochondrial matrix 
(space inside the inner membrane) is the site for the Krebs cycle.(70) Mitochondria have 
their own autonomously replicating DNA (mtDNA) separate from the cells nuclear DNA 
and thought to be inherited only from the maternal line. mtDNA is arranged in structures 
called nucleoids which are composed of DNA-binding proteins involved in mtDNA 
maintenance and transcription as well as a range of peripheral signalling factors that 
regulate mitochondrial biogenesis. In humans, mtDNA is arranged in circular sets of 
16,569 base pairs and codes predominantly for mitochondrial RNA. (71, 72) 
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It is worth recognising that, as well as being the site of cellular metabolism, mitochondria 
play a number of additional roles within the cell, these include: cell signalling, generation 
and clearance of reactive oxygen species (ROS), regulation of cell apoptosis (to some 
degree), transport of the mitochondria within the cell and regulation of intra-cellular 
calcium. As a result of their diverse functions a number of definitions of ‘mitochondrial 
dysfunction’ have been described.(73-75)  
Mitochondrial dysfunction can be described in terms of; reduced mRNA levels of 
mitochondrial markers,(76) reduced protein levels (1, 5) or a reduction in enzymatic activity 
of key components of mitochondria driven oxidation (1, 6, 7, 8, 9), changes in mitochondrial 
size and shape (by electron microscopy),(5, 7, 10) impaired flexibility for substrate 
oxidation (6, 8) or propensity for production of ROS. The ability of mitochondrial to produce 
ATP through oxidative phosphorylation (oxidative capacity) is a component of 
mitochondrial function. Methods for the assessment of oxidative capacity will be discussed 
in subsequent sections.  
1.3.2 In Vitro assessment of oxidative capacity 
In vitro examination of skeletal muscle tissue biopsies allows oxidative capacity to be 
probed at the cellular and molecular levels. This is an important approach when 
investigating the underlying mechanisms involved in oxidative phosphorylation. Methods 
for in vitro and in vivo assessment of oxidative capacity are discussed in further detail in 
this and the section below. An overview of the main methods used to assess mitochondrial 
oxidative capacity of skeletal muscle is provided in table 1.1. This table is not exhaustive.  
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Table 1.1 An overview of some of the key aspects of mitochondrial oxidative 
capacity and example methods for assessment. ETC; electron transport chain, 
PGC1α; Peroxisome proliferator-activated receptor γ coactivator α, NRF; nuclear 
respiratory factor 1, MRS: magnetic resonance spectroscopy, PCr; 
phosphocreatine. 
Mitochondrial size, morphology & position 
A transmission electron microscope can be used to visualize size morphology, position 
and number of mitochondria within skeletal muscle cells. In the early 1970s Hoppeler et al, 
showed an increase in number and size of the mitochondria in the skeletal muscle in 
response to endurance training.(77) More recently Burkart et al, described increased 
mitochondrial numbers that were smaller in size in the pluripotent stem cells of individuals 
with diabetes.(78) The placement of mitochondria inside the myocytes (subsarcolemmal or 
intermyofibrillar) has also been shown to determine their oxidative capacity; 
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intermyofibrillar mitochondrial content was positively associated with metabolic fuel source 
flexibility.(79) 
Enzyme activities 
A commonly applied approach to assessing mitochondrial capacity for oxidative 
phosphorylation  is to quantify concentration or maximal activity of selected complexes in 
the ETC, such as NADH-dehydrogenase (NADH:CoQ Oxidoreductase; complex I) or 
Cytochrome-C-Oxidase (complex IV), or Krebs cycle enzymes such as citrate synthase 
(figure 1.7).(74) Enzyme concentrations (protein content) can be assayed using antibody 
technology. To determine enzyme activity, skeletal muscle tissue samples can be frozen 
and analysed using spectrophotometric-based enzyme activity assays that are 
commercially available. This makes both methods simple and appealing. In addition, 
expression of these enzymes can be determined by assaying transcripts in microarrays.  
The benefit of these measurements is that they do not require large amounts of sample 
tissue and the tissue can be frozen allowing analysis to be conducted at a later time, they 
are therefore a fairly simple and useful technique for mechanistic insight into human 
muscle tissue. However, there are a few important limitations. The assumption which 
these methods are based on is that alteration the protein(s) investigated directly alters rate 
of oxidative phosphorylation, thus, if the protein is not altered function is not impaired. In 
this scenario false positive, and false negative, results can be produced; single reactions 
are not likely to be representative of the entire complex process of oxidative 
phosphorylation. A further limitation of these measurements is that they require 
degradation of cell structure and, therefore, damage to the morphology of the 
mitochondrial reticulum (the way that the mitochondrial are arranged within the cell). The 
mitochondrial reticulum is thought to provide a conductive pathway for energy distribution 
throughout the skeletal muscle cell, thus allowing rapid communication between 
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mitochondria; destruction of this is likely to be detrimental to overall functional 
capacity.(80)  
 
Figure 1.7 A simplified overview of mitochondrial oxidative phosphorylation and the 
enzymes typically measured. Oxidation of carbon substrates in the Krebs cycle (or 
tricarboxylic acid (TCA) cycle) within the mitochondrial matrix generates reducing 
equivalents (NADH) that subsequently provide electron flow to the electron 
transport chain (ETC). Electrons are transferred from NADH through NADH 
dehydrogenase and oxidation of succinate by complex II (succinate 
dehydrogenase). The proto gradient generated across the inner mitochondrial 
membrane drives phosphorylation of ADP to ATP by ATP synthase. Succinate 
dehydrogenase is also sometimes known as Succinate-Q oxidoreductase. 
Cytochrome c oxidoreductase is also sometimes known as 
cytochrome bc1 complex. α-KGDH; alpha ketoglutarate dehydrogenase, NADH; 
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Nicotinamide adenine dinucleotide. This figure was adapted from Lanza et al, 
2009.(74) 
ATP production  
ATP synthesis rate can be quantified directly from isolated mitochondria. This involves 
exploitation of a photon-emitting reaction between luciferin, firefly luciferase and ATP.(74) 
Briefly, Isolated mitochondrial (in solution) are provided with the appropriate substrates to 
generate ATP. In the presence of ATP, Luciferin adenylate is generated from Luciferin, if 
oxygen is also present, luciferin adenylate becomes oxyluciferin and photons are emitted 
during this reaction. A microplate luminimeter with a photoncounting photomultiplier tube 
measures bioluminescence and, the concentration of ATP present is quantified by the light 
signal generated. This is performed several subsequent times, thus the rate of ATP 
synthesis is determined as the slope of the concentration over time. This technique has 
previously been described in detail.(74) The authors also describe methods for isolating 
mitochondria which extricate subsarcolemmal from intermyofibrillar placed mitochondria; 
an important distinction given the differences in functional capacity of these differentially 
placed mitochondria discussed above.(79) 
On the surface, this appears to be a very simple method of assessing oxidative capacity, 
however, the combination of substrates and inhibitors included in the medium needs 
careful consideration.(74, 81) Different substrate combinations (conditions) allows 
investigation of specific ETC complex activities and, if an overall function is to be 
determined, then all pathways should be considered. For example, addition of glutamate 
and malate (GM) allows exclusive assessment of ATP production through NADH 
dehydrogenase (Complex I; figure 1.7). This is because addition of GM provides the 
substrates for dehydrogenase reactions within the Krebs cycle generating NADH which is 
oxidised by NADH dehydrogenase. Concurrently the increased malate concentration 
inhibits succinate dehydrogenase activity (complex II), therefore, specifically complex I 
54 
activity is measured. Assessment of ATP production is undertaken using a step-wise 
protocol involving addition of substrate, inhibitors and uncouplers. This includes non-
mitochondrial ATP production via non-oxidative pathways; therefore, comprehensive 
assessment of oxidative ATP production capacity can be determined. Methodological 
details of the different substrate combinations typically used for specific complex activity 
has previously been described in detail.(74)  
ATP synthesis rate determined during each condition can be compared by adjusting (or 
normalizing) the rate for the amount of mitochondria present in each individual medium. 
Typically normalization is for tissue weight or a marker of mitochondrial content such as 
citrate synthase activity, mitochondrial protein content or mitochondrial DNA copy 
number.(73, 74) 
Oxygen consumption 
As oxygen is reduced in the process of oxidative ATP production, quantifying the rate of 
oxygen consumption in mitochondria is also a way of examining oxidative capacity. The 
technique of measuring oxygen consumption is also referred to a mitochondrial (or 
cellular) respirometry. In skeletal muscle it can be carried out in isolated mitochondria, 
cultured cells and permeabilized muscle fibres. Previously this was not appropriate for 
human studies because a large amount of tissue was necessary; however, advances in 
technology have led to this technique of high resolution respirometry being possible with 
smaller sample volumes.(82, 83) 
Oxygen consumption can be measured in a medium of respiring mitochondria using a 
Clark-type oxygen electrode. This is known as polarographic measurement of oxygen 
consumption and it can be carried out with small tissue samples. In the Clark-type system 
the anode and cathode are attached by a salt bridge covered in an oxygen permeable 
membrane. When O2 diffuses over the membrane it is reduced creating a current which is 
proportional to the concentration of oxygen. Similarly to the techniques for assessing ATP 
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synthesis rates, a protocol is employed where substrates, inhibitors, and uncouplers are 
added to the medium in subsequent phases to provide comprehensive assessment of 
oxidative capacity across selected mitochondrial enzymes.(82)  
Mitochondrial Biogenesis 
Production of new mitochondria (mitochondrial biogenesis) is regulated by a co-ordination 
of multiple nuclear and mitochondrial genes. Peroxisome proliferator-activated receptor γ 
coactivator α (PGC1α) is a transcriptional coactivator (a protein or protein complex that 
increases the probability of a gene being transcribed by interacting with transcription 
factors but not itself binding to DNA) that plays a major role in regulating mitochondrial 
biogenesis.(84) PGC1α interacts with nuclear respiratory factor 1 (NRF1) to stimulate 
transcription of other mitochondrial genes. Transcription factor A (TFAM) is also stimulated 
by the PGC1α/NRF1 interaction which controls mitochondrial DNA replication and 
transcription. Because of its key role as a regulator of energy metabolism, expression of 
PGC1α indicates greater presence of mitochondrial and therefore, increased capacity for 
oxidative phosphorylation. Endurance exercise training is known to increase expression of 
PGC1α in human skeletal muscle(85) and expression of PGC1α has been reported to be 
down regulated in the presence of diabetes.(86, 87)  
Limitations of in vitro assessment methods 
Removing tissue from its  physiological environment, either to isolate mitochondria or to 
perform measurements at the cellular level, exposes the it to non-physiological oxygen 
levels and temperatures.(73) Although tight control is usually employed to ensure minimal 
exposure, there still remains potential for this exposure to influence the measurements that 
are subsequently made and conclusions drawn from the experiment. Furthermore, and 
perhaps most importantly, muscle biopsies require a relatively large needle to extract the 
tissue sample; this may cause the participant some discomfort and potentially cause 
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psychological stress.(88) Many of the studies that closely examine the molecular detail of 
skeletal muscle enroll small sample sizes 
To understand functional capacity of skeletal muscle it would be useful to develop non-
invasive in vivo methods of assessment which can be made accessible for use in greater 
participant numbers and in a wider range of dynamic environments.  
1.3.3 In Vivo assessment of oxidative capacity 
Magnetic resonance spectroscopy (MRS) 
Phosphorous magnetic resonance spectroscopy (31P-MRS) can be used to measure any 
phosphorous-containing metabolites, therefore, ATP and phosphocreatine (PCr) 
concentrations can be quantified in vivo. MRS is based on the same principles as 
magnetic resonance imaging (MRI); instead of the hydrogen nuclei (H+), a phosphorous 
nuclei is detected. The 31P-magnetic resonance spectrum of skeletal muscle has 5 peaks: 
inorganic phosphate (Pi), PCr and the three phosphate moieties of ATP (α, β & γ). These 
peaks are due to differences in resonance frequency in the magnetic environment, which 
is shifted depending on the molecule or molecular site of the nuclei.  
A saturation transfer experiment can be carried out to determine the effect of different 
nuclei that are associated i.e. in the case where one nuclei is consumed in order to 
produce another, for example, inorganic Pi and ATP. In this scenario, the resonance signal 
is sensitized to the rate of exchange (Pi – ATP) by selectively saturating the equilibrium 
magnetization of one of the nuclei and measuring the effect on the signal strength of its 
partner.(89)  
The saturation transfer method has previously been used to determine resting rate ATP 
synthesis and interpreted as a measure of mitochondrial oxidative capacity.(90, 91) 
However, the problem with this interpretation is that, compared to other methods, this 
method overestimates resting oxidative ATP production in skeletal muscle as it cannot 
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differentiate between glycolytic, oxidative and PCr pathways; synthesis rates are not in line 
with rate of oxygen consumption measured directly from the tissue.(92, 93)  
MRS also offers a valuable alternative to the saturation transfer method. This method 
depends on the rate of PCr recovery following exercise. It is useful to first describe the PCr 
shuttle system in order to fully understand this method. 
1.3.4 The phosphocreatine (PCr) shuttle 
The phosphocreatine (PCr) “shuttle” system provides a means for rapid ATP synthesis 
through the enzyme Creatine Kinase (CK). PCr is a smaller and less negatively charged 
molecule than ATP which allows it to diffuse into the cytoplasm more readily. CK is present 
in the mitochondria and in the cytosol. The mitochondrial isoform of CK catalyzes 
production of PCr using energy from ATP, synthesized through oxidative phosphorylation. 
The cytosolic isoform of CK facilitates the breakdown of PCr to provide the energy to 
generate ATP from ADP (equation 1.1) in the cytosol which facilitates cross-bridge 
formation.(94)  
𝑀𝑔𝐴𝐷𝑃 + 𝑃𝐶𝑟2−  + 𝐻+  ↔ 𝑀𝑔𝐴𝑇𝑃2+ + 𝐶𝑟   (1.1) 
Figure 1.8 provides an overview of the phosphocreatine shuttle system. This system 
provides the basis for a further method that can be used to assess the functional capacity 
of the mitochondria in skeletal muscle.  
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Figure 1.8 Schematic overview of the Phosphocreatine “shuttle” system. ADP: 
adenosine diphosphate; ATP: adenosine triphosphate; CK: creatinine kinase; Cr: 
free creatinine; PCr: phosphocreatine. Adapted from Guimarães-Ferreira, 2014.(94) 
PCr is rapidly depleted within the first ~1minute of exercise. Immediately post-exercise PCr 
is regenerated and the ATP used for re-synthesis is exclusively derived from oxidative 
phosphorylation.(95) As described above, dynamic changes in ATP turnover can be 
assessed with high temporal resolution 31P-MRS. If it is assumed that ATP is stable, that 
there is negligible glycolysis during recovery and that  there is a mono-exponential 
recovery of PCr, the recovery rate of PCr can be used as an indicator of maximal oxidative 
capacity in the muscle.(73, 89, 93) Figure 1.9 demonstrates this technique by showing the 
change in resonance spectra with exercise (top panel) and the plot of recovery against 
time with a mono-exponential fit to the points.  
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Figure 1.9 An example data set where MRS has been used to determine 
phosphocreatine (PCr) recovery following a short bout of exercise. The top panel is 
a stack plot showing the 31P-MR spectra of skeletal muscle during rest (no colour), 
exercise (green) and recovery (orange). During the exercise PCr stores are depleted 
and there is a spike in the signal from inorganic phosphate (Pi; blue triangle). 
During recovery, PCr stores are re-synthesised. The rate of re-synthesis of PCr is 
derived as a time constant from a plot of PCr during recovery against time (example 
data is shown in the lower panel). Adapted from Prompers et al.(89) 
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The limitations of MRS are that it is expensive, some individuals cannot tolerate MRI 
scanning (largely due to claustrophobia) and contraindications to MRI, such as any 
metallic implants, mean that it is not suitable for everyone. In addition, there are limited 
dynamic activities which can be initiated inside the scanner due to the small environment 
and the common necessity that the participant is lying supine. 
Faster recovery rates of PCr, determined in this way, represent better skeletal muscle 
oxidative capacity. Superior PCr recovery rates have previously been demonstrated in 
athletes versus non-athletes; including wrist flexor recovery rates in rowers(96) and 
gastrocnemius recovery in track athletes.(97) In competitive track athletes, training to 
compete over different distances imparted skeletal muscle benefits to varying extents. 
Endurance runners profited most greatly in terms of skeletal muscle PCr recovery.(98, 99) 
1.3.5 Oxidative capacity and exercise capacity (performance) 
Although, over a broad range of values, V̇O2max has an established relationship with 
exercise capacity, inside a narrow range of values, individuals with a similar V̇O2max may 
perform differently in terms of exercise capacity. For example, elite endurance runners 
who have similar V̇O2max may complete a 10-k race in different times.(100) In 1980 
Conley et al described these differences in performance being due to differences in 
‘running economy’. Running economy is quantified as the V̇O2 required for running at a 
given pace.(100) Holloszy and Coyle proposed that improved endurance performance (a 
lower V̇O2 for a given pace that is maintained) is permitted via an increase in mitochondrial 
enzymes which results in fewer disturbances in mitochondrial homeostasis by : (I) 
increased fat oxidation (sparing valuable stores of glycogen) and (II) reduced lactate 
production.(60) 
Typically, these kind of performance studies are carried out in young, healthy and usually, 
relatively fit individuals or athletes who are motivated to undertake maximal exercise tests 
and rigorous training regimes. The effect of minimal, unsupervised training, which is 
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typically undertaken in ‘real-world’ populations, has not previously been examined. 
Oxidative capacity, measured locally in the muscle, is not typically carried out in the 
context of a clinical exercise test. 
In older adults oxidative capacity, characterized using 31P-MRS to assess PCr recovery 
rate (the maximum rate of oxidative ATP production), has previously been shown to 
associate positively with peakV̇O2.(101) Some aspects of this study were repeated in a 
larger sample of even older adults (n=37, mean age 78 years) with the addition of analysis 
of permeabilized muscle fibers for maximum ATP synthesis rate. In vitro and in vivo 
measurements of oxidative ATP synthesis were positively correlated (r2=0.47, p=0.004) 
Inclusion of these measured values in multiple linear regression models improved 
prediction of preferred walking speed (r2=0.647,p<0.0001).(102) In another study, older 
men (74±3 years) showed favorable mitochondrial responses to aerobic exercise training, 
suggesting that the capacity to gain benefit from exercise is maintained into later life.(103) 
These are important findings which suggest that mitochondrial efficacy for oxidative 
phosphorylation is an important modifiable determinant of capacity of submaximal exercise 
capacity (walking speed) in older adults. Despite including a larger sample size than 
previously recruited, Coen et al(102) avoided the need to adjust for co-morbidities in their 
older adult population by applying strict inclusion criteria (BMI 20–32 kg/m2; ability to walk 
without the assistance; free of basic activities of daily living disability, no history of hip 
fracture; no cardiac disease or cardio-vascular disease within the past 3 months; no 
regular pain, aching, or stiffness in any joints when walking; no bilateral difficulty bending 
or straightening fully the knees; not regularly taking Coumadin, Plavix, Aggrenox, Ticlid, or 
Agrylin/Xagrid). Thus, generalizability of these results to low-functioning participants is 
difficult to appreciate. They were also underpowered to examine gender differences and 
did not report the ethnicity of their participants. 
62 
The potential role for exercise in enhancing mitochondrial biogenesis has attracted a lot of 
interest as a therapeutic target for diseases such as T2D.(104) Exercise training is 
regarded as a substantial promoter of insulin sensitivity and has been associated with 
attenuation of lipid-induced insulin resistance.(105) Exercise training programs have 
delivered improved mitochondrial function in patients with type-2 diabetes.(106) As well as 
improvements in levels of oxidative stress and blood pressure. 
1.4 Skeletal muscle metabolic function in the presence of disease 
Understanding metabolic function of skeletal muscle is of value in a multitude of disease 
states. Recently, interest in skeletal muscle metabolic dysfunction associated with 
cardiometabolic diseases (e.g. obesity, diabetes, insulin resistance) and cardiovascular 
disease (CVD; e.g. myocardial infarction, stroke, heart failure, peripheral arterial disease)) 
has greatly increased. Type 2 diabetes and insulin resistance have been of particular 
focus with debate for and against a role of mitochondrial dysfunction in the disease 
development.(107)  
Type 2 diabetes (T2D) was selected for investigation in this thesis because of its 
association with reduced exercise capacity/cardio-respiratory fitness well as its increased 
prevalence with age and the predisposition previously described in Asians.(108) Evidence 
from epidemiological studies in the UK suggests that higher levels of self-reported physical 
activity predict improved survival and reduced CVD mortality in people with diabetes.(109) 
1.4.1 Diabetes mellitus (diabetes) 
The global health burden of diabetes is high with mortality in 2012 estimated as much as 
1.5 million according to the World Health Organization (WHO).(110) The number of people 
with diabetes globally is predicted to increase from 415 million (in 2015) to 642 million by 
2040.(111) The global economic burden of diabetes on healthcare systems across the 
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world was placed at 12% per person in 2010 with a predicted rise in spending over the 
next decade.(112)    
Diabetes consists of a group of metabolic diseases characterized by elevated blood 
glucose (hyperglycemia) due to defects in insulin secretion, insulin action, or both.  
Diabetes has been classified into the following general categories by the American 
Diabetes Association(113): 
1. Type 1 diabetes (due to pancreatic -cell destruction, usually leading to absolute 
insulin deficiency) 
2. Type 2 diabetes (due to a progressive insulin secretory defect on the background 
of insulin resistance) 
3. Gestational diabetes mellitus (GDM) (diabetes diagnosed in the second or third 
trimester of pregnancy that is not clearly overt diabetes) 
4. Specific types of diabetes due to other causes, e.g., monogenic diabetes 
syndromes (such as neonatal diabetes and maturity-onset diabetes of the young 
[MODY]), diseases of the exocrine pancreas (such as cystic fibrosis), and drug- or 
chemical-induced diabetes (such as in the treatment of HIV/AIDS or after organ 
transplantation) 
Diabetes is diagnosed by measuring fasting plasma glucose (FPG), monitoring plasma 
glucose following an oral glucose challenge or by measuring heamoglobin-A1C (HbA1C). 
Criteria for diagnosis are any one of the following;(113) 
 FPG > 126 mg/dL (7.0 mmol/L) 
 2-h plasma glucose > 200 mg/dL (11.1 mmol/L) during an OGTT (glucose load 
containing the equivalent of 75 g anhydrous glucose dissolved in water) 
 HbA1C > 6.5% (48 mmol/mol) 
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 In a patient with classic symptoms of hyperglycemia or hyperglycemic crisis, a 
random plasma glucose > 200 mg/dL (11.1 mmol/L) 
The following background will focus on type 2 diabetes (T2D) as it is the most common 
form of diabetes and is most relevant to the population studied in this thesis.  
People with T2D are at a higher risk of developing cardiovascular disease (CVD) than 
those without.(114) This can manifest as aggressive coronary artery disease (CAD) 
resulting in ischemia which can lead to myocardial infarction and subsequent heart failure 
or death. In addition, T2D also predisposes to heart failure in a pathway independent of 
CAD or hypertension.(115) Rates of CVD mortality in people with diabetes are thought to 
be as high as 50%.(116) Micro-vascular damage in the eye can lead to diabetes-
associated blindness and, similarly, damage to the nephrons of the kidney can lead to 
kidney failure.(117) Accumulation of reactive oxygen species (ROS) and oxidative stress in 
the vascular smooth muscle and endothelial cells are characteristic in the development of 
diabetes-associated vascular disease. One of the sources of ROS in the endothelial cells 
lining blood vessels of people with diabetes is via the mitochondrial ETC.(114) The effect 
of skeletal muscle mitochondrial dysfunction in the vasculature in the presence of T2D 
remains unclear. 
T2D is usually preceded by an asymptomatic period prior to diagnosis of diabetes. This 
period sometimes termed ‘pre-diabetes’,(118) is characterized by elevated insulin 
resistance, and offers a window of opportunity where insulin resistance can be targeted 
with lifestyle interventions such as diet or exercise, or medication such as metformin.(119, 
120) The mechanisms underlying the positive effects of exercise on these pathways are 
not clearly understood. 
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1.4.2 T2D and skeletal muscle metabolic function  
In healthy individuals, a post-prandial rise in blood sugar causes a rise in blood insulin. 
Insulin signals to cells to switch from the fasting fuel source, fatty acids (lipid), to 
carbohydrate. In the insulin-resistant state the capacity to oxidize fatty acids at rest and the 
ability to switch between fuel sources is impaired. This impairment has been termed 
metabolic inflexibility.(121, 122) Skeletal muscle is particularly susceptible to 
dysregulations of insulin signaling and the reduction in oxidation of fatty acids as a fuel 
source leads to accumulation of lipids in skeletal muscle.(123, 124)  
Evidence supports an association between insulin resistance and impaired skeletal muscle 
oxidative capacity.(107, 125) This was first shown by Kelley and colleges, who 
demonstrated that skeletal muscle from individuals with T2D had smaller and fewer 
mitochondria with lower oxidative enzyme activity; specifically citrate synthase and 
NADH:O2 oxidoreductase activity.(126, 127) Subsequent studies were carried out which 
supported this finding by demonstrating that T2D is associated with various other 
mitochondrial aberrations that lead to decreases substrate oxidation. Including reduced 
mitochondrial RNA content (128) and reduced protein content.(76) 
Mootha et al, describe use of a technique called gene set enrichment analysis (GSEA) 
which uses DNA microarrays to demonstrate a reduced expression of a profile of genes 
that are important regulators of oxidative capacity in skeletal muscle.(87) This is an 
interesting approach which exploits the idea that, rather than an individual gene 
expression being vastly altered, alterations in gene expression might manifest in co-
regulated gene sets. Using this technique they describe a coordinated reduction in 
expression of a group of genes involved in oxidative phosphorylation in men of a similar 
age (~60-70 years old) with T2D compared to men without.(87)  
To try and understand the gene expression patterns associated with pathogenesis of T2D, 
Patti et al also examined skeletal muscle gene expression in 10 non-diabetic participants, 
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either with, or without ,a family history of T2D, and 5 participants with diabetes.(86) Fasting 
insulin was higher in the T2D group and also the participants with a family history of T2D 
compared to those without and insulin-sensitivity was reduced in people with T2D and 
those who were healthy but had a family history of T2D. They found that pre-diabetic (the 
study arm who had a family history of T2D) and diabetic skeletal muscle showed 
decreased expression of genes involved in oxidative phosphorylation and that expression 
of the regulator of expression of these genes (PGC1α) was also reduced in these groups 
compared to controls.(86) Participants in this study were fairly young (~30-50 years old) 
and were all American-Mexican ethnicity and, aside from T2D, were otherwise healthy. 
Therefore, the generalizability of these findings to the wider population of people with T2D 
is questionable.    
Nevertheless, these studies both showed reduced PGC1α in the presence of pre-diabetic 
insulin resistance and T2D and, thus, suggested an intrinsic underlying mechanism for 
reduced mitochondrial function in T2D. They also provided evidence for a genetic 
predisposition to reduced oxidative capacity in T2D mitochondrial dysfunction, hinting at a 
causal effect of reduced oxidative capacity in T2D.  
The existence of a causal relationship between mitochondrial dysfunction and insulin 
resistance remains unclear.(129) Plausible mechanisms related to the decrease in 
substrate oxidation are: (1) decreased substrate oxidation leads to lipid accumulation and 
deposition of metabolically active lipid mediators (diacylglycerols (DAG) and ceramides 
(CER)) which inhibit insulin signaling in the cell,(130) and (2) decreased substrate 
oxidation leading to electron leakage from the ETC which results in the formation of 
reactive oxygen species (ROS) that cause damage to mitochondrial components (figure 
1.6).(107)  
67 
 
Figure 1.10 Aspects of mitochondrial dysfunction and potential causal effect on 
insulin resistance. Aspects of mitochondrial dysfunction that result in decreased 
substrate oxidation are shown in (A); reduced mitochondrial content, reduced 
protein content of proteins involved in the electron transport chain (ETC) and 
reduced mitochondrial biogenesis (through reduced expression of regulatory 
transcription factors such as Peroxisome proliferator-activated receptor-Ɣ 
coactivator  (PGC-1α). Potential mechanisms linking reduced substrate oxidation to 
insulin resistance are: ETC electron leakage leading to increased oxidative stress 
and thus a reduction in mitochondrial number and density (B). Cellular lipid 
accumulation resulting in increase in active lipid intermediates; diacylglycerols 
(DAG) and ceramide (CER) which interrupt insulin signaling (C). PKC; Protien kinase 
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C, TAG; triacylglycerols (triglycerides), IRS; insulin receptor substrate, Akt; protein 
kinase B. Figure first described by Montgomery & Turner, 2015.(107) 
Impaired oxidative capacity in association with diabetes has also been captured in vivo as 
a lengthening of the half time (t½) of recovery of PCr immediately post-exercise.(131) This 
method circumvents some of the limitations of removing tissue from its physiological 
environment. However, it does not indicate the precise underlying mechanism of 
dysfunction. It remains unclear whether dysfunction in oxidative capacity is due to intrinsic 
differences in metabolism within mitochondria, or, due to a reduction in the number of 
mitochondrial or the content of mitochondria. Boushel et al suggest that the reduced O2 
flux observed in the presence of T2D can be attributed to a reduction in mitochondrial 
content (quantified in their study as DNA content or citrate synthase activity), not a 
reduction in the ability of mitochondria to perform oxidative phosphorylation (oxygen 
consumption measured in permeabilised muscle fibers as described above).(132) 
Several studies report findings incongruent with the hypothesis that impairments in skeletal 
muscle mitochondrial function are directly caused by insulin resistance or obesity. Trenell 
et al, found no difference in PCr recovery between people with versus without T2D.(133) 
Although it was a small study (n=10 per group), participants were matched for age and 
physical activity level. The study also assessed participants’ response to an 8-week 
walking intervention which they report improved lipid oxidation in the participants with T2D 
but did not improve PCr recovery half time. They suggest that the previous finding that 
max ATP turnover is reduced in T2D could be due to differences in physical activity or a 
deconditioning phenomenon associated with T2D.(134) Van Tienen et al, subsequently 
supported this finding by showing that only inactive patients with a long duration of 
exposure to T2D exhibit impaired oxidative capacity.(135) 
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One very neat study by Ritov et al, presented findings to suggest that mitochondria 
specifically located in the subsarcolemere had reduced ETC activity in the presence of 
T2D compared to lean controls, as well as, obese non-diabetic participants.(136) 
1.4.3 Limitations of the current evidence 
Previous studies investigating metabolic function in the presence/absence of T2D have 
employed small sample numbers; the number of participants recruited to comparison 
groups ranges from 8-12 participants in four commonly referenced sources of 
evidence.(126, 131, 136, 137) While these detailed studies provide important mechanistic 
insights, they do not allow multi-variable analysis and therefore adjustment for co-
morbidities is not possible. Only in 3 small studies have the effects of either fitness, or 
physical activity level, been considered.(76, 133, 135) Often younger participants have 
been recruited for these studies (mean age range was 39-62 years old for the studies 
described above); this is perhaps because younger participants are less likely to have co-
morbidities which complicate analysis and impair exercise capacity. However, with disease 
progress and the effects of aging, results from these studies may not necessarily be 
generalizable to older adults.  
Muscle biopsy samples are frequently used to assess various aspects of mitochondrial 
function.(126, 136, 137) As discussed previously, the consequences of removing tissue 
from its physiological environment may is not fully understood. Furthermore, these 
techniques are based on the assumption that the maximum rate of ATP production, or 
oxygen consumption, achieved by tissue (or isolated mitochondria) in vitro, represents a 
limiting factor in the performance of skeletal muscle for either exercise (most likely elite 
athletes) or glucose clearance. In vivo assessment techniques are useful and, as 
mitochondrial activity is driven by ATP demand, it is additionally informative for techniques 
to permit functional assessments in a dynamic environment. As yet, dynamic in vivo 
assessments of mitochondrial function in people with diabetes have only been conducted 
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in the confines of an MRI scanner.(131) Therefore we do not know to what extent 
exercises, more associated with activities of daily living, are limited by skeletal muscle 
oxidative capacity. 
1.5 Ethnic differences in T2D, cardiorespiratory fitness and 
skeletal muscle oxidative capacity 
1.5.1 Prevalence of T2D  
People originating from India, Pakistan and Bangladesh (referred to here as South Asian 
origin) have a higher prevalence of T2D than people of European origin.(138) This ethnic 
difference has been shown to be marked when South Asians migrate to countries where 
the host population is of European decent.(139, 140) In Western countries, compared to 
Europeans, T2D prevalence is also higher in men and women of African origin.(139, 141) 
Cross-sectional analysis of a tri-ethnic (South Asian, African Caribbean and European), 
population-based cohort of older adults (60-89 years old), living in west London, showed 
that both ethnic minority groups had increased incidence of T2D (34% in Indian Asians 
and 30% of African Caribbean’s) compared to Europeans (14%).(142) In women from both 
groups this difference was attenuated by adjustment for insulin resistance and central 
obesity measured when the participants were middle aged (20 years previously) (adjusted 
sub-hazard ratio’s were: Indian Asian women 0.77 (0.49–1.42), p=0.3 and African 
Caribbean women 1.48 (0.89–2.45), p=0.13). However, in men, the differences in incident 
diabetes could not be accounted for (adjusted sub-hazard ratios were: South Asians 1.98 
(1.52–2.58), p=0.001 and African Caribbean’s, 2.05 (1.46–2.89), p=0.001).(143) Thus, the 
excess risk of T2D is South Asian and African Caribbean men could not clearly be 
explained suggesting that investigation into novel risk factors is necessary.  
Previous analysis showed that insulin levels remain higher in South Asians despite 
adjustment for BMI, waist-hip ratio, and adiposity.(144) BMI cut-off values for obesity 
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related diabetes and insulin resistant-associated metabolic dysfunction are lower in South 
Asians compared to people of European decent.(145) Therefore, it appears that risk 
factors for development of T2D are present at a lower BMI in South Asians than in 
Europeans.(139) 
1.5.2 Cardiovascular disease (CVD)  
South Asians are more susceptible to the adverse effects of T2D; they are at a higher risk 
of developing subsequent cardiovascular diseases (CVD) such as coronary heart disease 
(CHD) and stroke than Europeans. (146, 147) Overall, morbidity and mortality from stroke 
and CHD is higher in South Asians than in their European comparators.(146, 148) 
Although traditional risk factors, such as smoking and diet, are important in South Asians, 
they do not explain the excess risk of CVD in this group. 
Despite the same elevated risk of T2D and stroke, African-Caribbean’s do not appear to 
have the same elevated risk of coronary-heart disease seen in South Asians; in fact, 
coronary disease rates were ~50% lower in African Caribbean’s compared to 
Europeans.(142) The mechanisms for this difference are not entirely clear. However, Park 
et al describe poorer markers of arterial function in South Asians compared to Europeans 
and a stronger association of these with chronic hyperglycaemia (HbA1c).(149) While, in 
contrast, African-Caribbean’s in this study had improved arterial function compared to 
Europeans.(149)  
CVD is a risk factor for subsequent development of heart failure. This is especially 
important in older adults (>75 years old).(150) In addition to the T2D-CVD pathway that 
increases risk of heart failure, T2D also directly increases the risk of heart failure 
independently of CVD; known as diabetic cardiomyopathy. Interestingly, this pathway is 
thought to be driven by metabolic disturbances.(151) Heart failure is recognised as a multi-
system disorder with a key feature being impaired exercise capacity; the extent to which 
exercise capacity (or VO2max) is impaired in heart failure is not always reflected in in an 
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impairment in cardiac (left ventricular) function.(152, 153)  There is increasing interest in a 
cause-effect relationship between skeletal muscle metabolic disruptions and heart failure. 
The ethnic differences in T2D prevalence and the cardiovascular response to 
hyperglycaemia provide an interesting context in which to study the mechanisms of 
development of T2D and its negative cardiovascular consequences. In addition, it has 
been suggested that, with age, patterns of CVD development appear to be different from 
patterns seen in middle-aged populations.(154) Therefore, describing ethnic differences in 
T2D, cardiovascular function and risk factors for its development in aging population is 
constructive towards developing understanding and, perhaps, ethnicity-specific therapy. 
1.5.3 Exercise capacity, cardio-respiratory fitness and physical activity 
Lower cardiorespiratory fitness (V̇O2max)  has been reported in South Asians by several 
study populations, including; college-aged South Asian men,(155) middle-aged, BMI-
matched men and women(156) and healthy age- and BMI-matched men.(157) Lower 
physical activity levels are also described in South Asians.(158) In the UK-based study by 
Ghouri et al, lower habitual physical activity levels did not, however, explain the ethnic 
difference in cardio-respiratory fitness.(157) No data were available for women in this 
study.  
Data from the National Health and Nutrition Examination Survey (NHANES) also suggests 
ethnic differences in cardiorespiratory fitness exist independently of physical activity 
levels.(159) This study characterized participants, living in North America, into self-
identified ethnic groups; non-Hispanic White, non-Hispanic Black, Mexican American, and 
other. Results showed lower cardiorespiratory fitness (estimated V̇O2max) in non-Hispanic 
Black men and men from other racial/ethnic groups compared to non-Hispanic White and 
Mexican American men.(159) As this sample did not include a distinct South Asian group, 
direct comparison between South Asians and African-Americans could not be made. 
There is a known hereditary component to V̇O2max,(160) therefore, it is possible that 
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factors exist, common to ethnic origin, which may be associated with innate differences in 
V̇O2max.  
Hall et al, furthered insight into impaired exercise capacity in south Asians by showing that, 
as well as reduced cardiorespiratory fitness, age and BMI-matched South Asian men have 
reduced capacity to utilize lipid as fuel source during exercise.(161) In the same study they 
also showed that the association between reduced fat oxidation in exercise and lower 
insulin sensitivity is independent of total body adiposity.  
Prevention trials for T2D generally focus on increasing aerobic exercise or physical activity 
levels.(162) It has previously been suggested that guidelines should include higher 
physical activity recommendations for South Asians than Europeans.(163) If the underlying 
components responsible for reduced cardiorespiratory fitness in South Asians were clearly 
understood, guidelines could also include more targeted recommendations for physical 
activity such as specific resistance or cardiovascular exercise programs.  
1.5.4 Skeletal muscle metabolic function 
Forouhi et al observed elevated intra-myocellular lipid (IMCL) in non-diabetic South Asians 
men compared to Europeans also suggesting a deficiency in skeletal muscle lipid 
metabolism.(144) As described above, lipid accumulation has previously been linked to a 
vicious cycle of impaired skeletal muscle oxidative capacity and consequent insulin 
resistance.(107, 126) Observations have been made that the metabolic profile in people 
with and without T2D differs depending on their ethnicity. For example, South Asians are 
dyslipidaemic and have greater central adiposity than Europeans versus the African-
Caribbean’s who are less centrally obese and do not show the same pattern of 
dyslipidaemia.(108, 164, 165) 
However, Nair et al, found that although non-diabetic South Asians (Indian Asians) were 
more insulin resistant, they showed greater mitochondrial DNA abundance, greater 
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maximal ATP production rate and increased citrate synthase activity above rates that the 
found in age, sex and BMI matched Americans of European decent.(166) The study by 
Hall et al, described above, also did not find reduced expression of oxidative metabolism 
genes in the young South Asian men who participated.(161) 
The studies described above all enrolled young or middle-aged, mostly male, participants. 
Ethnic differences in cardiorespiratory fitness and skeletal muscle oxidative capacity have 
not previously been reported together in older adults. Previous studies have enrolled fairly 
small sample sizes, with the exception of Ghouri et al who compared 87 South Asian and 
99 European men. However, their study focused on differences in cardio-respiratory 
fitness between the ethnic groups and its influence on insulin resistance. The determinants 
of reduced cardiorespiratory fitness, or impaired exercise capacity, in older adults from 
different ethnic origins have not previously been described.  
Skeletal muscle measurements have previously all been done from biopsy sample 
analysis (mitochondrial ATP production rate, mtDNA content, citrate synthase activity); an 
overall, in vivo inspection of oxidative capacity by ethic group has not previously been 
described. 
1.6 Near-infrared spectroscopy (NIRS) for skeletal muscle 
measurements  
1.6.1 NIRS technology 
Beer-Lamberts Law 
Near-infrared light can penetrate biological tissues with less scattering and absorption than 
visible light offering a useful property allowing imaging and quantitative measurements in 
tissue.(167) In its simplest form, a NIRS device consists of a light-source emitting 2 or 
more wavelengths of light in the near-infrared range (650–1000nm) and a detector placed 
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at a known distance from the source(s). NIRS uses the principal of Beer-Lambert’s law to 
derive concentrations of chromophores in tissue from changes in absorbance of NIR light 
at specific wavelengths.(168)  
The Beer-Lambert law states that, in a non-scattering medium, for a given substance 
dissolved in a solute, molar absorptivity is constant (i.e. the absorption of photons is 
constant if the concentration of the solute in solution is constant).(168) Thus, the 
absorbance (A) is proportional to concentration (equation 1.2, Beer-Lambert Law). In Beer-
Lambert law; A= absorbance (amount of light absorbed, optical density (OD)), ε= 
absorptivity (absorption coefficient characteristic of the solute) (Mol/cm), l= path-length of 
light traveling through the solution (cm), c= concentration of the solute in solution (Mol). 
The chromophores, Hb and myoglobin (Mb), are oxygen carriers in blood and skeletal 
myocytes, respectively. Their absorbance of near infra-red light differs depending on 
whether they are in an oxygenated or deoxygenated state. Figure 1.7 shows the 
absorptivity (absorption spectrum) for oxygenated and deoxygenated 
hemoglobin/myoglobin.(169) The relative contribution of the two chromophores, 
haemoglobin and myoglobin, to the NIRS signal is discussed later.  
𝐴 (𝐴𝑏𝑠𝑜𝑟𝑏𝑎𝑛𝑐𝑒, 𝑂𝐷) =  𝜀 ∗  𝑙 ∗ 𝑐 (1.2) 
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Figure 1.11 Absorption spectra for oxygenated haemoglobin (HbO2, red) and 
deoxygenated haemoglobin (Hb, blue). This figure was generated from online open 
source data (169). 
The modified Beer-Lamberts law 
The Beer-Lambert law is only valid in non-scattering medium. Biological tissue is not 
homogenous and is therefore considered a scattering medium.(168) A non-homogenous 
medium does not have uniform properties throughout its volume, that is to say, it may 
contain irregular parts within it or layers which scatter light. When light is shone into 
biological tissue it can be either; scattered, absorbed or reflected. A schematic 
representation of light scattering, absorbance and reflection in shown in figure 1.12. 
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Figure 1.12 schematic representation of light transport through biological tissue. 
Light passes into the tissue (incident beam) and can be directly reflected (orange 
arrow), absorbed completely (purple arrow) or diffusely reflected (scattered) where 
its intensity is detected.  
In 1988 Delpy et al, described a modification of the Beer-Lambert Law which accounted for 
the scattering in biological tissue.(170) This was called the modified Beer-Lambert law, it 
permits relative, but not absolute, concentrations of oxy- and deoxy Hb/Mb to be 
estimated.(168, 171)  
 The modified Beer-Lambert law is as follows;  
Where Δc is the relative concentration of the chromophore (mM), ODλ is the optical 
density of the medium, ελ is the extinction coefficient of the chromophore (mM/cm), L is the 
∆𝑐 =  
∆𝑂𝐷𝜆
𝜀𝜆 ∗  𝐿 ∗ 𝐵
 
(1.2) 
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distance between the light source and the detector (4cm) and B is the differential path-
length factor (DPF) to account for the scattering. 
The original NIRS devices were all continuous wave devices. This means the device 
measures only changes in light intensity i.e. near-infrared light is shone into the tissue and 
the intensity of the scattered and diffusely reflected light is measured. Detailed discussion 
of NIRS instrumentation has been reviewed previously.(168) In brief, other than 
continuous wave, devices can be either time- or frequency-resolved. These NIRS 
techniques include a measurement of the absolute optical path-length and the intensity of 
light at the detector. This allows absolute concentration to be measured;(172) however 
scattering (and hence optical path-length) may change in skeletal muscle as a result of 
some typical interventions (e.g. exercise) complicating the interpretation of NIRS 
data.(173, 174) CW NIRS allows higher sampling frequencies than other NIRS devices 
permit. In this light, CW NIRS devices could be considered more robust when used during 
exercise. In this thesis, ‘NIRS’ should be considered as a reference to continuous wave 
NIRS.  
1.6.2 NIRS signal components 
Light passing into blood vessels >1mm diameter should contribute little to NIRS signals as 
it will be almost completely absorbed.(175) Oxy- and deoxy Hb signals therefore represent 
Hb concentrations in blood vessels smaller than this (i.e. small arteries, arterioles, 
capillaries and venules)(137, 176). It is generally assumed that the major part of the Hb-
related NIRS signal arises from capillaries since these micro-vessels compose the largest 
portion of vascular volume in skeletal muscle. However, the synchronous cardiac pulsatile 
nature of the signal observed at rest in both oxy- and deoxy Hb signals from skeletal 
muscle (figure 1.8) suggests that at least some of signal arises from small arteries and 
larger arterioles where cardiac pulsatility has not dissipated.(177) Since arteriolar and 
venular pulsatility are not usually synchronous(177, 178) the presence of simultaneous 
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oscillations in the oxy- and deoxy Hb signal in this example suggests some cross-talk 
between the signals, presumably due to limitations in the homogeneous medium 
assumption and with the use of a mean optical path length.(171)  
 
Figure 1.13 Example data showing pulsatility in the NIRS measured oxygenated 
(HbO2) in red and deoxygenated (HHb) in blue haemoglobin signals.  
Due to the stability of arterial O2 saturation under most conditions, changes in tissue 
saturation index (TSI%) that are unrelated to cardiac pulsatility or muscle contraction, are 
thought to predominantly represent changes in the venous compartment and have been 
used to examine recovery of muscle oxygenation post-exercise.(137, 179)  
1.7 Limitations of NIRS technology  
The central limitation of CW NIRS measurements is that only relative, and not absolute, 
concentrations are possible, as discussed above. To allow comparisons of results to be 
made between subjects, a physiological calibration can be applied; this involves calibration 
of the relative concentration values to a normalized scale: a baseline is achieved by 
application of a total ischaemic occlusion until the oxy-Hb signal plateaus.  
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The hyperaemic response, following cuff release, provides a functional maximum that can 
be used to scale responses.(98, 180) The hyperaemic response to 5 minutes occlusion of 
the brachial artery has recently been reported to show good intra-subject 
reproducibility.(181) The technique may however be limited by poor subject acceptance of 
total occlusion,(182) especially in older adults.  
1.7.1 Adipose tissue thickness  
Adipose tissue thickness at the site of measurement influences NIRS measurements 
through its effect on the scattering properties of the tissue.(183) This has implications for 
the choice of measurement site. For example, thigh muscle (e.g. Vastus Lateralis) is a 
major working muscle for locomotion but the thickness of adipose tissue in the thigh may 
exceed 3cm in people with diabetes.(184) Although not directly related to locomotion, 
muscle in the forearm is often examined because adipose tissue is less thick here and 
occlusive cuffs can be easily applied above the elbow. For NIRS measurements in the 
lower limb of older individuals, the gastrocnemius may be a useful compromise since 
subcutaneous adipose thickness rarely exceeds 1cm at this location.(185) 
1.7.2 The effect of myoglobin  
The spectral absorbance of the oxy- and deoxy-Hb and -Mb is almost 
indistinguishable,(186) therefore, attenuation by skeletal muscle is attributable to both 
chromophores. Estimates of relative contribution from Hb and Mb to the NIRS signal are 
conflicting: Hb has been proposed to contribute as much as ~90%(179) (187) or as little as 
~10-20%(188-190) to the signal. A recent paper by Davis and Barstow(191) critically 
reviewed the topic and estimated the likely contributions of Hb and Mb to NIRS signals 
based on anatomical and experimental data. They suggested that Mb is likely to contribute 
~50-70% of the NIRS signals at rest in many, but not all, mammalian skeletal muscles. 
They also estimated that the relative contribution from Mb was likely to increase during 
exercise.(191) Lai et al. used a mathematical model of O2 transport, metabolism and 
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distribution of blood volume in muscle and suggested that the Mb contribution is dynamic 
and varies in relation to blood flow.(192) On the basis of simulations of muscle response 
under hypoxic and normoxic conditions Spires et al.,(193) suggested the Mb signal would 
be more affected by reductions in blood flow than the Hb signal and proposed that the Mb 
contribution to NIRS signals may therefore differ in disease.(193)  
1.7.3 Skin perfusion  
During exercise skin perfusion may change significantly in response to the rise in body 
temperature(194) and both oxy- and deoxy Hb signals from skin may therefore confound 
the muscle signal. The contribution of skin to the NIRS signal has been considered 
minimal;(179) however, more recent studies indicate a more substantial contribution from 
skin blood flow.(195) Use of spatially resolved techniques may reduce the impact of the 
cutaneous layer.(196)  
1.7.4 Melanin contribution  
Melanin in the skin and Cytochrome C also absorb light in the near infrared range. 
Wassenaar et al, 2005 described attenuation of light reflectance in direct relation to 
increased melanin in a small study.(197) Technological developments addressing signal 
loss, such as increased signal intensity or improved detection, could be useful for reducing 
attenuation.  Applying a physiological calibration (described above) to the signal allows 
inter-subject comparisons to be made with different levels of skin pigmentation. 
1.7.5 Heterogeneity of blood flow in the muscle 
The heterogeneity of blood flow and O2 utilisation within the muscle can only be examined 
if multiple source-detector pairs are used.(198, 199) There has been a recent increase in 
the number of skeletal muscle studies exploiting multi-channel instruments.(69, 200, 201) 
Studies assessing the perfusion/utilisation relationship (matching of O2 delivery to 
requirement) provide a comprehensive assessment of skeletal muscle function but as the 
number of source-detector pairs increases data collection becomes more complex, and 
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less portable. With development of improved analysis techniques and more portable 
complex devices, parameters for assessing ‘matching’ of O2 delivery and utilisation can be 
studied more readily. These studies also highlight the importance of consistent probe 
position within a study where inter-subject comparisons are made using a simple device 
with fewer source-detector pairs.  
Despite these technical limitations, the non-invasive and cost effectiveness of CW NIRS 
makes it attractive. The technology has been developed in small, wireless instruments 
showing good intra- and inter-subject reproducibility.(202, 203)  
1.8 NIRS applications in clinical and research settings 
 NIRS has previously been used in various clinical populations where O2 delivery and/or 
utilization of O2 are implicated in the disease process.(204) Examples include muscle 
myopathies, (205) diseases causing muscle atrophy,(206) heart failure(207, 208) and 
peripheral arterial (or vascular) disease(209) (PAD). Parameters described in studies 
using NIRS are based on response to exercise and response to simple physiological 
interventions (arterial and venous occlusion). These include: post-exercise recovery time 
constants and recovery half time of tissue saturation, post-occlusion recovery time and 
recovery half-time of tissue saturation, hyperaemic response post-occlusion and recovery 
time constant for rate of V̇O2. 
As described previously, oxidative capacity within skeletal muscle can be measured using 
techniques involving  muscle biopsies or magnetic resonance spectroscopy (MRS).(73) 
However, repeated biopsies are uncomfortable for participants and MRS is an expensive 
tool. 
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1.8.1 Resting muscle oxygen consumption (V̇O2) measured with NIRS 
In the absence of changes in blood volume, NIRS signals represent the balance between 
O2 delivery and consumption. Applying an arterial or venous occlusion above the site of 
measurement can be used to provide a measure of local muscle V̇O2.(210) An arterial 
occlusion creates a closed circuit system with no blood flow in or out; therefore, in the 
absence of volume change between vascular compartments within the occluded tissue, 
the rate of decrease in oxy-Hb (or deoxy-Hb increase) is a measure of muscle V̇O2. During 
venous occlusion, arterial blood flow is maintained but venous outflow is obstructed until 
venous pressure exceeds the pressure in the occluding cuff. In the early quasi-linear 
phase following inflation of the venous occlusion cuff, the rate of increase in Hb is 
therefore proportional to inflow; if it is assumed that blood flow matches V̇O2, the rate of 
increase in deoxy-Hb represents V̇O2.(211)  
Studies comparing  V̇O2 measured by venous and arterial occlusion have reported 
moderate correlations (Pearson’s r = 0.647(210) and Spearman’s rho = 0.41(211)) but in 
both studies venous occlusion yielded estimates of resting V̇O2 that were ~14-25% higher 
than values calculated following arterial occlusion. The lower values measured by arterial 
occlusion may be explained by continued inflow of arterial blood during venous occlusion. 
Venous occlusion derived V̇O2 values show higher variability(211) and poorer 
reproducibility.(212) Therefore, muscle V̇O2 was derived from arterial occlusions only in 
this thesis.  
1.8.2 Exercise muscle V̇O2 measured with NIRS 
Exercise induces a large increase in muscle blood flow(213). During rhythmic exercise the 
muscle pump action acts on blood vessels to elicit volumetric shifts,(214) these can be 
seen as cyclic changes in the oxy- and deoxy-Hb signals, corresponding to stepping 
action. Performing arterial occlusions to estimate V̇O2 throughout exercise is not practical 
and unlikely to yield useful information. A simple alternative is to surmise that immediately 
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post-exercise the V̇O2 determined via arterial occlusion is equivalent to the V̇O2 during the 
final stages of the exercising protocol.(215) 
1.8.3 Skeletal muscle oxidative capacity 
A process of transient arterial occlusions in the immediate post-exercise period, originally 
described by Motobe et al in 2004,(216) can be used to generate a time constant, τ, for 
recovery of muscle V̇O2. As discussed above this represents skeletal muscle oxidative 
capacity. Good agreement has been demonstrated between NIRS derived recovery time 
constants and phosphocreatine (PCr) recovery time constants found with MRS(217) as 
well as good correlation with in vitro assessed oxidative capacity via muscle biopsy 
analysis.(218) The technique has shown good reproducibility that is uninfluenced by the 
type of exercise in healthy individuals (215, 219) and in patients with COPD.(220) 
Sensitivity of the time constant to athletic capacity has been demonstrated by several 
groups.(99, 221) Brizendine et al. reported muscle V̇O2 recovery time constants of the 
Vastus lateralis were nearly twice as fast in endurance athletes as non-athletic, age-
matched controls.(99) The effects of training and de-training on the recovery time constant 
of muscle V̇O2 measured by NIRS have also been shown in wrist flexor muscles.(222) 
1.9 Research questions 
The focus of this thesis is to investigate skeletal-muscle metabolic function, specifically 
oxidative capacity, and cardio-respiratory fitness and how they influence exercise capacity.  
The main questions to be addressed in this thesis are:  
1. How reproducible is the 6MST for assessment of sub-maximal exercise capacity 
and prediction of cardiorespiratory fitness in older adults (>65 years old)? 
2. How reproducible are NIRS-derived assessments of skeletal muscle oxidative 
capacity in the context of the 6MST? 
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3. What are the reasons for early 6MST termination? And are they different between 
people with versus without T2D? 
4. Are there differences in sub-maximal exercise capacity and skeletal muscle 
oxidative capacity between older adults with and without T2D? Is the relationship 
between submaximal exercise capacity and skeletal muscle oxidative capacity 
different between people with and without T2D? 
5. Are there ethnic differences in sub-maximal exercise capacity (6MST and grip-
strength) in older adults originating from South Asia, the Caribbean and Europe? 
And is oxygen uptake or predicted maximum oxygen uptake different by ethnic 
group?  
6. Is skeletal muscle oxidative capacity different between ethnic groups? And can 
this explain differences in exercise capacity/cardiorespiratory fitness? 
7. Does endurance exercise training improve skeletal muscle metabolic function in 
sedentary adults undertaking their first marathon without supervised training? 
8. Is skeletal muscle oxidative capacity and cardio-respiratory fitness independently 
associated with exercise capacity? 
Chapter-specific objectives are laid out in more detail at the end of each introduction 
section.  
1.10 Hypotheses  
The main hypotheses are:  
1. The 6MST will assess sub-maximal exercise capacity in older adults reproducibly 
and NIRS-derived assessments of skeletal muscle oxidative capacity will be 
reproducibly measured. 
2. Sub-maximal exercise capacity and skeletal muscle oxidative capacity will be 
impaired in older adults with T2D 
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3. Sub-maximal exercise capacity and cardio-respiratory fitness will be lower in older 
adults originating from South Asia compared to Europe. 
4. Is skeletal muscle oxidative capacity will be lower in older adults originating from 
South Asia compared to Europe and this will explain some of the differences in 
exercise capacity/cardiorespiratory fitness 
5. Endurance exercise training will improve cardiorespiratory fitness and skeletal 
muscle metabolic function in young, healthy sedentary participants.  
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Chapter 2: General methods  
2.1 Participants 
2.1.1 Older adult participants 
 
The older adults described in this thesis belong to a longitudinal, population-based cohort 
study called the Southall And BRent REvisited (SABRE) study. SABRE is a tri-ethnic 
cohort study comprised of first generation South Asian and African-Caribbean migrants 
and European individuals who were resident in West London, UK, at the time of initial 
recruitment in 1988. Tillin et al provided a full cohort profile in 2012.(223) SABRE 
originated as a combination of 2 studies; The Southall study and The Brent study.(224)  
The Southall study was designed in response to the observation that Indian Asians 
migrating to the UK (and other countries) were at greater risk of cardiovascular disease 
(coronary heart disease and stroke) and had higher rates of diabetes that their Caucasian 
counterparts.(224) The Brent study focused on health differences between white 
Europeans and African-Caribbean migrants to the UK. The latter group having high rates 
of diabetes and hypertension but paradoxically lower rates of coronary heart disease(225) 
Between 2008 and 2011 a 20-year follow-up was carried out of the original SABRE study 
participants. The objective of this follow-up was to further elucidate ethnic differences and 
to understand mechanisms underlying these differences in cardiometabolic risk. 
Information on survival and cardiometabolic morbidity was collected via questionnaires 
and healthcare record review. Participants were invited to attend a follow-up clinic day that 
included detailed cardiovascular phenotyping to determine the presence of pre-clinical 
cardiovascular disease or diabetes. Full details of attendance and measurements carried 
out can be found in the cohort profile.(223)  
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In this thesis the older adult population described in subsequent chapters were SABRE 
study participants who agreed to undertake a third follow-up clinic visit (2014-2018). In 
addition to the index participants (original SABRE study members) spouses or partners of 
participants were invited to participate. The (2008-2011) 20-year follow-up clinic attendees 
comprised 522 Indian Asians, 232 African Caribbean’s and 684 Europeans (total: 1438), 
this included 451 participants (31%) undergoing treatment for diabetes and 365 
participants (25%) with an ejection fraction <55%, indicating some level of systolic 
dysfunction. Therefore, the 2014-2018 third clinic visit provides apposite opportunity to 
investigate differences in exercise capacity and skeletal muscle function between ethnic 
groups with, or without, diabetes. 
2.1.2 Young adult participants undertaking Marathon training 
Young adult participants included in this thesis had been enrolled in a prospective 
observational study investigating the effect of training for a marathon for the first time on 
cardiac remodeling: The Marathon Study.  
The Marathon Study recruited young healthy men and women who had never previously 
run a Marathon and self-reported little or no current participation in running. Inclusion 
criteria were: age 18-35 years old at recruitment, no past significant medical history, no 
previous marathon-running experience and less than 2 hours of running participation per 
week at recruitment. As the majority of people who enter to run a marathon are not elite 
athletes and race entry requires no prior marathon running experience or qualifying time, 
the study inclusion criteria were set in order to allow a representative sample of the novice 
runners to be recruited. A Consort flow diagram describes the recruitment process and 
attrition to the study for all participants enrolled in The Marathon Study (figure 2.1). Details 
of the sub-group of participants who underwent skeletal muscle measurements are 
provided in the results section of Chapter 6.  
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Figure 2.1 Consort flow diagram describing the recruitment, attendance and drop-
out for The Marathon Study in full. Unpublished data with permission from the 
authors.  
Participant characteristics and basic results from the CPET for all participants enrolled in 
The Marathon Study pre-training and post-training are provided in table 2.1.  
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
	
Total marathon runner places 2016 
(n=51000) 
Excluded  (n= 220) 
¨			Not meeting inclusion criteria (n= 42) 
¨			Declined to participate (n= 23) 
¨			Unavailable for recruitment (n= 155) 
Attended second time point  (n=92) 
¨			Completed marathon and training (n=68)* 
¨			Injured during training (n=24) 
 
Recruited into study (n=120) 
	
Follow-Up	
Targeted population receiving E-mail 
advertisement (n=4170) 
 
Enrollment	
Lost to follow-up  (n=28) 
¨			Excluded on discovery of LQTS (n= 1) 
¨			Unavailable for appointments (n=23) 
¨			Unable to contact (n= 3) 
¨			Declined to continue in study (n= 1) 
 
Subjects contacting study team (n=340) 
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Table 2.1 Participant characteristics and cardiopulmonary exercise test results for 
all participants enrolled in The Marathon Study. Data expressed as mean±SD if 
normally distributed and median [IQR] if non-normally distributed. BMI, body mass 
index; BP, blood pressure; VO2 oxygen consumption. 
2.2 Exercise testing in older adults 
2.2.1 The 6-minute stepper test 
The exercise test used to test exercise capacity in the older adult population was a self-
paced, 6MST (Homcom, miniStepper), as pictured (figure 2.2). Exclusion criteria were 
based on the ATS/ACCP guidelines(17) and included; angina or a recent cardiovascular 
event (MI, stroke, TIA), an uncontrolled arrhythmia, uncontrolled arterial hypertension, 
severe aortic stenosis, severe symptoms of COPD and any orthopedic impairment 
severely compromising exercise performance. Reason for exclusion was recorded if the 
participant met criteria. 
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The testing protocol is described to participants using the following instructions: 
 The objective of this test is to complete as many steps as possible within 6 minutes 
 Start at a pace you feel you could continue at for 6 minutes and try to maintain this 
pace 
 If you become exhausted or experience dizziness or chest pain please stop 
immediately 
Prior to undertaking the test participants were permitted to familiarize themselves with the 
stepping procedure, all participants were permitted to use the custom-built wall support for 
balance during the test if necessary. Termination of the test prior to 6 minutes was made 
based on ATS/ACCP guidelines(17) or because the participant reported intolerable 
dyspnea or muscle fatigue. Participants were not permitted to re-start stepping if they 
stopped before 6 minutes was completed. Duration was not limited by heart rate in line 
with previous research (226). The number of steps completed and duration was recorded; 
if 6 minutes was not completed, the reason for early termination of the test was recorded. 
Number of steps completed was divided by duration (minutes) to determine step-rate 
(steps/min). At the end of the test, participants were asked to grade their perceived level of 
exertion on a 0-10 Borg scale where 0 is resting and 10 is maximal exertion.(227) 
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Figure 2.2 A & B. Example set-up for the 6-minute stepper test (6MST). Rails are 
fixed on the wall for support (A). A face mask covers the mouth and nose (B) and 
portable gas analyzer allow gas exchange to be measured. Other physiological 
measurements; blood pressure and muscle oxygenation are also demonstrated 
here (A).   
2.2.2 Calibration of the stepper 
Calibration of the stepper was carried out using weights and a tape measure. The tape 
measure is used to measure the distance from the underside of the pedal to the red floor 
bar. Height can be adjusted via a dial at the front of the stepper; clockwise raises the 
height of the pedals. At maximum height there was a distance of 24 cm (figure 2.3), this 
allowed the distance that the foot travelled with one step to be 15cm. 
The weights were used to check that, with time, the resistance, from the hydraulic jacks, 
did not drift up or down i.e. pedals do not become easier/harder to depress. It should 
require no less or no more than 5Kg + the weight of the bar (4X1.25kg weights on the bar) 
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to initiate a downward motion of either pedal from a starting point of its highest (figure 2.3). 
To check this, the following steps were taken:  
 Using the right foot pedal, place one 1.25kg weight on the right of the bar and 
screw it to the bar, add the 3 other 1.25kg weights sequentially to the left side of 
the bar 
 The pedal should not start to move downwards until the third 1.25kg weight has 
been added to the left side of the bar 
 Repeat the above steps for the left pedal 
Calibration of the stepper was performed several times in the initial few weeks of the 
study. The settings were found to be stable across these initial calibrations; therefore, the 
calibration interval was increased to 3-4 months.   
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Figure 2.3 Process for calibration of the stepper for the 6-minute stepper test. The 
height is calibrated to ensure the pedal travels a vertical distance of 15cm; the 
distance from the bottom of the pedal to the floor is 24cm (left panel). The hydraulic 
jacks are calibrated using four 1.25 weights (right panel). 
2.2.3 Heart rate and V̇O2 measurement during the 6MST 
Heart rate and expired gas variables were measured continuously throughout the 6MST 
using a heart rate monitor strap and portable gas analyzer, belonging to the same system 
(K4b2, CosMed, Rome ). The gas analyzer was warmed-up prior to calibration which was 
carried out between tests according to manufacturer guidelines.(228) Three stages of the 
calibration are; (1) room air calibration which determined temperatures, pressures and 
humidity of the air in the testing room as well as % O2 and CO2 in the room air (2) 
reference gas calibration using a cylinder of known mixed gas concentrations (16% O2, 5% 
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CO2; BAL. N2) and (3) turbine calibration using a 3L syringe. Gas delay calibration was 
performed every 2 weeks which involved timed breathing through the turbine.  
One of 3 masks (small, medium or large) was selected for the participant and fitted 
securely over the participant’s nose and mouth and the straps adjusted over the head; 
care was taken to ensure there were no air was leaking through the mask by asking the 
participant to breath out for a very short period against a blocked flow turbine.  
The portable gas analyzer was not validated to a larger CPET platform for the purpose of 
this study. A comparison of portable gas analyzers previously found V̇O2max differences of 
between 0.01-0.29L/min during submaximal exercise between devices.(229) Direct 
comparison of the K4 device with a large platform stationary gas exchange system 
(Medgraphics D-Series) has also been independently carried out, funded by the National 
Institute for Health (NIH). This study reported excellent agreement between the 2 systems 
when measuring during steady-state, self-paced exercise on a treadmill; ICC ranged from 
0.93 to 0.97 for weight indexed V̇O2max (ml/kg/min), total V̇O2max (ml/min), and VCO2 
(ml/min).(230) The O2 cell in the K4 device was replaced 3 times across the whole of the 
data collection phase as recommended by the manufacturer.  
2.2.4 Post-processing  
Breath-by-breath values for V̇O2 and heart rate were collated using manufacturer software 
(OMNIA, CosMed, Rome) and, for each participant, values were exported to excel. Post-
processing of expired gas analysis and heart rate was carried out using open source 
software (Python Software Foundation, version 2.7. http://www.python.org) and custom 
written scripts. Measured oxygen consumption (V̇O2, ml/min/kg) is reported as the highest 
value determined from a rolling 60-second average calculated across the duration of 
exercise. Peak heart rate is reported as the highest measured value determined from a 
rolling 60-second average calculated across the duration of exercise.  
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Predicted maximal heart rate (maxHR) was estimated using two equations (1 & 2) 
commonly used in the literature(231, 232) : 
𝑚𝑎𝑥𝐻𝑅(𝐹𝑜𝑥)  =  220 –  𝑎𝑔𝑒 (𝑦𝑟) (2.1) 
     𝑚𝑎𝑥𝐻𝑅(𝑇𝑎𝑛𝑎𝑘𝑎) =  208 − (0.7 ×   𝑎𝑔𝑒 (𝑦𝑟)) (2.2) 
The percentage of predicted maximum heart rate achieved was calculated from the 
achieved heart rate (measured) and the predicted max heart rate for both methods 
described above. 
2.2.5 Exercise blood pressure 
Blood pressure was measured using a motion-insensitive validated device (Tango M2, 
SunTech) at rest, 2, 4 and 6 minutes following the start of exercise, immediately post-
exercise termination and at 3 minutes recovery. Measurements were carried out on the 
participant’s non-dominant arm (the arm belonging to their hand which they do not use for 
writing). Participants were asked to relax their non-dominant arm grip on the rails during 
the measurement.  
2.3 Exercise testing in young adults pre- and post-marathon 
2.3.1 Semi-supine ergometer 
The CPET in the Marathon Study was carried out on a semi-supine ergometer 
(Ergoselect1200, Ergoline, Germany) (figure 2.4) paired to software that allowed an 
incremental workload protocol to be programmed (OMNIA, Quark CPET, CosMed, Rome). 
A semi-supine ergometer was used to allow concurrent echocardiography to be performed 
during exercise; echocardiographic results are not presented in this thesis.  
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The participant was invited to sit on the recumbent cycle ergometer and place their feet on 
the pedals. The seat height, arm rest and head rest were adjusted to ensure safety and 
comfort. Feet were then strapped securely into the pedals using Velcro and the waistband 
was placed around the participant to hold the torso securely on the ergometer. The 
backwards tilt of the ergometer was kept the same for each test. 
 
Figure 2.4 Example experimental set up of the supine cycle ergometer 
(Ergoselect1200) used for cardio-pulmonary exercise testing in young adult 
participants of The Marathon Study.  
2.3.2 Analysis of expired gas and heart rate during exercise  
Expired gases were analyzed throughout using a metabolic cart system (Quark CPET, 
CosMed, Rome). The Quark CPET includes a fast-response O2 sensor to measure 
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changes in total body oxygen consumption and rapid infrared for changes in CO2 as well 
as a bidirectional flow-meter for respiratory changes.  
The machine was warmed-up for 15 minutes prior to first test of the day. Calibration of the 
flow meter was carried out using a 3L syringe. The gas sensors were calibrated using a 
cylinder of known concentrations of mixed gas (16% O2, 5% CO2; BAL. N2). Calibration of 
room air was also performed. All calibrations were carried out according to the 
manufacturer’s instructions at the start of the day and after, at most, 3 tests; or more 
frequently at the discretion of the lead technician.  
ECG electrodes were attached across the participant’s chest; these were not placed in the 
standard position in order to allow access to echocardiographic windows. The ECG leads 
were visualized on a PC using software (Quark T12x, CosMed, Rome) to ensure the QRS 
complex could be visualised; the R-wave is used by the software to continuously measure 
heart rate. The EGC is monitored throughout the test for presence of abnormal rhythms or 
ECG changes that indicate ischemia.  
A blood pressure cuff was placed around the participants arm above the elbow. 
Measurements were made at rest, at 2 minute intervals throughout exercise and at the end 
of the recovery phase. 
A mask was fitted and adjusted securely across the participant’s nose and mouth. Care 
was taken to ensure there were no leaks around the seal between the mask and the face.  
The participant’s height, weight, age and unique ID number were entered into the gas 
analysis software. An incremental testing protocol was used for all participants; for men 
workload increments were 25 Watts per minute (W/min) and for women 20W/min. This 
could be adjusted at the discretion of the lead technician according to the participant’s 
body size: If participants are shorter than average (<160 cm women; <170 cm men) 
deduct 5 W/min and if participants are taller than average (>180 women; >190 cm men) 
add 5 W/min. All technicians were trained and experienced in exercise testing and had 
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discussed the process of protocol allocation in previous study meetings. The decision to 
allocate different protocols was made with the objective of each participant exercising for 
roughly the same amount of time (despite reaching different workloads). 
Participants were given a 2 minute resting phase while wearing the face mask followed by 
a 3-minute unloaded pedalling phase as a warm-up before the incremental protocol began. 
2.3.3 Terminating the test 
All participants were required to achieve a respiratory exchange ratio (RER) value above 
1.1 during the CPET, however, the test was not terminated until the participant reported 
exhaustion or could no longer maintain the cycling cadence (~60-70rpm). Encouragement 
was given by the technician for the participant to continue pedalling at a cadence >60rpm 
as long as possible.  
2.3.4 Post-processing 
The peakV̇O2 was determined as the rolling 30-second average value between the final 
15-seconds of exercise and first 15-seconds of recovery. Maximal predicted V̇O2 was 
calculated according to the equation by Wasserman et al,(188, 189) and the percentage of 
this predicted value reached during the exercise test was calculated. Resting heart rate 
was measured using a 12-lead ECG conducted in the semi-recumbent position, 45 
degrees to the horizontal, following a 2-5 minute resting period. Peak heart rate was the 
highest rolling 60-second average value during the final 30-seconds of exercise. 
2.4 skeletal muscle measurements 
2.4.1 NIRS device 
All skeletal muscle measurements included in this thesis were made using the same 
commercially available continuous wave NIRS device (Portamon, Artinis Medical Systems, 
Netherlands). This device is a portable wireless system with 3 light sources each emitting 
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2 wavelengths of light (730nm and 830nm) and one detector. Changes in oxy-Hb, deoxy-
Hb, total-Hb and the difference between oxy- and deoxy-Hb (diff-Hb) were measured from 
the lateral gastrocnemius.  
Position and orientation of the device was standardized between individuals. The device 
was attached using tape and covered completely using a neoprene sleeve. Measurements 
were acquired at a frequency of 10Hz throughout all protocols (figure 2.5).  
 
Figure 2.5 A, B, C & D. Example set up of the 6-minute stepper test (6MST) including 
skeletal muscle monitoring with near-infrared spectroscopy (NIRS) and the rapid 
inflation cuff for arterial occlusions. The 6MST set up is shown (B) including the 
face mask for analysis of expired gases (A). The NIRS device (Portamon) is attached 
to the lateral gastrocnemius of the left leg (C & D) and covered entirely by a 
neoprene sleeve (C).  The occlusion cuff is wrapped around the upper leg directly 
above the patellofemoral articulation (C). 
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The gastrocnemius was selected for measurement because it is likely to be covered by 
less adipose tissue than the thigh or larger locomotive muscles (233) therefore the 
influence of adipose tissue thickness (ATT) on NIRS measurements is less.  
2.4.2 Measuring ATT 
Prior to attaching the NIRS device, ATT was measured at the site of NIRS measurement 
using B-mode ultrasound (vivid I, GE healthcare) equipped with a 3.5-10MHz linear array 
transducer. Higher frequency ultrasound produces better resolution but is limited in depth 
while lower frequencies allow greater depths but have poorer resolution.(234) The 
ultrasound transducer was placed on the measurement site over the skin and was 
orientated longitudinally along the direction of the muscle fibres, a thick layer of ultrasound 
gel was applied under the transducer so that minimal force could be applied to avoid 
compression of the adipose layer. Analysis was made offline using GE software; fat was 
measured using onscreen electronic callipers and defined as the perpendicular distance 
between the upper border of the dermal/adipose interface and the upper border of the 
adipose/muscle interface (Figure 2.6). Three measurements were made and the final ATT 
calculated as the average.  
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Figure 2.6 An example measurement of adipose tissue thickness (ATT) above the 
gastrocnemius. Measurements were conducted using B-mode ultrasound (vivid I, 
GE healthcare) equipped with a 3.5-10MHz linear array transducer. A thick layer of 
ultrasound gel is applied above the skin to allow propagation of ultrasound waves 
with minimal pressure to the area of interest.  
2.4.3 Arterial occlusions 
An arterial occlusion prevents blood from flowing into, or out of, the tissue of interest. In a 
limb, it is applied proximal (closer to the heart) to the tissue of interest and is usually 
performed using an inflatable cuff and a sphygmanomometer which allows measurement 
of the pressure which the cuff is applying around the limb. This allows the pressure to be 
adjusted appropriately; in the case of an arterial occlusion a pressure above systolic blood 
pressure is necessary to illicit a total arterial occlusion (figure 2.7). 
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Figure 2.7 schematic representation of a total arterial occlusion. A picture of the cuff 
position and near infrared spectroscopy (NIRS) device position (right side) and a 
schematic diagram of the effect of cuff occlusion on the underlying blood vessels 
(left side) is shown.  
Arterial occlusions were performed at rest and immediately following the exercise test 
using a rapid inflation cuff (Hokanson, SC10D/E20, PMS Instruments, UK) placed on the 
thigh directly above the patellofemoral articulation (figure 2.7). The cuff was inflated to a 
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pressure above 250mmHg and inflation or deflation was complete in 0.3 seconds. At rest 
the cuff was inflated twice for 30 seconds each time, post-exercise the occlusion duration 
was 5-8 seconds. Care was taken to minimize the time from the end of exercise to the 
initial occlusion post-exercise by leaving the cuff in place throughout exercise, however, 
one limitation of this method is that, despite care, the time from the end of exercise to the 
initial occlusion of the recovery phase may vary between participants. 
2.4.4 Post processing NIRS signals; resting and post-exercise muscleV̇O2  
Analysis of NIRS data was conducted using custom written programs in MATLAB R2014a 
(MathWorks Inc.). Signals were rejected if visual inspection showed movement artifact or if 
there was evidence that complete arterial occlusion had not been achieved. Complete 
arterial occlusion was judged on (a) absence of a pulsatile signal in the oxy-Hb signal and 
(b) the direction of the oxy-Hb and deoxy-Hb signals which, under complete arterial 
occlusion, are expected to move in opposite directions. Presence of movement artifact 
was assessed by the person analyzing the signals and was assigned if there was so much 
artifact in the signal that the appearance of the downward slope of oxy-Hb during the 
occlusion could not be identified.  
Example data from one participant is shown in Figure 2.8 A. Resting and post-exercise 
muscleV̇O2 measurements were estimated by fitting the slope of the difference between 
oxy-Hb and deoxy-Hb signal during each occlusion (Figure 2.8 B & C).(235) Using the 
difference signal is in line with previous research suggesting a greater signal-noise-ratio 
and that this method corrects for blood volume shifts that may accompany arterial 
occlusion. (236) More negative values represent higher muscle oxygen consumption 
(oxygen declines with consumption); therefore, in order to align our values with the cardio-
pulmonary peak V̇O2 and simplify statistical interpretation, we inverted the values to 
provide a positive indices of muscle oxygen consumption (Figure 2.8 D). Exercise-related 
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increases in muscleV̇O2 (ΔmusV̇O2) were calculated as the absolute difference between 
resting muscleV̇O2 and muscleV̇O2 measured immediately post-exercise (Figure 2.8 D).  
Therefore, three indices of muscle oxygen consumption were calculated for each 
participant; resting muscleV̇O2, post-exercise muscleV̇O2 and the difference ΔmusV̇O2.  
The units for these indices are changes in the difference between oxy-Hb and deoxy-Hb in 
micro-molars per second (∆HbdiffµM/s).  
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Figure 2.8 A, B, C, D & E. Example data from one participant for the process of data 
collection and post-processing for generation of skeletal muscle measurements 
using NIRS. Example NIRS data collected before, during and after a period of 
exercise; changes in oxy-Hb (red), deoxy-Hb (blue) and the difference between them 
(diff-Hb; green) are shown (A). A 30-second arterial occlusion is performed at rest in 
order to derive resting muscleV̇O2 from the slope of the difference between oxy-Hb 
and deoxy-Hb. Vertical dashed lines show the onset of occlusion and release of cuff 
(B). Immediately post-exercise transient 5-8 second arterial occlusions are 
performed throughout a 3-minute recovery period; the first 2 minutes of recovery is 
shown here. The initial occlusion is used to derive post-exercise muscleV̇O2 (C). The 
time constant for V̇O2 recovery (τ) is generated using the subsequent transient 
occlusions carried out through the recovery period (E). The example values for each 
measurement are given (D). 
2.4.5 Correction for ATT 
Variance in ATT affects NIRS signals (237, 238) and the influence of ATT on 
measurements of muscle oxygen consumption rate should not be ignored.(239) During an 
arterial occlusion, oxygen consumption rate measured by NIRS is underestimated with 
increasing ATT.(235) Various methods for correcting for ATT during occlusions have been 
described(237, 239, 240) based on phantom studies and Monte Carlo simulations.(241)  
Niwayama et al, provided a simple equation for generating an ATT correction factor which 
can be used to correct the values derived from the slope of decline in oxy-Hb during 
ischemic occlusions.(240) It was later reported that these values compared well with 31P-
MRS (previously named 31P-NMR) measurements of muscle V̇O2.(242)  
Resting and peak muscleV̇O2 were corrected for ATT using a correction factor calculated 
from the measured ATT according to an equation previously determined using model data 
and simulations,(240, 243) the equation is as follows: 
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𝑆𝑚𝑢𝑠𝑐𝑙𝑒 =  exp [− (
h
𝐴
)
2
] 
(3.1) 
        
Where Smuscle is the correction factor to be applied to the NIRS-measured oxygen 
consumption, h is the measured adipose tissue thickness and A is a constant depending 
on the separation of the light source and detector in the NIRs device (4cm in the Portamon 
which was used here).  
2.4.6 The time constant for muscleV̇O2 recovery  
The time constant (τ) was derived by fitting a slope to the changing diff-Hb signal during 
each of the occlusions throughout the recovery period. Each slope was then plotted 
against time (figure 2.8 E) and these data were fit to a mono-exponential curve to derive τ. 
Goodness of fit for the curve was defined as the r2 of the time constant values were 
rejected if the r2 for the curve fit to the data was <0.6. The specific cut-off value of 0.6 was 
selected arbitrarily based on the reasonable assumption that if less than 60% of the 
variation in the data points could not be explained by a mono-exponential curve, then there 
was likely to be excessive noise in the signal. When the distribution of the r2 values was 
examined <5% of the curves have an r2 <0.6.  
2.4.7 ATT corrected muscleV̇O2 versus cardio-respiratory peak measured V̇O2 
ATT-corrected values of muscle V̇O2 at rest and immediately post-exercise were higher 
than the uncorrected values; because correction factors were always < 1 (table 2.2).  
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Table 2.2 Median (IQR) values of skeletal muscle oxygen consumption (muscle V̇O2) 
at rest and immediately post-exercise with and without a correction for adipose 
tissue thickness (ATT) 
Corrected and uncorrected values of muscle V̇O2 at rest are presented against ATT 
measurements in figure 2.9. ATT-corrected values of resting and post-exercise muscleV̇O2 
were higher and had a greater scatter around the mean than the uncorrected values. The 
median uncorrected values for resting and exercise muscle V̇O2 are ~40% smaller than 
the corrected values; this is similar to other groups who have reported mean values ~50% 
lower.(240) In figure 2.9 corrected and uncorrected values are plotted against ATT. One 
previous study also made this comparison, although they present their values in different 
units and fewer participants were enrolled, the relationship between corrected and 
uncorrected tracks the changes in ATT with a similar trend.(242) 
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Figure 2.9 Corrected and uncorrected muscle oxygen consumption (muscleV̇O2). 
Resting values are plotted versus adipose tissue thickness measured locally at the 
V̇O2 measurement site. ATT-corrected values (blue points) and uncorrected (pink 
points) are shown with the line of best fit plotted for each relationship to ATT.  
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Chapter 3: reproducibility of assessment of 
exercise capacity using the 6MST and skeletal 
muscle oxidative capacity using NIRS 
3.1 Introduction 
3.1.1 Overview 
Exercise capacity is an importance facet of physical function, as described above. It is 
valuable to develop methods for determining exercise capacity in older adults because of 
the known decline in both physical function with age and in disease processes associated 
with age.  
Cardio-respiratory fitness is measured as V̇O2max which is the maximum capacity for 
oxygen uptake measured at the whole body level. V̇O2max is the gold standard marker of 
cardio-respiratory health and it has previously been shown to predict cardiovascular 
morbidity, cardiovascular mortality and all-cause mortality.(62, 64)  
Skeletal muscle metabolic dysfunction is associated with a number of diseases (126, 208) 
and is also thought to decline with healthy ageing (244, 245) (as described in Chapter 1). It 
is therefore valuable to develop and understand methods which assess skeletal muscle 
metabolic function and are suitable for use in age-diverse populations. It is also valuable to 
develop methods that can be paired with exercise testing to allow the physiological limits 
of the muscle to be assessed.  
3.1.2 Assessing exercise capacity 
An exhaustive cardio-pulmonary exercise test (CPET) is the most well established test for 
determining V̇O2max. However, this may not be acceptable to older individuals, in whom 
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up to 50% may be unable or unwilling to undertake maximal exercise testing.(15, 246) 
Moreover, in older adults achievement on these testing protocols may not represent real-
life functionality (247, 248) and exercise to exhaustion is often not achieved (67). 
Exhaustive CPETs are time-consuming, require specialist exercise laboratory testing 
facilities and, as they carry risk of adverse events, should be carried out under trained 
medical supervision. Submaximal exercise testing is a valuable alternative(21) and 
numerous ways of predicting V̇O2max from submaximal test results have been 
described.(22) 
Incremental protocols, regardless of modality, also pose the difficulty of selecting an initial 
work rate. An initial work rate needs to be achievable and also provide adequate exertion 
from which increments in power can be added resulting in either maximal or submaximal 
exertion being reached at a similar time across the individuals being compared. The initial 
workload that can be tolerated by older adults, which still allows higher workloads to be 
achieved, will be considerably different between individuals as, while absolute exercise 
capacity declines with age, heterogeneity in achievable capacity increases. Allowing 
participants to exercise at a continuous, self-selected pace circumvents these difficulties 
and has been shown to provide reproducible outcomes.(249) It is also likely to improve 
acceptability by older adults who become anxious performing even the lowest 
programmable workloads on treadmills.    
In older adults barriers to performing well on exercise testing protocols are often related to 
poor balance and frailty(13). Self-paced walking tests, such as the 6 minute walk test, 
have previously been well tolerated in older adult population studies (250, 251) but are 
limited by the need for a long corridor (20)  and are not conducive to accurately measuring 
physiological changes during the exercise period such as observing skeletal muscle 
changes.  
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To address some of these limitations a 6-minute step test (6MST) was developed for 
patients with chronic obstructive pulmonary disease (COPD) (252). Borel et al, 2010(253) 
used the test in a group comprising older people with COPD and healthy young 
participants (COPD patients mean age: 61.4 years, healthy subjects mean age: 29.0 
years), and reported that the step test was sensitive to ability, secure, reproducible and 
well tolerated.  
A 6-minute stepper test (6MST), conducted on an upright stepper ergometer, was 
previously developed for patients with chronic obstructive pulmonary disease (COPD) 
(252). There are several benefits of this test: first, the stepper test does not require a 
corridor or similar space which is often limited in clinical and research settings. Second, 
the stepper test can be used to assess exercise capacity in frail elderly subjects or those 
with poor balance by using support rails. And third, the stepper allows a wider range of 
physiological responses to be measured during exercise; importantly, the assessment of 
skeletal muscle changes prior to and following the test is markedly easier with the testing 
being carried out in the static environment.  
Borel et al, 2010 concluded that the step test was reproducible and well tolerated in COPD 
patients and distinguished between healthy individuals and patients with COPD (253). This 
was a small but comprehensive assessment of the reproducibility of the 6MST (n=16 
patients with COPD and n=15 healthy controls) in which the 6MST was carried out twice 
on 3 days within a week (Monday, Wednesday and Friday). The authors suggest that the 
test is reproducible because there was no significant difference between the numbers of 
steps completed on the second test of each day; a two-way repeated measures ANOVA 
(‘test number’ versus ‘day’ was used across the tests. This detected a greater number of 
steps completed on the second test of each day which the authors attribute to ‘warming-
up’ of the hydraulic jacks on the stepper. It could be argued that, if the hydraulic arms 
warm up with use, then, as the test progresses it should become easier and therefore 
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more steps would be completed in the final minutes than the first. It is more likely that, the 
first task of the day acts as a ‘warm-up’ for the participant and they are either unable to 
perform as well or they consciously conserve some effort for the second test. The test has 
since been shown to correlate with the 6 minute walk test (6MWT) and maximal exertion 
CPET in a larger study sample of COPD patients.(249, 254) 
The feasibility of this test for a population-based sample of older adults, with no upper limit 
for age, has never previously been assessed. Furthermore, although free-standing step 
tests have been advocated for the prediction of maximal aerobic capacity,(255) the 
stepper test has not previously been used for this purpose. Previously reasons for 
exclusion or poor uptake of exercise testing protocols in older adults have not been 
described in detail. It is therefore, difficult to fully appreciate the determinants of 
acceptability of exercise tests in this population. 
3.1.3 Assessing skeletal muscle oxidative capacity  
Human skeletal muscle metabolic function can be evaluated in vitro using muscle biopsy 
samples to assess mitochondrial content, measure enzymatic activity and to sequence 
mitochondrial DNA(74) (as described in Chapter 1). This can provide valuable mechanistic 
insight into the systems necessary for oxidative phosphorylation but does not provide a 
measure of overall oxidative capacity within a physiological environment. The gold 
standard in vivo techniques to examine muscle metabolic function involve 31P-MRS(73) 
which is expensive and limits the type and intensity of exercise/muscle activation that can 
be carried out during the test.  
Continuous wave near infrared spectroscopy (NIRS) is a non-invasive, optical technology 
that measures relative changes in oxy- and deoxy-Hb up to a depth of ~1.5cm.(256) 
Measurements can be acquired using wireless NIRS devices and are therefore 
appropriate for use in a dynamic environment. The technology is cheap compared to MRS 
and requires less skill in its application. Although NIRS circumvents some of the limitations 
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that accompany tissue biopsies or MRS, it is not without limitations (these were described 
in detail in Chapter 1). 
Two important limitations in application of NIRS to skeletal muscle are: (I) changes in the 
Oxy- and deoxy-Hb signals represent a composite of blood flow changes and changes in 
oxygen consumption rate; these cannot be distinguished from each other using NIRS 
alone, and (II) the variability in adipose tissue thickness (ATT) at the site of measurement 
alters the scattering of photons which influences the signal returning to the device. 
Oxy- and deoxy-Hb signals derived using NIRS are not absolute values and represent 
relative concentration changes. During exercise changes in oxygen consumption rate and 
blood flow occur concurrently, therefore, it is impossible to differentiate these effects using 
NIRS alone. Applying an arterial occlusion above the site of NIRS measurement 
temporarily nulls the influence of blood flow allowing rate of oxygen consumption to be 
measured.(257) Capacity to utilize O2 in the muscle measured during an arterial occlusion, 
has previously demonstrated good reproducibility.(171, 235) Applying transient arterial 
occlusions in the post-exercise period can also be used to determine the kinetics of 
muscleV̇O2 recovery(216, 236, 258) these measurements have also shown good 
reproducibility(215) and results compare well with results from established 31P-MRS 
measurements of muscle oxidative capacity(259) and results from in vitro assessments 
using tissue samples.(260)  
3.1.4 Objectives 
The objectives of this chapter were: 
(1) To investigate uptake and performance of the 6MST in terms of (a) the number of 
participants who are eligible and the number who decline to start the test and (b) 
the number of participants who do not complete 6 minutes of stepping and the 
reasons for not completing the test.  
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(2) To determine if the 6MST is sensitive enough to detect the expected sex 
differences in performance and predicted maximal oxygen uptake. Further to this to 
determine if differences in workload of the exercise (stepping-rate) result in 
differences in measured V̇O2max 
(3) To compare 2 methods of predicting V̇O2max from the submaximal workload and 
heart rate achieved during the 6MST: a method using predictive equations only 
with a method that uses an extrapolated maximum workload with a predictive 
equation 
(4) To evaluate intra-test reproducibility for the 6MST and determine if improvement of 
performance due to a ‘learning effect’ is in line with previously reported learning 
effects in exercise testing 
(5) Establish if the measurement of performance (number of steps completed) agrees 
with performance measured on the, well established, self-paced exercise test, the 
6-minute walk test (6MWT)  
(6) Determine the reproducibility of NIRS measured skeletal muscle oxidative capacity 
(the time constant) when carried out during the recovery from the 6MST 
3.2 Methods 
3.2.1 Participants 
Participants in this study were recruited from the Southall And Brent REvisited study 
(SABRE) which is described in detail in Chapter 2.(223) Participants and spouses or 
partners of participants, attending the 3rd SABRE follow-up clinic visit, were invited to 
undertake the exercise test unless exclusion criteria were met.  
All procedures were in accordance with the principles of the Helsinki declaration, all 
participants gave written informed consent and the study was approved by the National 
Research Ethics Service (NRES) Committee London – North Fulham. 
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A sub-set of 20 participants completed a second 6MST within one week of the first test, 
including physiological measurements, to assess test-retest reproducibility. Number of 
steps completed, perceived exertion, heart rate, systolic blood pressure in the final minute 
of exercise, measured V̇O2 and predicted V̇O2max were compared between the first and 
second 6MST. A further sub-set of 10 participants also completed a standard 6MWT (20). 
Number of steps or distance walked, perceived exertion, measured heart rate and highest 
measured V̇O2 were compared between the 6MST and the 6MWT.  
Inclusion criteria for skeletal muscle NIRS measurements were; the participant was 
wearing loose fitting clothing which facilitated attachment of the NIRS device to the 
gastrocnemius and cuff to the lower part of the thigh, trained staff available to carry out the 
measurement and the participant was able to tolerate inflation of the cuff above systolic 
blood pressure. 
A sub-set of participants (n=9) were enrolled to undergo the exercise test and muscle 
measurements twice, on different days, to determine reproducibility of the skeletal muscle 
measurements. 
3.2.2 The 6-minute stepper test 
The participants undertook a 6MST as described in Chapter 2 including analysis of expired 
gases and heart rate monitoring. A repeat test was carried out on a separate day within 1 
week of the initial test. Participants were asked to abstain from caffeine and alcohol on the 
day of the test. Participants were not asked to fast prior to either test, this was for practical 
reasons relating to the clinic visit design, however, participants were asked not to eat a 
large meal within 2 hours before the exercise.   
As described in detail in Chapter 2, heart rate and expired gas variables were measured 
using a heart rate monitor and portable gas analyser (K4b2). Measured peak oxygen 
consumption (V̇O2, ml/min/kg) is given as the highest value determined from a rolling 60-
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second average calculated during the 30 seconds prior to and following the transition from 
exercise to recovery.  
3.2.3 Six minute walk test (6MWT) 
Participants were directed to walk up and down a 40 meter corridor (this was the longest 
available corridor within the department) at a pace as fast as could be maintained without 
running. Their objective was to walk as many lengths of the corridor a possible. The total 
number of lengths and the distance covered from the start to the stop position was 
recorded. Thus, the total number of meters covered could be calculated.(231, 232)  
3.2.4 Predicting maximal oxygen consumption 
Predicted maximal heart rate (maxHR) was estimated using two equations (Fox 3.1 & 
Tanaka 3.2) commonly used in the literature:(231, 232) 
𝑚𝑎𝑥𝐻𝑅(𝐹𝑜𝑥)  =  220 –  𝑎𝑔𝑒 (𝑦𝑟) (3.1) 
     𝑚𝑎𝑥𝐻𝑅(𝑇𝑎𝑛𝑎𝑘𝑎) =  208 − (0.7 ×   𝑎𝑔𝑒 (𝑦𝑟)) (3.2) 
The percentage of predicted maximum heart rate achieved was calculated from the 
achieved heart rate (measured) and the predicted max heart rate for both methods 
described above. 
Maximal oxygen consumption (V̇O2max) was estimated in 2 ways: (1) using predictive 
equations previously described for men(31) and women.(30) and (2) using an 
extrapolation method. 
Predictive equations  
(𝑀𝑒𝑛) 𝑉𝑂2𝑚𝑎𝑥 = 1.29 ∙ √
𝐿𝑜𝑎𝑑[𝑘𝑔. 𝑚. 𝑚𝑖𝑛−1]
𝑃𝑒𝑎𝑘 ℎ𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒[𝑏𝑝𝑚] − 60 
∙ 𝑒−0.0088∙𝑎𝑔𝑒 
(3.3) 
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(𝑊𝑜𝑚𝑒𝑛) 𝑉𝑂2𝑚𝑎𝑥 = 1.18 ∙ √
𝐿𝑜𝑎𝑑[𝑘𝑔. 𝑚. 𝑚𝑖𝑛−1]
𝑃𝑒𝑎𝑘 ℎ𝑒𝑎𝑟𝑡 𝑟𝑎𝑡𝑒[𝑏𝑝𝑚] − 60 
∙ 𝑒−0.0090∙𝑎𝑔𝑒 
(3.4) 
 
The workload (or power) was calculated from stepping rate (steps/min), step height 
(meters), which was constant at 15cm for all tests, and participant weight (Kg), equation 
3.5.  
𝑊𝑜𝑟𝑘𝑙𝑜𝑎𝑑(𝑘𝑔. 𝑚. 𝑚𝑖𝑛−1) = (𝑠𝑡𝑒𝑝 𝑟𝑎𝑡𝑒 ∙ 𝑠𝑡𝑒𝑝𝐻𝑡 ∙ 𝑊𝑡 + 5) + (
𝑠𝑡𝑒𝑝 𝑟𝑎𝑡𝑒 ∙ 𝑠𝑡𝑒𝑝𝐻𝑡 ∙ 𝑊𝑡 + 5
3
) 
(3.5) 
Participants were excluded from this analysis who were medicated with a β-blocker (n = 
79) or who did not achieve a heart rate of at least 95bpm during exercise (n=25). The 
percentage of predicted V̇O2max during the exercise was calculated using the highest V̇O2 
measured during the test.  
Extrapolation method 
The work rate (Watts) at maximal exertion was estimated by extrapolation of the linear 
relationship between workload and heart rate from resting and measured sub-maximal to 
the age predicted maximal heart rate (using Tanaka method for prediction of maximum 
heart rate).(10, 261) Maximal oxygen uptake was then estimated using the equation 
previously employed by Celis-Morales et al.(64) as follows:  
𝑉𝑂2𝑚𝑎𝑥(𝑚𝑙. 𝑚𝑖𝑛. 𝑘𝑔) = 7 + 1.8(
𝑊𝑎𝑡𝑡𝑠
𝑤𝑒𝑖𝑔ℎ𝑡
) 
(3.7) 
3.2.5 Statistical analysis 
Categorical data are presented as n (%). Continuous data were examined for normality 
and participant characteristics are presented as means ±standard deviation or median 
(interquartile range) if skewed; other results are presented as means (95% confidence 
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interval) after log transformation of skewed data. Reproducibility data were assessed using 
Bland-Altman plots and are presented as mean differences [limits of agreement (LOA), i.e. 
±1.96 x standard deviation of differences]. Correlations were assessed using Pearson’s 
correlation coefficients, or concordance correlation coefficients for reproducibility data, and 
the latter are presented as plots including the line of equality for reference. Student’s t-
tests or analysis of covariance was used for statistical comparisons. Statistical significance 
was assigned if p<0.05. 
3.3 Results  
3.3.1 Participants undertaking the 6MST 
635 participants underwent screening for exercise testing, of these 518 (82%) undertook 
the 6MST. 117 participants (18%) did not undertake the exercise test. Only 4 participants 
who were invited to undertake the test declined because they did not want to do the 6MST. 
The remaining 113 participants were not eligible for inclusion for the following reasons: 
uncontrolled hypertension (n=40), severe arthritis (n=17), non-arthritic mobility-related 
limitations (n=20), recent episode of angina or cardiovascular event including TIA, stroke 
or MI in the past 6 weeks (n=18), uncontrolled arrhythmia (n=10), no trained staff present 
to conduct the test or lack of time during the visit (n=5), severe COPD (n=1), recent aortic 
root repair (n=1) and visual impairment (n=1).  
Expired gas analysis was possible in 476 (92%) participants who performed the exercise 
test. Gas analysis was not possible in 8% of participants because of a technical problem 
with the equipment or because the participant declined to wear the face mask. Participant 
characteristics and exercise performance, stratified by gender, are shown in Table 2.1.  
363 participants (70%) completed 6 minutes of stepping. Reasons for terminating the test 
before 6 minutes were: excessive diastolic or systolic blood pressure (>115 & >230mmHg, 
respectively) (n = 43), a sudden blood pressure drop (n=1), instability (n=3), excessive 
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dyspnea (n = 18), muscle fatigue (n =29), general fatigue or arthritic joint/back pain (n = 
61).  
 
Table 3.1 Participant characteristics, exercise performance and physiological 
response (mean±SD) for 518 participants who undertook the 6 minute stepper test 
and the 476 who had expired gasses analysed. The p value refers to the unadjusted 
comparison of men and women.  
3.3.2 Participants undergoing skeletal muscle measurements 
180 participants underwent 2 measurements of resting muscleV̇O2. Participant 
characteristics for this sub-group are given in table 3.2. 9 participants underwent resting 
skeletal muscle measurements on different days and undertook a second exercise test. 
Post-exercise muscleV̇O2 was also measured in these participants and the time constant 
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representing skeletal muscle oxidative capacity was determined. Participant demographics 
for this further sub-group are given in Table 3.2.  
 
Table 3.2 Participant characteristics for 180 participants who underwent 2 resting 
skeletal muscleV̇O2 measurements and 9 participants who underwent skeletal 
muscle measurements on 2 separate days. Data are mean±SD for continuous 
variables and n(%) for categorical variables. 
3.3.3 Gender differences 
Men outperformed women in terms of steps completed (213±77 versus 175±72 steps, 
p<0.001) and measured V̇O2 (16.9±4.1 versus 14.3±3.6 steps, p<0.001) (table 3.1). For 
both men and women, the measured V̇O2max showed the expected correlation with the 
self-selected workload (stepping rate); Pearson’s r was 0.74 (p<0.001) and 0.72 (p<0.001), 
for men and women, respectively. 
V̇O2max was predicted for 372 participants (men, n=208 (56%)); both methods predicted 
higher values for men compared to women (Astrand-Von Dobeln(AVD) equations: 
28.4±4.2 versus 25.2±5.0 ml/min/kg; extrapolation: 24.7±3.0 versus 23.0±4.8 ml/min/kg) 
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Figure 3.1 Correlation between step rate and the highest measured oxygen 
consumption during exercise (peak V̇O2) stratified by gender. Squares (blue) and 
diamonds (red) are individuals’ data for men and women respectively. Blue and red 
lines are lines of best fit with correlation coefficients of 0.74 (p<0.001) and 0.72 
(p<0.001), for men and women, respectively. 
3.3.4 Predicting max heart rate and V̇O2max  
Maximum heart rate predicted using the Tanaka method was 9.4bpm higher than that 
predicted using the method described by Fox et al (158±5 versus 149±6 bpm, p<0.0001). 
Percent maxHR(Fox) or maxHR(Tanaka) and percent predicted V̇O2max showed strong 
positive correlations (r = 0.74; p < 0.001 and r =0.74; p < 0.001 respectively). 61 
participants achieved a higher heart rate than their predicted maximum HR, as determined 
using the Fox method; 28 participants exceeded predicted maximum HR using the Tanaka 
method. 
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V̇O2max was predicted for 372 participants using both methods (equation and 
extrapolation). The Tanaka method of predicting maximum HR was used in the 
extrapolation method. For the 28 participants who achieved a heart rate above the 
predicted maximum, the workload achieved in the test was assumed to be the maximal 
workload in equation 3.7.  
V̇O2max values predicted using the AVD were 2.8ml/min/kg higher than values predicted 
via extrapolation (mean±SD: AVD 27.0±4.8ml/min/kg; extrapolation 24.2±3.2ml/min/kg). 
Values determined via the 2 methods were strongly correlated (Pearson’s r = 0.71, 
p<0.0001; figure 3.2) 
 
Figure 3.2 shows correlation between values for maximal oxygen consumption 
(V̇O2max) predicted using equations described by Astrand-Von Dobeln (AVD) (y-
axis) and values predicted using the extrapolation method. 
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3.3.5 Reproducibility of the 6MST  
20 participants completed a repeat 6MST. On average participants completed 34 steps 
more in the second test compared to the first (table 3.2). Figure 3.3a shows a Bland-
Altman plot of agreement between the number of steps completed in the first and second 
step tests (Mean difference=34 steps, LoA = -62, 130).  
Perceived exertion, measured V̇O2 and measured peak heart rate were all higher on the 
second test compared to the first. The difference between the highest measured V̇O2 
between tests did not reach significance (table 3.2). The mean predicted V̇O2max did not 
differ between the tests and values show good agreement between the first and second 
stepper tests (table 3.2 and Figure 3.3b). Blood pressure measurements were possible 
during the final 3 minutes of exercise in all participants; the average systolic blood 
pressure in the final 3 minutes of exercise was not significantly different between stepper 
tests (table 3.2).  
 
Table 3.2 shows differences in performance and physiological measures and 
predictions from stepper test 1 to stepper test 2. The p value given in column 4 was 
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calculated using a paired t-test and r is Pearson’s for the correlation between each 
variable at test 1 versus test 2, p for the significance of the correlation was <0.01 for 
all the correlations. AVD; Astrand-VonDoubln, Est; estimated.  
 
126 
Figure 3.3 a & b Bland-Altman plots demonstrating levels of agreement between 
stepper test 1 (T1) and stepper test 2 (T2) for (a) steps completed, and (b) predicted 
maximum oxygen consumption (V̇O2max). Mean difference is plotted as a purple 
dashed line, upper and lower limits of agreement are plotted as red-dashed lines. 
Mean difference [limits of agreement] were (a) 34[-59.8, 127.7] steps and (b), 0.11 [-
3.95, 3.72] ml/min/kg. 
3.3.6 Correlation of the 6MST with the 6MWT 
10 participants completed a 6MST and a 6MWT. Walking rate and step rate were 
positively correlated (r=0.77; p<0.001) as were walking distance and total number of steps 
(r = 0.61). Average values for peak heart rate, measured V̇O2 and perceived exertion 
(modified Borg) were similar and measured V̇O2 (ml/min/kg), peak heart rate and 
measured V̇O2 also showed positive correlations between the 6MST and the 6MWT; 
however, there was no relationship between perceived exertion on the two tests (table 
2.3).  
 
Table 3.3 Results of the stepper test and walk test and Pearson’s correlation 
coefficient (r) for the two tests with a p value for the correlation. Data are means±SD 
of 10 observations. Pk HR; peak heart rate, BPM; beats per minute. 
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3.3.7 Reproducibility of resting muscle V̇O2 
Agreement between 2 resting muscleV̇O2 measurements made on the same day without 
removing the NIRS device was good. Mean difference[LoA] was 0.00[-0.14, 0.14] (Bland-
Altman plot; Figure 3.4 A). Figure 3.4 B is a plot of the first muscleV̇O2 (R1) versus the 
second (R2); concordance correlation coefficient was 0.93.  
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Figure 3.4 A & B Agreement between 2 measurements of resting muscle V̇O2. (A) A 
Bland-Altman plot demonstrating levels of agreement between resting muscleV̇O2 
measurements 1 (R1) and 2 (R2). Mean difference is plotted as a purple line, upper 
and lower limits of agreement are plotted as red-dashed lines; mean difference 
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(limits of agreement) were 0.00(-0.143, 0.143) ∆HbdiffµM/s. (B) resting muscleV̇O2 
measured R1 versus R2 are plotted; concordance correlation coefficient(SE) were 
0.931(0.010). The line of equality (x=y) is plotted in red. 
Agreement between measurements of resting muscle V̇O2, made on 2 separate days was 
excellent. Mean difference(LoA) was 0.05(0.16, 0.25) (Bland-Altman plot; Figure 3.5 A;). 
Figure 3.5 B is a plot of the first resting muscleV̇O2 (D1) versus the second (D2) 
(concordance correlation coefficient(SE)=0.90(0.07)).  
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Figure 3.5 A & B Agreement between 2 measurements of resting muscle V̇O2 made 
on separate days. (A) Bland-Altman plot demonstrating levels of agreement between 
resting muscleV̇O2 (restMusV̇O2) carried out on day 1 (D1) and day 2 (D2). Mean 
difference is plotted as a purple line, upper and lower limits of agreement are 
plotted as red-dashed lines; mean difference(limits of agreement) were 0.05(-0.162, 
0.254) ∆HbdiffµM/s. (B) resting muscleV̇O2 measured on D1 versus D2 is plotted; 
concordance correlation coefficient(SE) were 0.901(0.067) ∆HbdiffµM/s. The line of 
equality (x=y) is plotted in red. 
3.3.8 Exercise capacity in the sub-group 
In the sub-group of 9 participants who underwent 2 exercise tests there was good 
agreement between the number of steps achieved on each test. Mean difference(LoA) 
was 14.8(-37.6, 67.2) steps (Bland-Altman plot; Figure 3.6 A). The concordance 
correlation coefficient(SE) was 0.84(0.11) (Figure 3.6 B). 
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Figure 3.6 A & B. Agreement between exercise capacity measured by the 6MST 
completed on 2 different days. (A) Bland-Altman plot demonstrating levels of 
agreement between the steps completed on day 1 (D1) and 2 (D2). Mean difference 
is plotted as a purple line, upper and lower limits of agreement are plotted as red-
dashed lines; mean difference (limits of agreement) were 14.778(-37.629, 67.184) 
steps. (B) steps completed on D1 and D2 are plotted; concordance correlation 
coefficient(SE) were 0.841(0.106) steps. The line of equality (x=y) is plotted in red. 
3.3.9 Reproducibility post-exercise muscleV̇O2 
Agreement between post-exercise muscleV̇O2 (Post-Ex MusV̇O2) measurements made on 
2 separate days was good. Mean difference(LoA) was 0.60 (-1.01, 2.21) (Bland-Altman 
plot; Figure 3.7 A). Figure 3.7 B is a plot of the first exercise muscleV̇O2 (D1) versus the 
second (D2) (concordance correlation coefficient(SE)=0.73(0.14)).  
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Figure 3.7 Agreement between 2 measurements of post-exercise muscleV̇O2 
(ExMusV̇O2) made on separate days. (A) Bland-Altman plot demonstrating levels of 
agreement between ExMusV̇O2 carried out on day 1 (D1) and day 2 (D2). Mean 
difference is plotted as a purple line, upper and lower limits of agreement are 
plotted as red-dashed lines; mean difference(limits of agreement) were 0.604(-1.006, 
2.213) ∆HbdiffµM/s. (B) ExMusV̇O2 measured on D1 versus D2 is plotted; concordance 
correlation coefficient(SE) was 0.749 (0.140) ∆HbdiffµM/s. The line of equality (x=y) is 
plotted in red.  
3.3.10 Reproducibility of the time constant for muscleV̇O2 recovery 
Data from one participant was excluded from the time constant analysis because too few 
recovery arterial occlusions were achieved to allow curve fitting. Agreement between the 
recovery time constant for muscleV̇O2 made on 2 separate days was good. Mean 
difference(LoA) was 1.74(-41.24, 44.73) (Bland-Altman plot; Figure 3.8 A). Figure 3.8 B is 
a plot of the first time constant (D1) versus the second (D2) (concordance correlation 
coefficient(SE)=0.89(0.09)).  
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Figure 3.8 A & B. Agreement between 2 measurements of time constant. (A) Bland-
Altman plot demonstrating level of agreement between time constant of recovery 
carried out on day 1 (D1) and day 2 (D2). Mean difference is plotted as a purple line, 
upper and lower limits of agreement are plotted as red-dashed lines; mean 
difference(limits of agreement) were 1.743(-41.239, 44.725) s. (B) Time constant 
measured on D1 versus D2 is plotted; concordance correlation coefficient(SE) were 
0.887(0.085) s. The line of equality (x=y) is plotted in red. 
3.4 Discussion 
3.4.1 Key findings 
This study demonstrates that the 6MST is a reproducible method for assessing exercise 
capacity in a population-based sample of adults over the age of 65 and that the expected 
sex-differences in exercise capacity can be detected. Performance on the 6MST, in terms 
of either steps completed or stepping rate, was positively correlated with performance on 
the 6MWT (p=0.06 & p<0.01, respectively). Although only <1% of the study population 
declined to start the test, 30% of participants did not manage to complete 6 minutes of 
stepping. 
The 6MST provided an adequate sub-maximal heart rate allowing aerobic capacity 
(V̇O2max) to be predicted via 2 different approaches, a valuable marker of physical 
function that is difficult to measure directly in this population (248). However, 25 (5%) 
participants were excluded from this analysis because they did not achieve a heart rate of 
>95bpm and 79 (15%) were excluded because of medication with β-blockers. 
This study also describes application and reproducibility of NIRS for assessment of resting 
muscleV̇O2, post exercise muscleV̇O2 and a recovery time constant for muscleV̇O2 
representing skeletal muscle oxidative capacity. Good agreement was demonstrated 
between two resting measurements of muscleV̇O2, performed using NIRS, conducted on 
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the same day in the same older adult cohort and two resting muscleV̇O2 measurements 
conducted on different days. Good agreement was also demonstrated between two post-
exercise measurements of muscleV̇O2 and two measurements of the time constant for 
muscleV̇O2 recovery.  
3.4.2 Uptake and acceptability of the 6MST in older adults 
Free standing step tests are widely used to assess exercise capacity and predict 
V̇O2max(255) but stepper tests are a less commonly described method of exercise testing. 
Previous studies verifying the 6MST were carried out in COPD patient populations with a 
younger mean age than the sample in this study (253, 254). In this study of an older adult 
population who were expected to experience increased frailty and poorer balance, we 
fastened support rails to the wall in front of the stepper. Although there are some 
limitations in allowing participants to hold onto rails (discussed later), all participants 
elected to use the rails for support suggesting they were a valuable addition to the test in 
the older-adult population. Most of the excluded participants were excluded due to a 
medical condition. Only 4 participants out of 522 (<1%) declined to exercise because they 
felt the stepper was not an acceptable activity for them. This compares very favourably 
with the acceptability of maximal exercise testing using a bicycle ergometer in similar age 
group, where 20% refused to undertake the exercise.(246) The exclusion of the remaining 
113 participants (18%) for health related safety requirements (given in the guidelines(17)) 
is similar to a previous report in this age group. (246) 
30% (n=155) of participants who started the exercise test did not manage to complete 6 
minutes of stepping. In 30% (n=47) of these cases, the test was terminated by the 
technician because of a risk factor such as adverse blood pressure change or instability. 
This would presumably have been the same outcome regardless of the mode of exercise. 
Excessive dyspnea (n = 18), muscle fatigue (n =29) and general fatigue or arthritic 
joint/back pain (n = 61) contributed to 70% of the incomplete tests. This equates to 9% of 
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the total participants who elected to undertake the test. Therefore, if acceptability of the 
6MST is assessed by ‘drop-out’ rates, then, overall, the 6MST has ~91% acceptability in 
older adults.  
In the German Health Interview and Examination Survey for Adults (DEGS) 57% of 
participants were eligible to undertake a sub-maximal cycle-ergometer test and 97% of 
these test-qualified participants agreed to undertake the test.(14) This latter result is 
similar to the percentage of participants who agreed to undertake the 6MST; however, 
DEGS was comprised of participants aged 18-64 years old and had a higher exclusion on 
eligibility criteria. 
There was a strong positive relationship between performance (step rate) and measured 
V̇O2 suggesting the 6MST is sensitive to increases in load (Figure 3.2). The 6MST 
detected expected gender differences in performance (262) providing some evidence of 
validity.   
3.4.3 Predicting V̇O2max 
Submaximal exercise testing with a prediction of V̇O2max is frequently described.(Smith, 
Evans et al. 2016; Bennett, Parfitt et al. 2016) In this study we used an equation to predict 
V̇O2max from the sub-maximal heart rate, first described by von Dobeln et al. (263). We 
selected this equation because the population used to derive this equation included 
individuals up to 70 years old; unlike some alternative equations.(264) Numerous 
equations have been reported to predict maximum heart rate with age, we chose two that 
have been widely used.(231, 232); while all such equations have limitations,(265) in this 
study they were only used to give an indication of the intensity of the sub-maximal exercise 
achieved using the 6MST.   
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3.4.4 Reproducibility of the 6MST and predicted V̇O2max 
Steps completed during the second stepper test improved by an average of ~14% with 
associated improvements in physiological markers of exertion: heart rate & measured V̇O2 
(table 3.2).  This difference is likely attributable to a ‘learning effect’. Other studies report 
similar findings using other field tests.(266) Despite this, predicted V̇O2max using AVD 
equations showed very good agreement between the first and the second test (figure 3b), 
suggesting that the estimate is valid during a primary test. Prediction of V̇O2max using the 
extrapolation method were higher after from the second test. 
3.4.5 Correlation between the 6MST with the 6MWT 
The comparison between 6MST and 6MWT was conducted to assess the validity of the 
6MST, since the 6MWT is a very widely used test of performance. Results from the 6MWT 
are usually summarised as distance travelled or walking rate, whereas performance on the 
6MST is measured as steps completed or step-rate. Both markers of stepping 
performance correlated positively with markers of walking performance; meters travelled 
and walking rate (m/min) (Pearson’s r=0.61 and 0.77, respectively). Physiological 
measurements, V̇O2 and heart rate at the end of exercise, were also positively correlated 
between the tests although less strongly. Perceived exertion, assessed as a Borg score 
(0-10), was scored by the participant at the end of each test. Scores after stepping were 
not correlated with scores after walking. One explanation may be that individuals 
perceived the severity of the two tasks within a limited range which reduces the 
correlation.(267) It is also possible that participants experienced these different types of 
exercise as being more, or less, difficult for reasons unrelated to the intensity of the 
exercise. Further investigation into the perception of difficulty of an exercise is beyond the 
scope of this study but further investigation into its contribution to the acceptability of the 
stepping test would be interesting. 
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3.4.6 Reproducibility of NIRS for skeletal muscle measurements  
NIRS has previously been used for assessment of skeletal muscle blood flow and 
metabolism in the context of exercise testing and techniques have been developed to 
assess various features of muscle function.(256) The findings in this study are in line with 
previous studies that have reported good reproducibility of measurements of 
muscleV̇O2(235) and good reproducibility of the time constant.(215, 219, 220) One study 
examined reproducibility of the time constant in a group of older adults approaching the 
same mean age as the participants enrolled in this study (60±7 years old); they reported 
an ICC of 0.93.(220) 
The measurements of post-exercise muscleV̇O2 were lower on the second test (D2) 
compared to the first test (D1). This appears out of line with the previously described ~30% 
improvement in exercise performance (Chapter 2). However, participants in the sub-group 
who also underwent muscle measurements, only completed an average of 15 more steps 
in the second stepper test compared to the first; ~6% improvement from the 1st test (D1). 
Compared with the results presented in Chapter 2 which included 20 participants, this was 
a smaller improvement in performance from D1 to D2 and therefore less likely to yield a 
higher muscleV̇O2 response. 
ATT-corrected values of resting and post-exercise muscleV̇O2 were higher and had a 
greater scatter around the mean than the uncorrected values. The median uncorrected 
values for resting and exercise muscle V̇O2 are ~40% smaller than the corrected values; 
this is similar to other groups who have reported mean values ~50% lower.(240) In figure 
3.9 corrected and uncorrected values are plotted against ATT. One previous study also 
made this comparison, although they present their values in different units and fewer 
participants were enrolled, the relationship between corrected and uncorrected tracks the 
changes in ATT with a similar trend.(242) 
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3.5 Limitations 
3.5.1 The 6MST 
The 6MST is a self-paced test with an instruction to maintain stepping pace throughout. 
While this allows the protocol to be simple and increases acceptability, performance on the 
test is limited by a combination of physiological and psychological factors. Therefore, the 
physiological response, measured peak V̇O2, will be determined, to varying degrees, by 
the participants’ self-efficacy in performing exercise, previous experience of exercise and 
perception of how hard the exercise is. However, self-perception of intensity also depends 
on physiological efficiency – the ability to deliver and effectively utilize oxygen influences 
the perception of muscle fatigue and therefore, effort; a typical example is accumulation of 
lactic acid in muscle.(44) 
Although performing an incremental, maximal exertion exercise test would circumvent this 
limitation, maximal exertion cardio-pulmonary exercise tests (CPETs) are also not exempt 
from the effects of varying participant effort. When conducted according to current 
guidelines,(268) the incremental, maximal exertion CPET has been considered to under-
represent cardio-respiratory V̇O2max.(66)   
A further limitation of a self-paced test is that we cannot be certain that the participant has 
maintained pace throughout the test and, therefore, kept the work load constant. 
Participants were asked to try to select a pace from the onset of exercise that they felt 
could be maintained but the technician did not control the pace at any point during the test.  
We fixed support rails to the wall in front of the stepper. This may also compromise the 
accuracy of calculating workload because we cannot be sure to what extent each 
participant used the rails to assist themselves during exercise. We found that all 
participants opted to support themselves by holding on to the rails during the test. Holding 
onto rails may have altered the measured V̇O2 as the participant exerts force from their 
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arm muscles to grip. An obvious limitation is that we did not directly validate the predicted 
V̇O2max by conducting maximal exercise tests in our study sample. However, as 
discussed above many older people are unwilling to undertake maximal exercise 
testing(246) and, in those who do, exercise to exhaustion is often not achieved(67); 
moreover the use of maximal exercise testing has safety implications. Previously, 
performance on the 6MST has been shown to correlate well with V̇O2max in younger 
COPD patients (254).  
3.5.2 NIRS measured skeletal muscle oxidative capacity 
The influence of skin perfusion on the NIRS signals remains unclear and no attempt was 
made to correct for this. Carrying out NIRS measurements following a period of exercise 
where skin perfusion is likely to increase to allow body cooling is likely to introduce some 
error and increased variability to the measurements.(194) Although this has previously 
been considered to influence the muscle measurements only minimally,(195) future 
muscle studies would merit including an adjustment or correction for increased skin 
perfusion during exercise. This could potentially be addressed by including a channel with 
a short source-detector distance; previous estimates suggest that, for adults 8.4mm is the 
ideal distance.(269) The shortest source-detector distance available in the device applied 
here was 30mm.  
Absolute values of oxy- and deoxy-Hb cannot be measured using continuous wave NIRS 
because the Beer-Lambert law assumes that the medium which the photons are passing 
through is homogenous (non-scattering). As explained in Chapter 1, biological tissue is not 
homogenous (comprised of layers: epidermis, dermis, fat and muscle) and differences in 
thickness of adipose tissue above the area of interest alters the light-scattering properties 
of the tissue.(168) Variance in ATT between participants is therefore a major technical 
limitation for NIRS. Values of muscleV̇O2 presented here were corrected for the ATT using 
equations previously described.(240) There are some limitations to using these equations: 
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First, derivation of the original correction curves were based on simulated data and 
experimental data obtained from 15 participants,(243) in these studies 12 participants 
were male and 3 female; the 12 men had ATT ranging from 0.3-0.8cm(239) while 2 of the 
women represented the upper limit of measured ATT (~1.1cm). This leaves some 
uncertainty whether the relationship between ATT and muscle muscleV̇O2 described in this 
study could have been partially attributed to a gender difference.(242) Second, using ATT-
corrected values of muscleV̇O2 to examine differences between groups of participants 
potentially risks attenuating differences between groups that could be the result of 
generally greater adiposity. For example, if we are interested in the difference in 
muscleV̇O2 between people with and without diabetes, correcting for ATT is appropriate in 
technical terms because it corrects for the increase in scattering; however, having greater 
adiposity in general may influence the ‘true’ value of oxygen consumption in the muscle, 
and therefore, correcting the muscleV̇O2 measurement for ATT has the potential to 
attenuate underlying ‘true’ differences between people with and without diabetes. 
Alternatively, if we have some prior knowledge that adiposity influences ‘true’ skeletal 
muscleV̇O2, it would be appropriate to conceptually model ATT/adiposity as a confounder, 
in which case using corrected values is appropriate.  
3.6 Conclusion 
In conclusion, the 6MST is an appropriate method of assessing fitness that is well 
accepted by older adults and has some advantages compared with the 6MWT. V̇O2max 
can be estimated reproducibly using the relationship between workload and submaximal 
heart rate and a previously described predictive equation. Conducting a study to compare 
V̇O2max results of an exhaustive CPET with the 6MST may confirm this. The results from 
the 6MST test correlate with the 6-minute walk test in terms of outcome for exercise 
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capacity. Skeletal muscle metabolic function can be examined reproducibly using NIRS in 
this population-based group of older adults undertaking a 6MST. 
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Chapter 4: Exercise capacity and skeletal 
muscle metabolic function in the presence of 
diabetes 
4.1 Introduction 
4.1.1 Overview  
Type 2 diabetes mellitus (T2D) is a debilitating, chronic disease and public health 
problem.(110) The prevalence of diabetes has increased over the last few decades and is 
predicted to rise to as much as 642 million by 2040.(111) People with T2D consistently 
have excess cardiovascular and all-cause mortality despite aggressive cardiovascular risk 
factor intervention.  
T2D is associated with impaired cardiorespiratory fitness compared to age, weight and 
activity-level matched people without diabetes.(270-272) This impairment in fitness is 
clinically relevant as it potentially contributes to the increased cardiovascular and all-cause 
mortality seen in T2D.(273-275) Evidence from epidemiological studies suggests that 
higher levels of physical activity reduce morbidity and mortality in people with 
diabetes.(109) Thus, it is important to understand which aspects of the components that 
make up cardio-respiratory fitness can be improved via increasing physical activity and 
which activities are most effective. Cardio-respiratory fitness, measured by CPET, 
provides an overall, total-body measurement of maximal oxygen uptake (as described in 
Chapter 1). This type of test does not usually incorporate an assessment of oxygen uptake 
kinetics and oxidative capacity specifically in the muscle.(276)  
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As described in Chapter 1, evidence suggests that impaired skeletal muscle oxidative 
capacity exists in people with T2D; whether this is due to reduction in the number of 
mitochondria or the intrinsic functional capacity of the mitochondria is still open for debate. 
An association between impaired mitochondrial function and development of insulin 
resistance and disease progression has also been described(107) although the cause-
effect relationship remains unclear.(129)  
While muscle metabolic disruptions associated with T2D are not likely to be the primary 
limiting factor for exercise capacity, evidence suggests that exercise intervention improves 
metabolic function of skeletal muscle(277) and attenuates lipid-induced insulin 
resistance.(105) It is therefore valuable to consider, in the same individuals, the 
relationships between exercise capacity, cardio-respiratory fitness (V̇O2max) and local 
skeletal muscle oxygen kinetics. Because of the technical limitations of conducting skeletal 
muscle measurements (described in Chapter 1), previous studies have tended not to 
include a simultaneous measure of cardio-respiratory oxygen consumption and to employ 
small sample sizes prohibiting multivariable analyses. Previous studies that include an 
exhaustive CPET tend to recruit younger participants who are more able to achieve 
maximal exertion.  
Submaximal exercise tests are a valuable way of assessing exercise capacity and 
predicting cardio respiratory fitness (VO2max). As well as having improved ease of 
administration, submaximal exercise tests are more representative of everyday exercise. 
NIRS is an emerging tool that permits non-invasive skeletal muscle measurements to be 
carried out in a dynamic environment.  
4.1.2 Objectives 
(1) To compare sub-maximal exercise capacity, in terms of steps completed and step-
rate selected on the self-paced 6MST, and muscle strength, measured by grip-
strength, between older adults (>65 years old) with or without T2D.  
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(2) To describe reasons for drop-out on the 6MST before completion of 6 minutes and 
compare reasons for drop-out between older adults with, or without, T2D. 
(3) Compare perception of exertion (Borg score) during exercise between individuals 
with, or without, T2D.  
(4) Compare measured sub-maximal oxygen uptake (measured peak VO2) and 
predicted VO2max between older adults with or without diabetes. Other markers of 
cardio-respiratory exertion measured during exercise; heart rate (HR), HR 
response (HRR), oxygen uptake efficiency slope (OUES) and blood pressure are 
also compared in the presence and absence of T2D. 
(5) Compare locally measured skeletal muscle oxygen consumption (muscle V̇O2) and 
skeletal muscle oxidative capacity between older adults with and without T2D  
(6) Determine the association (or disassociation) between submaximal exercise 
capacity and skeletal muscle oxidative capacity and if this relationship is different in 
the presence of T2D. 
4.2 Methods  
4.2.1 Participants 
Participants in this study were recruited from the SABRE study as described in Chapter 
2.(223).  
All procedures were in accordance with the principles of the Helsinki declaration, all 
participants gave written informed consent and the study was approved by the National 
Research Ethics Service (NRES) Committee London – North Fulham. 
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4.2.2 Anthropometrics and questionnaires 
Height was measured barefoot using a standard stadiometer (Seca217, Hamburg, 
Germany). Weight, body fat mass and body fat percentage were measured using digital 
bio-impedance scales (BC-418,Tanita, USA).  
Diabetes was defined as self-reported physician diagnosis or reported use of anti-diabetic 
medication, hypertension was defined as self-reported physician diagnosis, or reported 
use of medication for hypertension. Details of medication, years of education, ethnicity, 
smoking habit, alcohol intake and physical activity were obtained by questionnaire.  
4.2.3 Exercise testing 
Participants were invited to undertake the 6MST; this was carried out as described in 
Chapter 2. Measurements of exercise capacity were recorded as; steps completed, 
stepping rate and the power achieved on the stepper which is calculated via equation 5 
(Chapter 2).  
At the end of the exercise test participants were asked to rate how hard they perceived 
their effort to be on a modified Borg score (0-10).(227) Two scores were recorded; one for 
their perceived cardio-respiratory effort (how hard they perceived their breathing to be) and 
one for leg muscle fatigue.  
Muscle strength was measured as grip strength, carried out using a hand held pneumatic 
bulb dynamometer (Baseline, Patterson Medical). Grip strength was measured 3 times at 
1 minute intervals and the highest value achieved was accepted as the final maximum grip 
strength.  
4.2.4 Cardio-respiratory fitness  
Heart rate and expired gas variables were measured using a heart rate monitor and 
portable gas analyser (K4b2, COSMED). Measures of cardio-respiratory fitness were; peak 
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measured oxygen consumption (V̇O 2, ml/min/kg), peak heart rate, oxygen uptake 
efficiency slope (OUES) and predicted V̇O2max.  
Peak measured V̇O2 is calculated as the highest value determined from a rolling 60-
second average calculated across the duration of exercise. Peak heart rate (peak HR) was 
the highest measured heart rate during exercise. Heart rate response (HRR) is the 
difference between the peak heart rate and resting heart rate. V̇O2max was predicted 
using the equations presented in Chapter 2 (for men; equation 2.3, for women; equation 
2.4). OUES is the slope of the measured V̇O2 (ml/min) regressed against the log of 
ventilation (ml/min).(278)  
Blood pressure (BP) was measured using a motion insensitive monitor (Tango M2, 
SunTech Medical, NC, USA) at rest and during the 2nd, 4th and 6th minute of exercise. The 
highest measured BP during exercise was assigned as the maximum exercise BP. 
4.2.5 Skeletal muscle measurements 
Skeletal muscle measurements were carried out as described in Chapter 3 using NIRS 
(Portamon, Artinis Medical Systems, Netherlands) to measure changes in oxy-Hb and 
deoxy-Hb from the lateral gastrocnemius. Position and orientation of the device was 
standardized between individuals. The device was attached using tape and covered 
completely using a neoprene sleeve.  
During the muscle measurements the participant stood with their weight distributed equally 
between both feet. Arterial occlusions were performed at rest and immediately following 
the exercise test as described in Chapter 3, figure 3.1. Participants were excluded from 
skeletal muscle measurements and arterial occlusions for the following reasons: restrictive 
clothing which prevented the device or cuff being attached appropriately, intolerance of the 
arterial occlusion or if no trained staff were available to conduct the measurement. 
151 
Parameters marking skeletal muscle metabolic function were calculated as described in 
Chapter 3, figure 3.3. Resting muscleV̇O2, post-exercise muscleV̇O2 were reported as 
measures of skeletal muscle oxygen consumption. Exercise-related increases in 
muscleV̇O2 (ΔmusV̇O2) were calculated as the absolute difference between resting 
muscleV̇O2 and post-exercise muscleV̇O2. The time constant (τ) was calculated as the 
recovery rate of muscleV̇O2 and represents the oxidative capacity of the skeletal muscle.  
4.2.6 Statistical analysis 
Categorical data are presented as n (%). Continuous descriptive data were examined for 
normality and participant characteristics are presented as means ±standard deviation or 
median (interquartile range) if skewed; results are presented as means (95% confidence 
interval). Comparison of means was done using an unpaired Student’s t-test for 
continuous data and chi squared test for categorical data.  
Multivariable linear regression was used to adjust for potential confounding factors. All 
models included a basic adjustment for age and sex because of the generally accepted 
influence of these factors on exercise capacity, cardio-respiratory fitness and muscle 
function. Markers of exercise capacity were further adjusted for ethnicity and BMI based 
on previous evidence suggesting ethnic-differences in cardiorespiratory fitness and 
physical activity exist.(158, 161) BMI is adjusted for in these models as an index of 
adiposity to account for differences that could confound the differences in exercise 
capacity, cardio-respiratory fitness and muscle function in the presence of T2D. Models of 
the differences in cardio-respiratory fitness markers in the presence of T2D were adjusted 
for β-blocker use because of higher β-blocker use in participants with T2D and the known 
effect of β-blockers on HR and oxygen uptake. Differences in skeletal muscle 
measurements were also adjusted for age, gender, ethnicity and BMI.  
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4.3 Results  
4.3.1 Participants 
Participant characteristics are shown in table 4.1 for 580 participants who undertook an 
exercise test. Participant characteristics are shown in table 4.2 for 139 participants who 
underwent all skeletal muscle measurements.  
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Table 4.1 Participant characteristics for all participants who undertook an exercise 
test. Data are stratified by presence of diabetes. Where information was missing 
from self-reported sources of smoking, alcohol consumption and diabetes duration; 
n is given in parenthesis for the number of participants with available data in each 
group. P-values indicate significance of the difference between participants with 
and without diabetes. For Ethnicity E; European, AC; Afro-Caribbean, OTH; all other 
ethnicities (excluding south Asians).  
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Table 4.2 Participant characteristics for all participants who undertook muscle 
measurements. Data are stratified by presence of diabetes. Where information was 
missing from self-reported sources of smoking, alcohol consumption and diabetes 
duration; n is given in parenthesis for the number of participants with available data 
in each group. P-values indicate significance of the difference between participants 
with and without diabetes. For Ethnicity E; European, A; Asian, AC; Afro-Caribbean, 
OTH; all other ethnicities (excluding south Asians).  
4.3.2 Exercise capacity, drop-out & muscle strength  
Step-rate was lower in the presence of diabetes (difference = -3.6 steps/minute, CI:-5.3,-
1.8, p<0.001; table 4.3) and people with diabetes completed fewer steps during the 6MST 
(difference = -27steps, CI:-41,-13, p<0.001) (table 4.3). The lower overall step number can 
be explained by a combination of a lower step rate and a greater proportion of participants 
with diabetes terminating exercise prior to completion of a full 6 minutes of stepping (27% 
versus 36%, p=0.063).  
Reasons for terminating exercise early included; a systolic blood pressure drop by 
>20mmHg, a blood pressure increase (diastolic BP>115mmHg or systolic BP>230mmHg ), 
dizziness, excessive heart rate, instability, arthritic or joint pain, excessive dyspnea, 
muscle fatigue, general fatigue or for an undefined/unspecified reason reported by the 
participant. Differences in the reasons for stopping exercise early between participants 
with or without diabetes are shown in figure 4.1. There were no differences between 
people with or without diabetes in reason for stopping the test early (p=0.82). 
Grip strength was lower in people with diabetes (difference = -3.7KPa, CI:-7.0,-0.4, 
p<0.01) (table 4.3).
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Table 4.3 Exercise capacity and muscle strength. Data in columns 2 and 3 are age and gender adjusted means (95%CI) for each 
outcome in column 1 stratified by presence/absence of diabetes. Data in columns 4-6 are the differences between individuals with 
and without diabetes with adjustment for confounders (see statistical methods section). P-values for the difference between 
people with and without diabetes are as follows:   p<0.05*, p<0.01** or p<0.001***. BMI; body mass index, kPa; kilopascals 
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Figure 4.1 Reasons for stopping the exercise test prior to 6-minutes. Data are given as percentages of the total number of 
participants in each group who stopped exercising before 6 minutes was completed. Results are stratified by absence of diabetes 
(grey bars) or presence of diabetes (blue bars). The total number of participants who did not complete 6 minutes of stepping and 
the total for each group is given in parenthesis in the key. Chi2 tests were used to test for differences in the reasons for stopping 
before 6 minutes was complete; there were no differences in the reasons for stopping early between people with and without 
diabetes (p=0.82). 
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4.3.3 Perceived exertion  
Perceived exertion quantified by the modified Borg score (0-10) was similar between 
people with and without diabetes (mean±SD; 4.9±2.3 & 5.2±2.2, p=0.19, respectively). 
This was unaffected by adjustment for age and gender (adjusted means(CI); 4.9(5.0,5.4) &  
5.2(5.0,5.4), p=0.15). Perceived leg fatigue (0-10) was also similar between people with 
and without diabetes (mean±SD; 5.0±2.6 & 5.1±2.2, p=0.47, respectively). This was also 
consistent after adjustment for age and gender (adjusted means(CI); 5.0(4.9,5.3) &  
5.0(4.6,5.4), p=0.59). 
4.3.4 Cardiorespiratory fitness in the presence of diabetes 
530 (91%) participants underwent cardio-respiratory monitoring during the 6MST. People 
with diabetes achieved lower peak measured V̇O2 than those without (difference = -
2.0ml/min/kg, CI:-2.7,-1.2, p<0.001) (table 4.4). Predicted V̇O2max was calculated in 446 
participants (84 participants were excluded from this calculation because they were taking 
a β-blocker). Predicted V̇O2max was lower in the presence of diabetes (difference=-
2.5ml/min/kg, CI:-3.6,-1.3, p<0.001) (table 4.4). 
Other markers of cardiorespiratory effort were not markedly different between participants 
with and without diabetes (table 4.4). Peak HR reached during exercise was similar in 
older adults with T2D compared to those without (difference=1.4, CI:-3.3, 6.1, p=0.57; 
table 4.4), however, the difference between resting and peak HR (HRR), was lower in 
older adults with diabetes (difference =-6.6 bpm, CI:-11.3,-1.9, p=0.006; table 4.4) 
reflecting the higher resting heart rate in people with T2D (Tables 4.1 & 4.2). OUES was 
not different between individuals with T2D compared to those without (difference=-0.05, 
CI:-0.11, 0.03, p=0.23; table 4.4).The rise in systolic blood pressure during exercise was 
slightly lower in participants with diabetes (difference =-1.3, CI:-6.6, 4, p=0.62).  
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Table 4.4 Cardiovascular measurements during exercise. Data in columns 2 and 3 are age and gender adjusted means (95%CI) for 
each outcome in column 1 stratified by diabetes present or absent. Data in columns 4-6 are the differences (i.e. β-coefficients) for 
diabetes in models 1-4 respectively. P-values for the difference between people with and without diabetes are as follows:  
p<0.05*, p<0.01** or p<0.001***. BPM; beats per minute, Pk HR; peak heart rate, Pred VO2 max; predicted VO2max,  HRR; heart rate 
response, OUES; oxygen uptake efficiency slope, SBP; systolic blood pressure.
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4.3.5 Skeletal muscle oxidative capacity 
Skeletal muscle function was measured in 139 participants who undertook exercise. In this 
sub-group of participants the number of steps completed and the cardio-respiratory 
response to exercise were found to follow similar trends as reported above in tables 4.3 
and 4.4.Table 4.5 briefly describes differences in exercise capacity between people with, 
and without, T2D in this smaller group.  
 
Table 4.5 Exercise capacity and cardio-vascular response to exercise in the sub-
group of participants who undertook skeletal muscle measurements. Data are age 
and gender adjusted means (95%CI) for each outcome in column 1 stratified by 
presence/absence of diabetes. P-values for the difference between people with and 
without diabetes are as follows:  p<0.05*, p<0.01** or p<0.001***.  HRR; heart rate 
response, Pk; peak.  
Resting and post-exercise muscle oxygen consumption were little different between 
participants with, versus without, diabetes (difference= 0.05, CI:-0.03,0.13, p=0.22 & -0.15, 
CI:-0.63,0.32, p=0.53 for resting and post-exercise values, respectively; table 4.6). The 
time constant was longer in older adults with diabetes (difference =10.88s, CI: 0.21, 21.54, 
p=0.046).This difference was marginally attenuated by adjustment for ethnicity and BMI 
such that the p-value for the difference in the presence of T2D did not reach significance; 
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however, the difference was still a greater than 10 seconds longer time constant in the 
presence of T2D (difference =10.39 s, CI: -0.44, 21.21, p=0.06; table 4.6). 
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Table 4.6 Skeletal muscle measurements. Data in columns 2 and 3 are age and gender adjusted means (95%CI) for each outcome 
in column 1 stratified by presence/absence of diabetes. Data in columns 4-6 are the β-coefficients for the effect of presence of 
type-2 diabetes (T2D) on the outcome variable with adjustment for the variables in models 1-3 respectively. P-values for the 
difference between people with and without diabetes are as follows:  p<0.05*, p<0.01** or p<0.001***. BMI; body mass index, Post-
Ex; post-exercise.  
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4.3.6 Oxidative capacity and exercise capacity 
There was no convincing association between the time constant and the number of steps 
completed during the 6MST (age and gender adjusted β-coefficient=-0.20steps, CI: -0.63, 
0.23, p=0.367).There was no association between the time constant and predicted 
V̇O2max (age and gender adjusted β-coefficient:0.001ml/min/kg, CI: -0.003, 0.005, 
p=0.60). 
There was no detectable difference in the relationship between the time constant and 
steps completed when analyses were stratified by presence of diabetes (T2D absent: 
difference=-0.04steps, CI: -0.51, 0.44, p=0.874, T2D present: difference=-0.17steps, CI: -
1.15, 0.80, p=0.716).  
Further adjustment of the diabetes-associated reduction in number of steps completed 
(table 4.6; -53steps, CI: -79, -27, p<0.001) for the time constant did not alter the 
differences (age/gender/time constant-adjusted difference=-52steps, CI: -79, -26, 
p<0.001). 
4.4 Discussion  
4.4.1 Key findings 
In this study, older adults with T2D had a lower submaximal exercise capacity than 
similarly aged participants without diabetes despite a similar score on perceived exercise 
intensity and leg fatigue. T2D in this population-based sample was also associated with 
markers of poorer cardiovascular response to exercise; including lower cardio-respiratory 
peak measured V̇O2 and lower predicted V̇O2max. Skeletal muscle oxidative capacity (the 
time constant) was impaired in T2D but there were no detectable differences in muscle 
V̇O2 at rest or post-exercise. Skeletal muscle oxidative capacity did not correlate with 
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exercise capacity in either the presence or absence of T2D or overall in this older adult 
population.    
4.4.2 Exercise capacity and cardiorespiratory fitness 
The findings reported here of lower exercise capacity in people with T2D are in line with 
previously conducted studies which suggest maximal exercise capacity is impaired in the 
presence of T2D and cardio-respiratory oxygen uptake (peak V̇O2) is lower.(270, 279) 
Cardio-respiratory peak V̇O2 was previously assessed during submaximal exercise 
workloads; the authors reported the relationship between V̇O2 and workload was 16% 
lower in the presence of T2D.(280) Bauer et al,(271) demonstrated poorer skeletal muscle 
oxygen uptake kinetics in the presence of T2D; they used NIRS measured deoxy-Hb as a 
measure of O2 extraction and estimated skeletal muscle blood flow attributed differences in 
exercise capacity to inferior vascular function in the presence of T2D.  
4.4.3 Oxidative capacity 
The finding that oxidative capacity is poorer in older adults with T2D supports findings from 
other studies.(208) These studies measure oxidative capacity from biopsy samples as; 
activity of rotenone-sensitive NADH:O2 oxidoreductase and citrate synthase,(126) and 
activity of succinate dehydrogenase .(104) However when O2 flux was measured in 
permeabilised muscle fibre biopsy samples (keeping the cells more intact), correction for 
mitochondrial DNA content or citrate synthase activity completely attenuated the difference 
between people with and without T2D; the authors therefore concluded that differences in 
oxidative phosphorylation between people with T2D can be attributed to lower 
mitochondrial content.(281) The findings presented here also agree with previous in vivo 
work which demonstrated ~45% longer time constants for PCr recovery post-exercise, 
measured using 31P-MRS, in the presence of T2D.(131) Although the differences 
presented here were comparatively modest, at ~20% longer. This concurs also with a 
study demonstrating good agreement between recovery time constants measured with 
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NIRS and 31P-MRS.(259) However, no previous studies have assessed oxidative capacity 
using NIRS with the objective of detecting differences in people with T2D, as has been 
reported here.  
The association between impaired oxidative capacity and T2D was only slightly attenuated 
by adjustment for cardio-respiratory peak measured V̇O2 (Chapter 4; table 4.7) suggesting 
that, at sub-maximal exertion, the measurement is uninfluenced by workload of the 
exercise. This is in line with previous studies that have applied different methods of 
exercise.(258)   
There was no discernible difference in resting muscleV̇O2, post-exercise muscleV̇O2 or 
ΔmusV̇O2 between older adults with and without diabetes. Peak measured V̇O2, assessed 
by analysis of expired gases, positively correlated with post-exercise muscle V̇O2. Locally 
measured muscle V̇O2 is not expected to be directly proportional to cardio-respiratory V̇O2, 
however, it is useful to acknowledge the positive direction of the correlation of these two 
marker of oxygen consumption immediately following a period of exercise. 
4.5 Limitations  
In this study submaximal exercise capacity was assessed using a self-selected paced test 
rather than maximal exercise capacity via an incremental exhaustive protocol. As 
discussed in Chapter 2, the issue of voluntary effort limits these findings because 
psychological factors could influence the participants elected level of exertion which would 
also influence the physiological responses measured. It is possible that people with 
diabetes participate in less physical activity in general and have less wide range of 
exercise intensity experience; this may result in lower effort during testing or selection of 
an inappropriate stepping speed. The latter would explain the higher rate of test 
termination before 6 minutes in people with diabetes. Previously, older women with T2D 
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were reported to have higher scores of perceived exertion when undertaking exercise 
workloads that were predicted to achieve equivalent cardio-respiratory exertion.(282)  
Although differences in oxidative capacity were seen in the presence of diabetes, it 
remains unclear to what extent oxidative capacity contributes to any limitation in exercise 
capacity in the presence of diabetes.   
This study found no relationship between exercise capacity and oxidative capacity (the 
time constant); differences in this relationship between people with diabetes were also 
considered. This is not in line with previous studies that suggest that, over a range of 
values, there should be a positive association between cardio-respiratory fitness and 
skeletal muscle metabolic function. There are several other potential explanations for this: 
(I) we measured sub-maximal exercise capacity and the predicted maximal aerobic 
capacity. This may not accurately reflect the true maximal aerobic capacity (II) there are 
potentially other factors in this age group that disturb the relationship between metabolic 
function and CR-fitness measures (III) Our measurement of skeletal muscle metabolic 
function is not accurately detecting metabolic function in this age group. 
This study examined cross-sectional data of older adults with and without diabetes. 
Therefore it is not possible to ascertain whether reduced oxidative capacity was causally 
linked to T2D. The study design is observational and, at the time of this analysis, only 27 
people with diabetes could be included. This fairly small sample size may have resulted in 
the study being underpowered for some of the outcomes examined.  
4.6 Conclusions 
Older adults with diabetes have lower submaximal exercise capacity and lower predicted 
maximal V̇O2 despite reporting similar levels of cardio-respiratory effort and leg fatigue. 
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Skeletal muscle oxidative capacity is poorer in the presence of diabetes but, in older 
adults, it is not associated with submaximal exercise capacity. 
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Chapter 5: Ethnic differences in exercise 
capacity, cardiorespiratory fitness and 
skeletal muscle oxidative capacity in older 
adults of South Asian, African Caribbean and 
European origin 
5.1 Introduction  
5.1.1 Overview 
The prevalence of T2D is higher is people of South Asian origin compared to those of 
European origin, this is particularly evident after migration out of their home country.(139, 
140) T2D is also more prevalent in men and women of African-origin living in the UK and 
also in North America (as described in Chapter 1).(139, 141) Risk factors for development 
of T2D are present at a lower BMI in South Asians than in Europeans(139) and South 
Asians may also be more susceptible to the adverse effects of T2D; South Asian people 
with diabetes are at a higher risk of developing subsequent cardiovascular disease than 
Europeans with diabetes.(149) Overall, morbidity and mortality from stroke and coronary 
heart disease is higher in South Asians than in their European comparators.(146, 148) 
Individuals of African origin also have increased incidence of stroke compared to 
Europeans, but, they do not experience the same elevated risk of coronary heart disease 
that is seen in South Asians.(149, 164)  
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5.1.3 Cardiorespiratory fitness and grip strength 
Cardiorespiratory fitness is poorer in South Asians.(155, 156) Lower cardiorespiratory 
fitness has previously been shown to account for 61% of the ethnic difference in fasting 
glycaemia seen in south Asians.(157) In general, physical activity levels are lower among 
South Asian populations.(158) However, lower physical activity could not account for the 
differences in cardio-respiratory fitness seen in South Asian men.(157) Lower cardio-
respiratory fitness has also been described, independent of physical activity levels, in non-
Hispanic Black men and men from other racial/ethnic groups compared to non-Hispanic 
White and Mexican American men (data from NHANES, described in Chapter 1).(159)  
Measuring grip strength is accepted as a simple way of capturing overall limb skeletal 
muscle strength previously shown to correlate strongly with leg strength.(283) Recently, 
Ntuk et al compared grip strength by ethnicity in the presence and absence of T2D in >400 
000 participants from the UK Biobank study.(284) They showed that in men and women of 
White European, African and South-Asian descent, living in the UK, there was an 
independent association between grip-strength and prevalence of T2D. Participants were 
middle-older aged adults (40-69 years old) and, although the greatest proportion were 
White (~26:1), the absolute number of African and South Asian participants was high (n= 
7266 & 8540, respectively). In South Asians (men and women) and also in African men, 
lower grip strength predicted a higher prevalence to a greater extent than the relationship 
in Europeans and African women. The authors suggest that specific resistance exercise 
intervention should be considered as part of future randomized trials in these groups. 
Interestingly, in the PURE study, described briefly in chapter 1, although lower grip 
strength was associated with cardiovascular disease and all-cause mortality, the 
association between grip strength and T2D did not reach significance.(63) Some small 
studies, have found positive correlations between grip-strength and cardio-respiratory 
fitness(285) and between grip-strength and exercise capacity, measured as distance 
walked during a 6-minute walk test.(285) However, ethnic differences in grip strength have 
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not previously been compared alongside differences in cardio-respiratory fitness in older 
adult populations.  
5.1.4 Skeletal muscle oxidative capacity 
The impaired fat oxidation seen in skeletal muscle of South Asians suggests an underlying 
link to skeletal muscle function;(161) although longitudinal studies would need to be 
carried out to discern the direction of this relationship. Observations have been made that 
the metabolic profile in people with and without T2D differs depending on their 
ethnicity.(108, 164, 165) Several other studies have observed skeletal muscle metabolic 
disruptions in South Asians compared to Europeans.(144) Although the evidence 
regarding overall impairments in skeletal muscle oxidative capacity is inconclusive. 
Focus is typically given to the determinants of excess insulin resistance/fasting glycaemia 
and increase risk of T2D that is seen in South Asians. Poor cardio-respiratory fitness is 
included in analysis as an explanatory variable (a mediator).(157, 161) The determinants 
of poor cardio-respiratory fitness have not previously been well investigated.  
Limitations of the current evidence are that, so far, ethnic differences in cardiorespiratory 
fitness have been assessed in young to middle-aged populations that include mostly male 
participants.(161) Previous studies have enrolled fairly small sample sizes (with the 
exception of Ghouri et al; described above). Skeletal muscle measurements have 
previously all been based on analysis of biopsy samples, and an in vivo assessment of 
oxidative capacity by ethnic group has not been described. 
5.1.5 Objectives  
The objectives of this chapter were: 
(1) Compare ethnic differences in sub-maximal exercise capacity (6MST and grip-
strength) in a population of older adults (>65 years old) comprised of people 
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originating from South Asia, the Caribbean and Europe, all resident in West 
London.  
(2) Compare measured oxygen uptake during sub-maximal exercise and predicted 
V̇O2max between ethnic groups of older adults 
(3) Compare skeletal muscle oxygen consumption at rest and recovery rates of muscle 
oxygen consumption post-exercise (a marker of skeletal muscle oxidative capacity) 
between ethnic groups. 
(4) Determine if differences in oxidative capacity can explain, to some extent, 
differences in sub-maximal exercise capacity observed in South Asian older adults 
We hypothesised that in people from ethnic minority groups, South Asians and African-
Caribbean’s, sub-maximal exercise capacity and predicted V̇O2max will be lower than in 
Europeans and poor exercise capacity will be associated with impaired skeletal muscle 
oxidative capacity. 
5.2 Methods 
5.2.1 Participants  
Participants were older adults recruited from the Southall and Brent Revisited (SABRE) 
study (as described in Chapter 2). Only participants who reported their ethnicity as 
European, South Asian or African-Caribbean were included in this analysis.  
5.2.2 Anthropometrics and questionnaires 
Height was measured barefoot using a standard stadiometer (Seca217, Hamburg, 
Germany). Weight, body fat mass and body fat percentage were measured using digital 
bio-impedance scales (BC-418, Tanita, USA).  
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Diabetes was defined as self-reported physician diagnosis or reported use of anti-diabetic 
medication, hypertension was defined as self-reported physician diagnosis, or reported 
use of medication for hypertension. Ethnicity was obtained by questionnaire.  
5.2.3 Exercise test and skeletal muscle measurements 
A 6MST was carried out to determine sub-maximal exercise capacity and to predict 
V̇O2max as a measure of cardio-respiratory fitness (as described in Chapter 2). Steps 
completed and step-rate were both recorded to describe sub-maximal exercise capacity. 
V̇O2max was predicted according to both the equation and extrapolation methods 
described in Chapter 2. 
Near Infrared Spectroscopy (NIRS) was used to non-invasively assess skeletal muscle 
oxidative capacity using changes in oxygenated and deoxygenated haemoglobin 
concentrations during arterial occlusions at rest and post-exercise (as described in 
Chapter 2). 
5.2.4 Statistical analysis 
Categorical data are presented as n (%). Continuous descriptive data were examined for 
normality and participant characteristics are presented as means ±standard deviation or 
median (interquartile range) if skewed; results are presented as means (95% confidence 
interval). Comparison of means was done using an unpaired Student’s t-test for 
continuous data comparing 2 groups or one-way ANOVA for multiple-group comparisons 
and chi squared test for categorical data. Multivariable linear regression was used to 
adjust for potential confounding factors. The effect of ethnicity on exercise capacity and 
cardio-respiratory fitness included a basic adjustment for age and sex to account for 
possible sampling bias, and further adjustment for presence of T2D as a potential mediator 
since this condition is known to be more frequent in South Asians and African-Caribbean’s 
and may affect outcomes. Further adjustment for oxidative capacity (τ) as a potential 
mediator of associations between ethnicity and exercise capacity was also performed. 
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5.3 Results 
5.3.1 Participants 
183 participants (mean age=72±6 years, male=137) undertook the both the exercise test 
and the skeletal muscle measurements. Participant characteristics, stratified by ethnicity 
and unadjusted for confounders, are show in table 5.1. There were fewer men, and 
participants had a higher BMI, in the African-Caribbean group compared to both the 
European and the South Asian group. Prevalence of T2D was highest in the South Asians 
and lowest in Europeans. Age, resting heart rate and use of β-blocker medication was 
similar across the groups (table 5.1).  
 
Table 5.1 Participant characteristics for all participants who undertook an exercise 
test. Data are stratified by ethnicity. P-values in column 5 indicate differences 
between the groups by Chi2 test for categorical data and analysis of variance 
(ANOVA) for continuous data. Between group pairwise comparisons were made 
using students t-tests or chi2 tests; p-values for pairwise comparisons are given in 
columns 6-8. E; European, SA; South Asian, AC; African-Caribbean, HR; heart rate.   
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5.3.2 Exercise capacity & cardio-respiratory fitness 
Compared to Europeans, after adjustment for age and sex, South Asians achieved fewer 
steps during the 6MST (difference (95%CI): -39.5 (-61, -18) steps, p<0.001) whereas 
African-Caribbean’s achieved a similar number (difference (95%CI): -10.9 (-39, 17) steps, 
p=0.5). These differences persisted when T2D was included in the model (South Asians: -
32.4 (-53, -12) steps, p=0.002; African-Caribbean: -5.6 (-33, 22) steps, p=0.7).  South 
Asians completed fewer steps than African-Caribbean’s although this difference did not 
reach significance (-27 (-55, 0.9) steps, p=0.06).  
Grip strength was lower in South Asians compared to Europeans after adjustment for age, 
sex and T2D (difference (95%CI): -8.6 (-13.9,-3.4) KPa, p=0.001). Compared to African-
Caribbean’s grip strength was lower in South Asians (difference (95%CI): -16.2 (-23.3, -
9.2) KPa, p<0.001) and lower in Europeans (difference (95%CI): -7.6 (-14.5, -0.67) KPa, 
p=0.03). Table 5.2 shows marginal means for the 3 ethnic groups for exercise capacity 
and grip strength. 
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Table 5.2 Adjusted means comparing ethnic differences in submaximal exercise capacity (steps completed and step rate) and 
maximal grip strength. Adjustment was made for potential confounders in model 1 (age and sex) and model 2 (age, sex and type 
2 diabetes (T2D)). Significance differences between South Asians (SA) and African-Caribbean’s (AC) compared to Europeans (E) 
is denoted by stars: *p≤0.05, **p≤0.01, ***p≤0.001 and differences between South Asians compared to African-Caribbean’s is 
denoted by dagger symbols: †p≤0.05, ††p≤0.01, †††p≤0.001.  AC; African-Caribbean, E; European, SA; South Asian, T2D; type-2 
diabetes. 
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Measured peak V̇O2 was lower in the South Asians compared to Europeans after 
adjustment for age, sex and T2D (difference (95%CI): -1.5(-2.7,-0.3) ml/min/kg, p=0.019) 
but similar in African-Caribbean’s compared to Europeans (difference (95%CI): -0.6(-
2.3,1.1), p=0.487). There was no significant difference in measured peak V̇O2 between 
South Asians compared to African-Caribbean’s (difference (95%CI): -0.9(-2.6,0.82), 
p=0.304).  
Compared to Europeans, the predicted V̇O2max (using equations) was not different in 
South Asians (difference (95%CI): 1.5(-0.2, 3.2), p=0.08) or African-Caribbean’s 
(difference (95%CI): -1.5(-3.8,0.8), p=0.19). Predicted V̇O2max using the extrapolation 
method was also not different between the ethnic groups (South Asians difference 
(95%CI): -0.17(-1.1,0.7), p=0.70); African-Caribbean difference (95%CI): -0.51(-1.7,0.66), 
p=0.39). There were no differences in predicted V̇O2max when South Asians were 
compared to African-Caribbean’s (South Asians difference(95%CI); 0.64(-0.44,1.74), 
p=0.24). 
5.3.3 Skeletal muscle oxidative capacity 
Compared to Europeans, after adjustment for age, sex and T2D, resting muscle oxygen 
consumption was not different in South Asians (difference (95%CI): 0.05(-0.12,0.01) 
ΔHbdiffµM/s, p=0.10) or African-Caribbean’s (difference (95%CI): 0.03(-0.05,0.12) 
ΔHbdiffµM/s, p=0.45). Resting muscle oxygen consumption was lower in South Asians 
compared to African-Caribbean’s, after adjustment for the same confounders (-0.09(-0.17,-
0.001) ΔHbdiffµM/s, p=0.05).  
Compared to Europeans, after adjustment for age, sex and T2D, South Asian ethnicity 
was associated with longer time constants (difference (95%CI): 10.1 (2.3, 17.9) s, p= 
0.011). The time constant was similar in African-Caribbean’s compared to Europeans 
(difference (95%CI): 5.8(-4.4, 16.0), p=0.264). There was no difference between South 
Asians and African-Caribbean’s (difference (95%CI): 4.3(-6.1,14.7), p=0.416).Table 5.3 
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shows marginal means for the 3 ethnic groups for resting muscle oxygen consumption 
(muscleVO2) and the time constant (τ).
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Table 5.3 Adjusted means comparing ethnic differences in resting muscle oxygen consumption (muscle VO2) and the time 
constant (τ). Adjustment was made for potential confounders in model 1 (age and sex) and model 2 (age, sex and type 2 diabetes 
(T2D)). Significant differences between South Asians (SA) and African-Caribbean’s (AC) compared to Europeans (E) is denoted 
by stars: *p≤0.05, **p≤0.01, ***p≤0.001 and differences between South Asians compared to African-Caribbean’s is denoted by 
dagger symbols: †p≤0.05, ††p≤0.01, †††p≤0.001.  AC; African-Caribbean, E; European, SA; South Asian, T2D; type-2 diabetes. 
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5.3.4 Oxidative capacity and exercise capacity 
The reduced exercise capacity observed in South Asian participants was not attenuated 
when the measure of muscle oxidative capacity (τ) was included in models (Model 3; age, 
sex, T2D & τ). South Asians still achieved fewer steps compared to Europeans (-36.6 
steps, 95%CI=-58, -16, p=0.001), stepped at a slower rate (-5.5 steps/min, 95%CI=-8, -3, 
p<0.001) and had a lower grip strength (-9.0 KPa, 95%CI=-14, -4, p=0.001). 
5.4 Discussion 
5.4.1 Key findings 
This study demonstrates that older adults of South Asian origin have lower submaximal 
exercise capacity than Europeans while African Caribbean adults, of a similar age, have a 
similar capacity for submaximal exercise and stronger grip strength compared to both 
South Asians and Europeans. South Asians had longer time constants for recovery of 
muscle V̇O2, suggesting impaired oxidative capacity compared to Europeans; this was 
independent of presence of T2D. However, when the ethnic differences in exercise 
capacity were adjusted for the time constant, they could not be explained by the poorer 
skeletal muscle oxidative capacity. These data indicate that the reduced submaximal 
exercise capacity and grip strength seen in older adults of South Asian origin is not 
explained by the higher prevalence of diabetes or impaired muscle oxidative capacity in 
South Asians. This is consistent with the finding that exercise capacity and skeletal muscle 
oxidative capacity were similar in African Caribbean’s and Europeans.  
T2D was more prevalent in South Asians compared to Europeans in this group of older 
adults (26% versus 11%, p=0.02); this is in line with previous finding from younger 
participants.(139, 140) Previously, increase prevalence of T2D has been described in 
African-Caribbean groups compared to Europeans.(141, 284) In this analysis, although 
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there was a trend towards a higher prevalence of T2D in African-Caribbean’s compared to 
Europeans, this difference did not reach significance (20% versus 11%, p=0.24). 
5.4.2 Exercise capacity and cardiorespiratory fitness 
The poorer exercise capacity seen in South Asians here is reflected in the fewer steps 
completed during the 6MST and the lower peak measured oxygen uptake during the 
submaximal exercise, even after adjustment for age, sex and increased prevalence of 
T2D. Differences in submaximal exercise capacity are generally in line with findings from 
other groups who have reported poorer achievement on maximal exertion CPET results 
and lower physical activity levels in South Asians.(157, 158) Measured oxygen uptake 
during exercise, compared to Europeans, was lower in South Asians and similar in African 
Caribbean’s. When V̇O2max was predicted using the sub-maximal heart rate and the 
workload achieved during testing, this was not different by ethnic group which is not in line 
with previous findings. Thus, we did not find differences in sub-maximal exercise capacity, 
or predicted cardio-respiratory fitness (predicted V̇O2max) between African Caribbean’s 
and either Europeans or South Asians; this appears contrary to the results of Caeser et 
al(159) who present lower predicted V̇O2max values in non-Hispanic Black Americans 
compared to White Americans. These discrepant findings could be explained by the 
younger age of participants enrolled in the National Health and Nutrition Examination 
Survey (NHANES) population.(159) It is possible that, in the older adult group, ethnic 
differences in V̇O2max become more subtle than in younger adults and, therefore, it is not 
possible to detect differences with a crude predictive measurement. It is also possible that 
the predictive equations we used here are not appropriate for the South Asian or African-
Caribbean groups. These equations were developed using data from European men and 
women. When the extrapolation method was used to predict V̇O2max, although there was 
still no significant difference between groups, the values were more in line with previous 
results.(157) Furthermore, a limitation to our study is that we were only able to recruit half 
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as many African Caribbean’s as Europeans or South Asians giving us less power to detect 
significant differences. 
5.4.3 Skeletal muscle metabolism 
Resting skeletal muscle oxygen consumption, measured using NIRS signal changes 
during a 30 second arterial occlusion, was highest in African Caribbean participants and 
lowest in South Asians, the difference between these two ethnic groups was significant but 
only after adjustment for age, sex and T2D. The difference from South Asians to 
Europeans or Europeans to African Caribbean’s did not reach significance (Table 5.3). 
This suggests that, at rest, metabolic turnover could be higher in African Caribbean’s. This 
could be the result of a difference in the muscle fibre-type, with African Caribbean’s having 
a higher proportion of type 2 fibres, as has previously been described.(286) An alternative 
explanation is that improved microvascular function in African Caribbean’s permits faster 
extraction of oxygen into the muscle cell, therefore, more rapidly reducing the 
concentration of oxygenated haemoglobin. This second explanation would be in line with 
the reduced arterial stiffness, indicating better arterial function, previously described in 
African Caribbean’s compared to Europeans and South Asians.(149) 
Skeletal muscle oxidative capacity, measured as the time constant for muscle V̇O2 
recovery, was poorer in South Asians compared to Europeans (longer time constants). 
There were no differences between African Caribbean’s and Europeans. This finding 
appears to directly oppose finding by Nair et al who describe enhanced skeletal muscle 
mitochondrial function in muscle biopsies from South Asian compared to European-origin 
participants.(166) They found that mitochondrial DNA copy number, transcription of genes 
involved in oxidative phosphorylation, citrate synthase activity, and maximal mitochondrial 
ATP production rate were higher in Indian Asian irrespective of their diabetic status.(166) 
However, Nair et al examined younger participants (mean age of ~50 years old), they 
excluded volunteers who had known cardiovascular disease (as well as other co-
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morbidities) and, importantly, they did not measure cardio-respiratory fitness or exercise 
capacity. Therefore, we cannot be certain that there were no differences in fitness or 
habitual physical activity that may have influenced skeletal muscle measurements or that 
participant selection introduced bias.  
Hall et al, also described poorer oxidative capacity in South Asians compared to 
Europeans but, like Nair et al, then found this was not due to reduced expression of 
oxidative and lipid metabolism genes. Hall et al found that expression of carnitine 
palmitoyl-transferase 1A (CPT1A) and fatty acid synthase (FASN) were nearly 2 times 
higher in South Asians than Europeans and there was no relationship between whole-body 
insulin sensitivity and expression of these genes. They also showed that the ratio of 
mtDNA to nuclear DNA was not different in South Asians. The authors suggest that 
differences in capacity for lipid oxidation could be a consequence of impaired vascular 
function. Taken together these findings largely agree with the findings of Nair et al.(205) 
Evidence from both studies suggests that excess insulin resistance seen in South Asians 
cannot be explained by reduced expression of genes involved in oxidative 
phosphorylation. The findings presented here, that non-invasively determined oxidative 
capacity of skeletal muscle is lower in South Asians independently of T2D, provide 
additional complementary evidence suggesting that, with age, these differences in skeletal 
muscle oxidative capacity persist. Oxidative capacity was not different between the 
Europeans and African-Caribbean’s despite a trend towards increased prevalence of T2D 
in the African-Caribbean group further suggesting a dis-association between oxidative 
capacity and exercise capacity in the presence of T2D.   
5.5 Limitations 
In this study we performed non-invasive measurements on skeletal muscle in vivo; 
therefore, conclusions regarding the mechanistic detail underlying impaired oxidative 
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capacity are not possible. We cannot determine if the impairment in function is due to 
reduced mitochondria function or reduced mitochondria number.  
While our sample size for European and South Asian participants was fairly even (n=79 & 
74, respectively), less than half of this number of African-Caribbean’s were enrolled 
(n=30). This limits our power to detect differences between African-Caribbean participants. 
We have not included self-reported physical activity as a potential mediator of the effects 
observed; however, adjusting differences in exercise capacity for habitual physical activity 
levels would be interesting in future analysis. We do not describe micro-vascular function 
in this group of older adults. 
5.6 Conclusions 
Exercise capacity is impaired in older adults of South Asian origin and this effect is 
independent of the increased prevalence of T2D in this group. Exercise capacity did not 
differ between Europeans and African Caribbean people despite a trend towards higher 
prevalence of diabetes in the latter group.   Skeletal muscle oxidative capacity is impaired 
in South Asian people but this does not explain the reduction in exercise capacity.  
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Chapter 6: The effect of exercise training on 
skeletal muscle metabolic function 
6.1 Introduction 
Skeletal muscle metabolic adaptions with endurance exercise training are well 
recognized.(59, 287) Recent research implicates skeletal muscle metabolic dysregulation 
in disease and pre-disease states and a potential role for exercise in enhancing 
mitochondrial biogenesis has attracted recent interest.(104, 288) There is a need to 
identify sensitive, non-invasive physiological markers of skeletal muscle metabolic function 
in order to recognize interventions that will deliver positive adaptations. 
The effects of exercise training on the cardio-pulmonary system can be quantified using a 
cardio-pulmonary exercise test (CPET) to assess peak oxygen consumption (peak V̇O2 or 
V̇O2max) via expired gas analysis. Multiple components contribute to peak V̇O2 including: 
pulmonary diffusion, cardiovascular function (predominantly capacity to increase cardiac 
output, but also capacity for transport and exchange via the peripheral macro- and micro- 
circulation), the capacity for oxygen carrying in the blood, and cellular energy metabolism 
and mitochondrial function, as discussed in detail in Chapter 1.(44) It is generally accepted 
that in humans, whole body peak V̇O2, as measured by analysis of expired gases, is 
limited by the rate of oxygen delivery, and not by the rate of uptake/utilization in the 
muscle.(44)  
V̇O2max has an established relationship with exercise capacity, however, within a narrow 
range of values, performance may differ in terms of exercise capacity.(100) In runners 
these differences have been described as differences in ‘running economy’ which is 
quantified as the V̇O2 required for running at a given pace.(100) Therefore, endurance 
185 
performance is strongly dependent on good running economy and it is thought that that 
this could be due to muscle adaptations, specifically increased mitochondrial enzymes, 
resulting in fewer disturbances to mitochondrial homeostasis.(60) Previously, increased 
physical activity, but not necessarily heavy exercise training, has been shown to enhance 
metabolic health independently of cardio-respiratory fitness.(289) 
Vigelso et al.(290) have summarized evidence suggesting a direct positive correlation 
between improvements in cardio-pulmonary peak V̇O2 and muscle mitochondrial 
enzymatic activity. However, inclusion of a skeletal muscle assessment of oxygen 
consumption is uncommon within the context of a CPET. This may reflect difficulties, or 
expense, required to undertake appropriate measurements; the limitations of muscle 
biopsy analysis and MRS are discussed in Chapter1.   
The generalizability of some of the previous work investigating skeletal muscle adaptations 
to low-functioning participants is debatable. Typically, these kind of performance studies 
are carried out in young, healthy and usually, relatively fit individuals or athletes who are 
motivated to undertake maximal exercise tests and rigorous training regimes. The effect of 
minimal, unsupervised training, in ‘real-world’ populations, has not previously been 
examined. Oxidative capacity, measured locally in the muscle, is not typically carried out 
alongside a CPET and non-invasive measurements using NIRS have never previously 
been carried out in this kind of setting.  
As described in detail in Chapter 1, near infrared spectroscopy (NIRS) is a non-invasive 
technique that can measure changes in oxy-Hb and deoxy-Hb in skeletal muscle up to a 
depth of ~1.5cm.(256) Indices previously described in studies using NIRS have been 
based on response to exercise with, or without, arterial occlusions. Without arterial 
occlusions it is impossible to differentiate changes in oxygen consumption from changes in 
blood flow. It is not feasible to perform repeated arterial occlusions to estimate V̇O2 
throughout exercise, so a simple alternative is to assume that immediately post-exercise 
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the V̇O2 determined via arterial occlusion is an acceptable estimate of the V̇O2 during the 
final stages of the exercising protocol.(215) Short, transient arterial occlusions have also 
been applied in the post-exercise period to determine the kinetics of muscleV̇O2 
recovery(216, 259) these measurements have shown good reproducibility and good 
agreement(215) with established 31P-MRI measurements of muscle oxidative 
capacity.(222) 
The three objectives of this chapter were:  
(1) To compare skeletal muscle oxygen consumption at rest and immediately post-
exercise, measured locally using NIRS, with cardio-respiratory fitness, measured 
using expired gas analysis to determine peak V̇O2 in young, healthy sedentary 
individuals  
(2) To investigate the effect of six months of endurance training in healthy individuals, 
undertaking preparation for a first marathon, on muscle oxygen consumption 
(muscleV̇O2) and cardio-pulmonary peak V̇O2 and to explore how these measures 
relate to first-time marathon running performance. 
(3) To investigate the effect of six months of endurance training on oxidative capacity 
measured as the time constant for recovery of muscle V̇O2  determined using NIRS 
6.2 Methods 
6.2.1 Participants 
Participants were drawn from an observational study investigating the effect of training for 
a first marathon on cardiac remodeling: The Marathon Study. Inclusion criteria for The 
Marathon Study were: age 18-35 years old at recruitment, no past significant medical 
history, no previous marathon-running experience and current participation in running for < 
2 hours per week.  
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Due to availability of equipment it was not possible to study all participants in the Marathon 
Study, so alternate participants attending clinic for cardiac MRI underwent NIRS. Figure 
6.1 shows full details of flow of participants through this study and selection for this 
analysis. All measurements were repeated after the marathon had been completed; this 
corresponded to a 6-months period for training (post-training). Figure 6.2 shows the study 
design, highlighting the timeline of measurements, for all participants included in this 
analysis.   
All procedures were in accordance with the principles of the Helsinki declaration, all 
participants gave written informed consent and the study was approved by the London – 
Queen Square National Research Ethics Service (NRES) Committee – 15/LO/0086.  
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Figure 6.1 Selection process and data flow of NIRS data. 
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Figure 6.2 Study design highlighting the process of pre-training and post-training 
measurements. In October 2015 ‘pre-training’ measurements were carried out soon 
after release of the ballot results for the Virgin London Marathon (VLM) which was 
due to take place in April 2016. Cardio-pulmonary peakVO2 was measured pre- and 
post-training (via cardio-pulmonary exercise testing (CPET)) and muscle 
measurements were made at rest and immediately post-exercise at pre- and post-
training. 
6.2.2 Training  
Participants were recommended to adhere to the ‘First-time finisher’ training 
schedule(291), aiming to run ~3 times per week for the 16-week period prior to the 
marathon. However, those eager to follow alternative, higher intensity, training plans were 
not discouraged. Some participants wished to start their training earlier than 16 weeks 
prior to the marathon and so we elected to conduct pre-training testing immediately 
following the release of the results from the ballot entry system which was 6 months prior 
to the marathon. Therefore, the minimum training period for all participants was 16-weeks 
but some participants may have trained for up to 26-weeks before the repeat assessment.   
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6.2.3 Anthropometric and blood pressure measurements  
Participants were not asked to fast prior to either pre-training or post-training study visit but 
were asked to abstain from heavy exercise in the 24 hours prior. We did not control for 
hydration during the study visits, however, participants were offered water throughout their 
visit but were asked not to have caffeinated drinks.  
Height was measured barefoot using a standard stadiometer. Weight, body fat mass and 
body fat percentage were measured using digital bio-impedance scales (BC-418, Tanita, 
USA). Body fat was included in this analysis because of the previously described 
substantial effect of adipose tissue thickness on the NIRS signal.(183)  
Brachial blood pressure was measured at rest using an electronic oscillometric monitor 
(Pulsecor, Cardioscope BP+, Uscom, Sydney). Measurements were made separately from 
each arm and the mean values are presented. 
6.2.4 Cardio-pulmonary exercise test (CPET) 
The CPET in the Marathon Study was carried out on a semi-supine ergometer 
(Ergoselect1200, Ergoline, Germany). Full details of the protocol are described in Chapter 
2.  
6.2.5 Skeletal muscle measurements 
The gastrocnemius was selected for investigation because it is recruited during running 
and cycling (292), it is therefore likely to undergo adaptations with training. NIRS 
measurements from this site have been shown to be reproducible(215) and since the calf 
is covered by less adipose tissue than the thigh or larger locomotive muscles (233) the 
influence of adipose tissue thickness (ATT) on NIRS measurements is less. 
Prior to attaching the NIRS device, ATT was measured at the site of NIRS measurement 
using B-mode ultrasound (Vivid I, GE healthcare) equipped with a 12L-RS linear array 
transducer; three measurements were averaged.  
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As described previously; a continuous wave NIRS device (Portamon, Artinis Medical 
Systems, Netherlands) was used to measure changes in oxy-Hb and deoxy-Hb from the 
lateral gastrocnemius. Position and orientation of the device was standardized between 
individuals. The device was attached using tape and covered completely using a neoprene 
sleeve. Measurements were acquired at a frequency of 10Hz throughout the protocol.  
For NIRS measurements the participant was seated in a semi-upright position with their 
gastrocnemius relaxed. Arterial occlusions were performed at rest and immediately 
following the exercise test using a rapid inflation cuff (Hokanson, SC10D/E20, PMS 
Instruments, UK) placed on the thigh directly above the patellofemoral articulation. The 
cuff was inflated to a pressure of 250mmHg and inflation or deflation was complete in 0.3 
seconds. At rest the cuff was inflated for 30 seconds, post-exercise the occlusion duration 
was 5-8 seconds.  
6.2.6 NIRS post-processing 
Analysis of NIRS data was conducted using custom written programs in MATLAB R2014a 
(MathWorks Inc.). Signals were rejected if visual inspection showed movement artifact or if 
there was evidence that complete arterial occlusion had not been achieved. Incomplete 
arterial occlusion was judged on the direction of the oxy-Hb and deoxy-Hb signals; under 
complete arterial occlusion these are expected to move in opposite directions. MuscleV̇O2 
was estimated by fitting the slope of the difference between oxy-Hb and deoxy-Hb signal 
during each occlusion.(236) More negative values represent higher muscle oxygen 
consumption; therefore, in order to align our values with the cardio-pulmonary peak V̇O2, 
we inverted the values to provide a positive index of muscle oxygen consumption. 
Exercise-related increases in muscleV̇O2 (ΔmusV̇O2) were calculated as the absolute 
difference between resting muscleV̇O2 and muscleV̇O2 measured immediately post-
exercise.  
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Parameters marking skeletal muscle metabolic function were calculated as described in 
Chapter 2, figure 2.8. Resting muscleV̇O2, and post-exercise muscleV̇O2 were reported as 
measured of skeletal muscle oxygen consumption. Exercise-related increases in 
muscleV̇O2 (ΔmusV̇O2) were calculated as the absolute difference between resting 
muscleV̇O2 and post-exercise muscleV̇O2. The time constant (τ) was calculated as the 
recovery rate of muscleV̇O2 and represents the oxidative capacity of the skeletal muscle. 
Muscle measurements were corrected for ATT according to equation 3.1 described in 
Chapter 2. 
6.2.7 Statistical analysis 
Categorical data are presented as n (%). Continuous data were examined for normality 
and participant characteristics are presented as mean±standard deviation or median 
(interquartile range) if skewed. Results are presented as means (95% confidence 
intervals). Comparison of means was done using a two-tailed, paired Student’s t-test and 
comparison of skewed data using a Wilcoxon signed-rank test. Pearson’s correlation 
coefficient (r) was calculated to assess correlations. Partial correlation coefficients (rpartial) 
were calculated for relationships between marathon completion time and peakV̇O2 or 
muscleV̇O2 after adjustment for age and gender. We tested if training for a marathon 
modified the relationship between variables using an interaction term for statistical 
significance and also by visual inspection by plotting the data points for each time point 
with line of best-fit on the same graph. Statistical significance was assigned if P<0.05.  
6.3 Results  
6.3.1 Participants 
27 participants provided complete data for analysis from pre- and post-training 
assessments, the characteristics of these participants are given in table 6.1. The mean 
duration from completion of the marathon to the post-training visit was 15.8±4.6 days.  
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Table 6.1 Participant characteristics. Data are mean±SD. 
6.3.2 Effect of endurance training 
The mean marathon completion time was 4.6±0.81 hours. This was longer for women 
versus men (4.9±1.0 versus 4.3±0.6 hours, p=0.07). Based on weekly mileage data and 
marathon completion times from 27,000 runners over a 16-week training period,(293) the 
average times achieved by participants in this study are consistent with a typical training 
schedule of between 6 – 13 miles/per week. 
There was a small reduction in resting heart rate from pre-training to post-training (mean 
difference=1.4 (95% CI: -4.5, 7.2) bpm, p=0.63; table 5.2) and cardio-pulmonary peakV̇O2 
did not differ (mean difference=-0.0 (95% CI: -2.1, 2.0) ml/min/kg, p>0.9; table 6.2). There 
was a small reduction in systolic blood pressure (mean difference= -2.8 (95%CI: -6.6, 1.1)) 
and slightly greater reduction in diastolic blood pressure (mean difference= -3.0 (95%CI: -
5.6, -0.5)). Post-exercise muscleV̇O2 was greater post-training compared to pre-training 
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measurements (median value(IQR); 1.04(0.85-1.29) versus 1.48(1.04-2.16) ΔHbdiffμM/s, 
p=0.004; table 6.2 & figure 6.3).  
ΔmusV̇O2 was also greater post-training (mean difference = -0.79 (95% CI:-1.1,-0.46) 
ΔHbdiffμM/s; p< 0.001; table 6.2) and there was little or no reduction in resting muscle V̇O2 
(median value(IQR); 0.25(0.19-0.32) versus 0.21(0.16-0.32) ΔHbdiffμM/s, p=0.35; table 
6.2). 
 
Table 6.2 Physiological measures before and after exercise training in all 
participants. Data are mean±SD for normally distributed data and median(IQR) for 
non-normally distributed data. Comparison of means was done using a paired 
Student’s t-test and comparison of skewed data using a Wilcoxon signed-rank test. 
ATT; adipose tissue thickness, BP; blood pressure, Post-Ex; post-exercise, Hb; 
haemoglobin. 
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Figure 6.3 Box and whisker plot showing post-exercise muscleV̇O2 pre-training 
(dark grey) and post-training (light grey). A box and whisker plot is used to describe 
this data because of its skewed distribution. The bottom and top of the box 
represent the first and third quartiles, the band inside the box is the median and the 
whiskers represent the lower and upper adjacent values within 1.5*IQR of the lower 
and upper quartile, respectively. Medians were compared using a Wilcoxon signed-
rank test; post-training values were significantly higher than pre-training. Hb; 
haemoglobin. 
6.3.3 MuscleV̇O2 and cardio-pulmonary PeakV̇O2 
Pre-training higher muscleV̇O2 following the exercise test correlated with higher cardio-
pulmonary peakV̇O2 (Pearson’s r= 0.64, p<0.001; figure 6.4; red circles). Post-training a 
positive correlation was also seen but it was less strong (Pearson’s r=0.27, p=0.17 (figure 
6.4; blue squares)). There was no significant interaction between the visit time (pre- versus 
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post-training) and the relationship between muscleV̇O2 and cardio-pulmonary peakV̇O2 
(p=0.251). 
 
Figure 6.4 Correlation between cardio-pulmonary peakV̇O2 and post-exercise 
muscleV̇O2 for 27 participants assessed pre-training and post-training. Participant 
data pre-training are represented by rose-coloured circles and a rose line of best fit 
and post-training by blue squares and a blue line of best fit. 
Figure 6.5 shows an example of NIRS signals from a single participant during arterial 
occlusions performed immediately post-exercise at the (a) pre-training and (b) post-
training visits (Figure 6.5 a & b, respectively). The dashed lines indicate the measurement 
area and green arrow indicates the slope of decline in HbO2 which represents rate of 
oxygen consumption in the muscle. The green arrow is shown at both time-points to 
highlight the change with training. 
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Figure 6.5 Example participant data showing the NIRS signal during arterial occlusions (OCC) performed immediately post-
exercise. Changes in oxygenated haemoglobin (HbO2), deoxygenated haemoglobin (HHb) and total haemoglobin (tHb) are shown 
for one participant at (a) pre-training visit and (b) post-training visit. The dashed lines indicate the measurement area and green 
arrow indicates the slope of decline in HbO2 which represents rate of oxygen consumption in the muscle. The green arrow is 
shown at both time-points to highlight the change with training. 
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6.3.4 Oxidative capacity with training and performance 
There was no difference between the time constant from pre-training to post-training 
(median value(IQR); 35(22-45) versus 36(23-60) s, p=0.24; table 6.2). Pre- and post-
training values were positively correlated (Pearson’s r= 0.84, p<0.001; figure 6.6). 
 
Figure 6.6 Correlation between pre- and post-training measurements of the time 
constant. Pearson’s correlation coefficient is 0.84, p<0.001.  
There was a positive relationship between the time constant and marathon performance 
(marathon running time) for both the pre- and the post-training measurements of the time 
constant, however, this was not statistically significant after adjustment for age and sex 
(rpartial=0.37, p=0.09 & rpartial=0.07, p=0.73, respectively). Unadjusted values for pre- and 
post-training time constants versus marathon running time are plotted in figure 6.7 (top 
panel). There was no significant interaction between the visit time (pre- versus post-
training) and the relationship between the time constant and marathon running time 
(p=0.332). The difference in time constant (post- minus pre-training value) showed a 
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negative trend with marathon time but this also was not statistically significant (rpartial= -
0.24, p=0.32; figure 6.7, bottom panel). 
 
Figure 6.7 Correlation between marathon running time (in hours) and the time 
constant for musleV̇O2 recovery. The top panel shows marathon time versus pre-
training (red circles and red line of fit) and post-training (blue squares and blue line 
of fit) time constants. The bottom panel shows marathon time versus the difference 
between pre- and post-training time constant (the post-training value minus the pre-
training value). 
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6.3.5 Marathon performance and cardiorespiratory fitness 
Higher cardio-pulmonary peakV̇O2 values post-training were associated with faster 
marathon completion times after adjustment for sex and age (rpartial=-0.58, p= 0.002). 
Greater increases in peakV̇O2 from the pre-training value also predicted shorter marathon 
completion times (rpartial=-0.53, p=0.007). Figure 6.8 shows the unadjusted correlation 
between marathon running time (in hours) and cardio-pulmonary peakV̇O2 pre- and post-
training (top panel) and marathon time versus the difference between pre- and post-
training peakV̇O2 (bottom panel). There was no interaction between the visit time (pre- and 
post-training) and the relationship between cardio-pulmonary peakV̇O2 and marathon time 
(p=0.744). 
There was no convincing relationship between muscleV̇O2 measured post-training and 
marathon completion time (rpartial=0.31, p=0.14) or ΔmusV̇O2 and marathon completion 
time (rpartial=0.31, p=0.14). The post-training recovery time constant was also not 
associated with marathon completion time (rpartial=0.18, p=0.41). 
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Figure 6.8 Correlation between marathon running time (in hours) and cardio-
pulmonary peakV̇O2. The top panel shows marathon time versus pre-training 
peakV̇O2 (red circles and red line of fit) post-training peakV̇O2 (blue squares and 
blue line of fit). The bottom panel shows marathon time versus the difference 
between pre- and post-training peakV̇O2. 
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6.3.6 Marathon performance and resting muscle oxygen consumption  
There were no strong relationships between resting muscle oxygen consumption (resting 
muscle V̇O2) at either pre- or post-training measurements (figure 6.9, top panel). There 
was no interaction between the visit time (pre- versus post-training) and the relationship 
between resting muscle V̇O2 and marathon time (p=0.237).There was no significant 
change in resting muscle oxygen consumption (Table 6.2, described previously) and there 
was no relationship between the change in resting muscle V̇O2 and marathon performance 
(rpartial=0.26, p=0.22) (figure 6.9, bottom panel). 
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Figure 6.9 Correlation between marathon running time (in hours) and resting 
musleV̇O2. The top panel shows marathon time versus pre-training resting 
muscleV̇O2 (red circles and red line of fit) post-training resting muscleV̇O2 (blue 
squares and blue line of fit). The bottom panel shows marathon time versus the 
difference between pre- and post-training resting muscleV̇O2. 
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6.3.7 Cardiorespiratory fitness, resting muscle oxygen consumption and oxidative capacity 
Cardiorespiratory fitness (peak V̇O2) was broadly positively correlated with resting skeletal 
muscle oxygen consumption at the pre- and post-training measurement visits (Pearson’s 
r=0.41, p=0.04 & Pearson’s r=0.45, p=0.02, respectively; figure 6.10, top graphs). 
However, the change in peak V̇O2 and resting muscleV̇O2 were not related. 
Cardiorespiratory showed no relationship with the time constant for recovery of muscle 
V̇O2 post exercise (figure 6.10, bottom graphs). Although, the change in time constant and 
change in peak V̇O2 with training were positively correlated (Pearson’s r=0.49, p=0.02; 
figure 6.10, bottom right graph).   
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Figure 6.10 six-panel graph plot. The relationship between cardiorespiratory fitness and resting muscle oxygen consumption 
(muscle V̇O2) is shown in the top 3 panels for; (left to right) pre-training, post-training and the change in resting muscle V̇O2. The 
relationship between cardiorespiratory fitness and the time constant is shown in the bottom 3 panels for; (left to right) pre-
training, post-training and the change in time constant.
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6.4 Discussion 
6.4.1 Key findings  
This study measured resting muscleV̇O2, post-exercise muscleV̇O2 and the recovery time 
constant of muscleV̇O2 using NIRS. Simultaneous assessment of cardio-pulmonary 
peakV̇O2 via CPET was carried out in this sample of young, healthy men and women. All 
measurements were carried out before and after 4 to 6 months of endurance training in 
preparation for a first-time marathon.  
Compared with pre-training, post-training was associated with an increase in post-exercise 
muscleV̇O2 and ΔmusV̇O2, despite no detectable change in cardio-pulmonary peakV̇O2. 
There was no change in the time constant representing skeletal muscle oxidative capacity. 
The magnitude of the increase in muscleV̇O2 was similar to that previously reported in 
healthy volunteers using NIRS following bicycle training (vastus lateralis)(294) or training 
of arm muscles,(222) or using succinate dehydrogenase(295) or citrate synthase(296) as 
indicators of muscle oxidative capacity. However, one study failed to observe an increase 
in maximum muscle oxygen consumption in finger flexor muscles following 6-weeks of 
training with a dynamic handgrip exercise.(297) Our findings suggest that, in these young, 
healthy individuals, a comparatively low-level of endurance training, while not sufficient to 
noticeably improve cardio-pulmonary function, still led to positive skeletal muscle 
adaptations resulting in improved oxygen extraction following exercise. 
6.4.2 Marathon training 
It is possible that the detected changes in gastrocnemius muscleV̇O2 reflect changes in 
muscle group utilization, due to training. Differences in training structure such as inclusion 
of strength, speed-endurance or interval training in the program are known to differentially 
affect muscle function.(298-300). For example, it may be the case that participants 
replaced other activities (gym sessions, cycling etc.) with run-training and therefore 
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increased conditioning in the gastrocnemius. Post-exercise muscleV̇O2 and the exercise-
induced increase in muscle oxygen consumption, ΔmusV̇O2, were moderately positively 
correlated with cardio-pulmonary peakV̇O2 pre-training and more weakly with post-training 
peakV̇O2. Consequently, it seems likely that these correlations relate to inherent 
participant characteristics (e.g. sex, age) rather than to the 6 months of training. A 
limitation of this study is that training was not supervised and information about training 
was not collected (discussed in the limitations section in more detail), therefore, we do not 
know to what extent participants undertook running, cycling or gym activities in their 
Marathon preparation. 
6.4.3 Marathon performance 
Marathon performance was judged as marathon completion time. As expected, faster 
marathon completion times were associated with higher cardio-pulmonary peakV̇O2,(65)  
but no relationship was observed between indices of muscle function, post-exercise 
muscleV̇O2 and ΔmusV̇O2 in gastrocnemius, and marathon completion time. This is 
consistent with cardiopulmonary factors rather than mitochondrial oxidative capacity 
(which typically exceeds maximal O2 supply in skeletal muscle) being a dominant factor in 
peak exercise capacity.(44, 301)  
6.4.4 Skeletal muscle oxidative capacity 
Previously, cross-sectional data have demonstrated improved metabolic function in athletic 
versus inactive subjects.(60, 99) In the study by Brizendine et al,(99) highly trained 
endurance athletes, with a mean peak V̇O2= 73.5±9.1 ml/min/kg, were compared to 
inactive individuals (mean peak V̇O2= 33.7±5.9 ml/min/kg) using the same NIRS methods 
for deriving a time constant representing skeletal muscle oxidative capacity; they found 
that in endurance trained individuals mean recovery time constants from the Vastus 
Laterialis were 18.4±3.2 s versus 32.4±5.2 s in the inactive control group.(99) Other 
studies have employed NIRS to study skeletal muscle response to run-training, however, 
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in studies where arterial occlusions are not performed, it is important to note that 
improvements could be attributed to either, or both, improved O2 delivery and/or increased 
mitochondrial capacity.(221) 
6.4.5 Cardiorespiratory fitness 
Cardiorespiratory fitness (Peak V̇O2) showed a broadly positive correlation with resting 
skeletal muscle oxygen consumption at both pre-training and post-training measurement 
times (Pearson’s r=0.41, p=0.09 & Pearson’s r=0.45, p=0.004, respectively; figure 6.10, 
top graphs). However, there were no changes detected in resting muscle oxygen 
consumption with training and there was no relationship between peakV̇O2 and resting 
skeletal muscle oxygen consumption.  
Cardiorespiratory fitness was not correlated with oxidative capacity (the time constant for 
recovery of muscle V̇O2 post exercise) in the group either before or after training (figure 
6.10, bottom left and central graphs). Although, the change in oxidative capacity and 
change in fitness with training were positively correlated (Pearson’s r=0.43, p=0.03) 
suggesting that improvements in cardio-respiratory fitness, over this wide range in values, 
was associated with an improvement in skeletal muscle metabolic function, a finding which 
is in line with previous findings.(100) 
6.5 Limitations 
We did not observe a significant improvement in peakVO2 between pre-training and post-
training which is contrary to expectation.(65)  It is possible that detraining following 
completion of the marathon may have contributed to this; however, the effect of short 
detraining periods is minimal(302) and is unlikely to fully explain this finding. It is possible 
that lack of supervision of a structured training program and/or lack of adherence to 
training by participants also contributed. Providing structured training programs and 
support throughout training was beyond the scope of this study. Appropriate methods of 
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collecting information describing participant adherence to training programs (e.g. wearable 
activity monitors) would be warranted in future similar studies. Nevertheless, our objective 
was to observe changes that occur in ‘real-world’ subjects undertaking their first marathon; 
therefore, our findings are likely to be representative of young, healthy adults undertaking 
endurance events. Esfarjani et al, randomized participants to structured high intensity 
training interventions versus consistent low-intensity running and showed similar, non-
significant, increases in peakV̇O2 as we report here in the low-intensity group.(303) 
Monitoring training behaviours of the participants in the 6 months prior to the marathon 
would undoubtedly have provided additional valuable data. However, the objective of this 
analysis was to investigate if there is an effect of moderate endurance training on skeletal 
muscle metabolic function in healthy but untrained individuals. The effect of the extent of 
training was not investigated, although we acknowledge that is likely to have implications 
for the extent of improvement in skeletal muscle function. All participants included in this 
analysis completed the marathon and we believe it is fair to assume that this is evidence 
that, at least minimal, endurance training was undertaken. 
Rejection of data due to noise in the NIRS signal was fairly high: ~12% at pre-training and 
~19% at the post-training visit.  This could be improved in future studies by using 
maximum cuff inflation pressures to ensure complete arterial occlusions and by preventing 
movement artifacts through use of a supportive-leg stand to ensure complete muscle 
relaxation.  
6.6 Conclusion 
In healthy individuals preparing for their first marathon, participation in a 4 to 6-month 
training programme is associated with an increase in the ability of gastrocnemius skeletal 
muscle to utilize oxygen following exercise, implying an improvement in metabolic 
capacity. Metabolic adaptions can be identified non-invasively using NIRS combined with 
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arterial occlusions within the setting of a supine CPET, although, caution is warranted 
regarding movement artifacts and insufficient occlusion pressures when using this 
technique. Post-exercise muscleV̇O2 was positively correlated with cardio-pulmonary 
peakV̇O2, particularly pre-training, but, in terms of performance, cardio-pulmonary peakV̇O2 
is a better predictor of faster marathon running.  
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Chapter 7: General discussion and conclusion 
7.1 General overview 
This thesis investigates skeletal-muscle metabolic function and cardio-respiratory fitness 
and how they influence exercise capacity. It is useful to understand these relationships in 
the context of diabetes where skeletal muscle metabolic function has previously been 
considered important in the physiology of disease development.(107, 277) Understanding 
the effect of exercise training on metabolic function and the importance of performance to 
this relationship informs on physiological adaptations of potential preventative/therapeutic 
targets. Two sample populations were considered; (I) a cohort study comprised of 
previously well-characterized, older adults known to have at least 23% prevalence of 
diabetes(223) and (II) a young/healthy adult study designed to investigate the effects of 
first-time marathon training on the heart.  
This thesis also contributes some understanding of NIRS as a muscle measurement tool 
by applying it to these novel study populations in the context of exercise tests where it has 
not previously been used.    
Eight research questions were initially identified (Chapter 1; section 1.8). These are 
reproduced in a summary of 5 concise points which will be discussed in the subsequent 5 
sections, as follows:  
1) How reproducible are the key methods described in this thesis, namely; 
submaximal exercise capacity determined via the 6MST and oxidative capacity and 
oxygen consumption, assessed using NIRS? And how well do the results of the 
6MST compare to results of the 6MWT? 
2) To what extent does the presence of T2D affect submaximal exercise capacity, 
cardiorespiratory fitness and skeletal muscle oxidative capacity? Is the relationship 
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between submaximal exercise capacity and skeletal muscle oxidative capacity 
different between people with and without T2D? 
3) Are there ethnic differences in sub-maximal exercise capacity, cardiorespiratory 
fitness and skeletal muscle oxidative capacity? If so, can oxidative capacity explain 
ethnic differences in exercise capacity/cardiorespiratory fitness? 
4) Does endurance exercise training in sedentary adults improve skeletal muscle 
metabolic function? 
5) Are skeletal muscle metabolic function and cardio-respiratory fitness independently 
associated with exercise capacity? 
An overview of the design of the studies to address these questions is summarized in 
figure 7.1. This chapter discusses each question with reference to the studies described in 
previous chapters and the hypothesis given in Chapter 1, section 1.9. 
 
Figure 7.1 Overview of studies designed to answer the research questions.  
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7.2 Development of methods 
How reproducible are the key methods described in this thesis, namely; submaximal 
exercise capacity determined via the 6MST and oxidative capacity and oxygen 
consumption, assessed using NIRS? And how well do the results of the 6MST compare to 
results of the 6MWT? 
In the older adult cohort described here, the 6MST was developed to be acceptable for 
testing submaximal exercise capacity in older adults and was then tested for reproducibility 
and agreement with the 6MWT. The results presented in Chapter 2 are the first to describe 
the 6MST for assessment of exercise capacity and prediction of V̇O2max in a large 
population-based cohort of older adults. Conducting the exercise test in a static 
environment (without requirement for corridor walking) allowed physiological response to 
exercise to be accurately monitored, therefore permitting investigations necessary to 
answer question 2, such as; analysis of expired gasses for determination of peak V̇O2, 
heart rate measurements throughout to exercise to predict maximum V̇O2 and skeletal 
muscle measurements immediately post-exercise. 
The novel use of the 6MST to permit measurements of skeletal muscle metabolic function 
is presented in Chapter 3. NIRS was selected as a skeletal muscle measurement tool in 
these studies because it is non-invasive and relatively inexpensive. The Portamon was 
selected because, at the time of study design, it was the only commercially available, 
wireless system providing measurement at a high sampling frequency. The methods for 
application of NIRS to derive resting muscleV̇O2, post-exercise muscleV̇O2 and for 
assessment of oxidative capacity are described in Chapter 3. Reproducibility of these 
muscle measurements was acceptable in older adults.  
NIRS methods for measuring skeletal muscle function were also applied in the study 
designed to examine the training effect on skeletal muscle metabolic function (Chapter 5). 
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In this study, NIRS measurements were conducted in the setting of a maximal exertion 
CPET. A direct comparison of resting or post-exercise muscleV̇O2 between the two study 
populations was not appropriate because of the different designs of the exercise tests; in 
the older adult population muscleV̇O2 was measured while participants were standing with 
weight distributed evenly between both legs, while in the young adults, muscleV̇O2 was 
assessed in the supine position with the gastrocnemius completely relaxed. However, 
comparison of the time constant between groups revealed longer values in the older adult 
population (46(41, 50) versus 35(22, 45)seconds), suggesting poorer oxidative capacity in 
this group; in line with other studies that report age-associated skeletal muscle metabolic 
aberrations.(304) 
NIRS is limited in its ability to provide the detailed physiological assessment of skeletal 
muscle that can be determined through muscle biopsy samples; such as mitochondrial 
number or enzymatic activity. However, its ability to provide an assessment of local 
oxygen consumption, without disruption to the physiological environment, makes it a 
valuable complementary tool for functional muscle assessments.  
7.2 Diabetes 
To what extent does the presence of T2D effect submaximal exercise capacity, 
cardiorespiratory fitness and skeletal muscle oxidative capacity? Is the relationship 
between submaximal exercise capacity and skeletal muscle oxidative capacity different 
between people with and without T2D? 
Older adults with diabetes had poorer exercise capacity and achieved a lower peak 
measured V̇O2 during submaximal exercise and lower predicted V̇O2max than adults 
without diabetes (Chapter 4). This is in line with previous studies that have demonstrated 
poorer cardio-respiratory fitness, measured as cardio-respiratory V̇O2 at maximal exertion 
in older adults with T2D.(270, 282) It is also possible that psychological factors influence 
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the lower self-selected pace achieved by people with diabetes, perhaps reflecting a lower 
general participation in exercise; less experience of exercise would limit a participants 
ability for pace control (as discussed in Chapters 2 & 4). The lack of differences in 
perceived exertion or leg fatigue between people with/without diabetes suggests that older 
adults with diabetes experience lower workloads as more intense than older adults without 
diabetes; in line with previous findings.(282) 
Muscle oxygen consumption immediately post-exercise (post-exercise muscle V̇O2) was 
marginally smaller (~15% less) in the presence of diabetes (Chapter 4). While this could 
represent an impaired ability to effectively increase oxidative phosphorylation in response 
to sub-maximal exercise, it is also likely that this reflects the lower workload - as discussed 
above. One further possibility is that the measurement of post-exercise muscle V̇O2 
represents slower repayment of the oxygen debt following exercise therefore reflecting 
poorer micro-vascular function. Bauer et al,(271) demonstrated a slowed response of 
skeletal muscle blood flow at the onset of exercise in the presence of T2D suggesting 
microvascular dysfunction in response to exercise may contribute to the overall impairment 
in V̇O2 kinetics previously reported in the presence of T2D. 
In this study we observed poorer oxidative capacity of skeletal muscle in older adults in the 
presence of T2D. As discussed in Chapter 4, this supports findings from other studies 
where enzymatic activity(126) or rates of PCr recovery have been assessed.(131) NIRS 
cannot determine the underlying biochemical mechanisms for this impaired function which 
could be due to a reduction in mitochondrial number or content or a reduced mitochondrial 
capacity for fatty acid oxidation (metabolic inflexibility) resulting in lipotoxicity.(161, 305) 
Nevertheless, NIRS provides a non-invasive, relatively cheap technique to assess skeletal 
muscle metabolic health. This analysis used cross-sectional data, therefore, conclusions 
cannot be drawn on the direction of the relationship between skeletal muscle oxidative 
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capacity and insulin resistance which has previously been subject to heated debate.(129, 
306)  
7.3 Ethnic differences 
Are there ethnic differences in sub-maximal exercise capacity, cardiorespiratory fitness 
and skeletal muscle oxidative capacity? Can oxidative capacity explain ethnic differences 
in exercise capacity/cardiorespiratory fitness? 
Ethnicity is an important risk for cardiometabolic disease: South Asians and African 
Caribbean’s, the 2 largest migrant ethnic groups in the UK, are at a higher risk for T2D 
than white Europeans.(139, 142) South Asians are also at a greater risk of developing 
subsequent cardiovascular disease.(307) Differences in skeletal muscle function have 
previously been explored in attempts to explain these differences;(161, 308) although 
results are inconclusive.(309) 
In the group of older adults enrolled in this study, we found that oxidative capacity was 
impaired in South Asians but similar in African Caribbean’s compared to Europeans. We 
found this effect to be independent of the effects of T2D on oxidative capacity, described in 
Chapter 4 and by others.(161, 166) This suggests an intrinsic impairment in oxidative 
capacity in South Asians which does not explain differences in prevalence of T2D in this 
group. This is further supported by the fining in this study that oxidative capacity was 
unable to attenuate the higher prevalence of T2D seen in African Caribbean’s; skeletal 
muscle oxidative capacity was similar between African Caribbean’s and Europeans and 
resting muscle oxygen consumption was highest in African Caribbean’s despite a trend 
towards higher prevalence of T2D in African Caribbean’s. Further work is needed to 
determine if ethnic differences in oxidative capacity could perhaps explain the ethnic 
differences in cardiovascular response to T2D; such as poorer cardiovascular outcomes 
for South Asians.(149)   
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We found that in our older adult tri-ethnic cohort, exercise capacity was impaired in South 
Asians compared to Europeans and similar between African Caribbean’s and Europeans. 
This effect was independent of the increased prevalence of T2D in both ethnic groups. 
Differences in skeletal muscle oxidative capacity did not explain the reduction in exercise 
capacity. 
While NIRS does not provide mechanistic detail at the level of enzymatic activities or 
mitochondrial number; it is interesting to describe ethnic differences in oxidative capacity 
captured in vivo in an older adult cohort. The SABRE study cohort provides an ideal 
opportunity to continue investigation into these differences. Participants have undertaken 
multiple clinic visits over a period of ~30 years and detailed cardiometabolic phenotyping 
has been carried out at the most recent 2 visits. 
7.4 Exercise training and skeletal muscle metabolic function 
Does exercise training improve skeletal muscle metabolic function? 
Chapter 6 of this thesis demonstrates the effect of endurance training on skeletal muscle 
function and cardio-respiratory fitness. In the study sample recruited here, very small gains 
in peak measured V̇O2 were detected while post-exercise muscle V̇O2 improved and there 
was no difference in the time constant at the post-training visit. 
The lack of overall improvement in cardio-respiratory peak V̇O2 was surprising and 
contrary to hypothesis 2 that postulated training would impart positive effects on cardio-
respiratory function. Completing the marathon in the average finishing time for this study 
sample suggests an average pace of nearly 11 minutes/mile, at the slowest completion 
time of 6 hours; pace would be nearly 14 minutes/mile. According to the British Heart 
Foundation website, suggested speeds for walking are; fast: 12 minutes/mile, moderate: 
15 minutes/mile and average: 20 minutes/mile ( https://www.bhf.org.uk/get-
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involved/events/training-zone/walking-training-zone/walking-faqs). Therefore, in the 
majority of participants, marathon performance (running time) reflected a running speed 
not much faster than walking.  It is therefore likely that participants enrolled here, 
predominantly undertook low-intensity training.  
It is encouraging that in this study, despite the low-intensity training and lack of 
improvement in peakV̇O2, skeletal muscle metabolic function improved. Other studies have 
also demonstrated skeletal muscle metabolic adaptations independent of cardio-
respiratory function in response to endurance training.(289, 310) Laye et al,(289) 
examined metabolic health cross-sectionally in runners and non-runners who were age, 
gender and BMI matched. They found higher oxidative enzyme content in the runners 
versus the non-runners; in a sub-group of participants they also matched cardio-
respiratory fitness (V̇O2max) and found similar differences in oxidative enzymes between 
runners and non-runners.(289) Helge et al,(310) observed no difference in V̇O2max 
following a period of 32-day of low-intensity cross-country skiing but an improvement in 
blood-lipid profile and a tendency towards improved fat oxidative capacity in the arm 
muscles suggesting metabolic adaptations occurred without improved cardio-respiratory 
fitness. 
These findings may have important implications for design of exercise therapy for people 
who are unable, or unwilling, to undertake moderate-high intensity exercise training. It 
would be interesting to design studies to determine the influence skeletal muscle metabolic 
(dys)function on subsequent risk of morbidity and mortality, in a similar way to other 
studies that report the longitudinal implications of cardio-respiratory fitness.(268, 274) It 
would also be interesting to determine if even lower intensity training has the same 
skeletal muscle benefits. If mitochondrial dysfunction can be targeted via low-intensity 
exercise, this could be a valuable finding for older adults who are likely to find low-intensity 
exercise, such as walking more acceptable.  
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Understanding the benefits of exercise in older adults is important as it is possible that the 
effects on skeletal muscle seen here in the young marathon runners may not translate to 
the older adult group because of differences in plasticity of metabolic function. Still, limited 
evidence from other studies suggests that the capacity to benefit from exercise may be 
maintained into older age.(103)  
It was not feasible to collect detailed information regarding the type of training program 
used by the marathon runners recruited here, therefore, the influence of exercise type (e.g. 
resistance versus endurance exercises) could not be assessed here. The health benefits 
of low-intensity resistance training, such as yoga, in the presence of T2D have previously 
been reported.(311) The type and duration of training appears to impact the effectivity of 
other training programs on muscle metabolic function. For example, a four week 
endurance training program did not improve oxidative capacity in older adults with heart 
failure (208), however, an 11 week resistance training program, in a similar group, had 
beneficial effects on the estimated ATP production rate (312).  
7.5 Metabolic function and exercise capacity 
Are skeletal muscle metabolic function and cardio-respiratory fitness independently 
associated with exercise capacity? 
One of the initial hypotheses was that impaired skeletal muscle oxidative capacity (a 
longer time constant) would be associated with poorer exercise capacity at equivalent 
cardio-respiratory effort. In the older adults shorter time constants were not associated 
with an increased number of steps completed during the 6MST; this was the case for all 
participants and when analysis were stratified by presence/absence of diabetes. The 
difference in the number of steps achieved between people with/without diabetes was also 
not attenuated by including the time constant in the model. This suggests that while 
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oxidative capacity differs in people with diabetes, it does not explain their lower capacity to 
exercise.   
In participants undergoing training there was no convincing association between shorter 
marathon completion times and shorter time constants.  Previously a two-fold faster time 
constant has been reported in endurance-trained athlete compared to non-training 
matched subjects.(99) This discrepancy is likely due to the inclusion of highly trained 
individuals (mean peakV̇O2 =73.5±9.1) in the study by Brizendine et al and the low-
intensity of the training undertaken by the participants enrolled here.  
7.6 Future directions 
Various diseases, other than diabetes, have been linked to skeletal muscle metabolic 
dysfunction.(303) Applying NIRS measurements in the older adult population-based cohort 
study described in Chapter 2 (the SABRE study) provides an opportunity to investigate the 
relationships between other disease processes or system functionality and skeletal muscle 
function. For example, participants enrolled in the SABRE study are well characterized in 
terms of cardiac and large blood vessel function; a further investigation into the 
relationship between capacity for perfusion of skeletal muscle and the metabolic function 
of the tissue would be interesting. Appling the methods of Bauer et al. (271) to derive an 
estimate of skeletal muscle blood flow by applying changes in deoxy-Hb and cardio-
pulmonary V̇O2 changes to the Fick equation at onset of exercise would also be of interest 
in the context of measurements of cardiac function in older adults.  
It would be interesting to further investigate the ethnic differences in oxygen consumption 
and oxidative capacity at future time points to determine changes in oxidative capacity and 
changes in cardiovascular function with time. To further the comparison between the 3 
ethnic groups described here, it may be useful to boost the number of African-Caribbean’s 
included in the study with a push to recruit more participants. An exercise training 
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intervention carried out in an ethnically diverse cohort could also further understanding into 
the relationship between exercise capacity and muscle function. If this were carried out in 
older adult participants, insight into the flexibility of oxidative capacity with age could be 
gained. 
In older adults from an ethnically diverse population sample, with, or without diabetes, 
NIRS provides an acceptable, non-invasive technique to assess overall skeletal muscle 
oxidative capacity. Despite having only limited ability to describe detailed physiological 
mechanisms, such as enzymatic activities or mitochondrial number, NIRS application to 
skeletal muscle provides a complementary assessment of overall physiological 
functionality.  
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